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ABSTRACT 
 
It has been suggested that periodontal disease, a disease that affects the supporting 
tissues of the teeth, represents a risk factor for adverse pregnancy outcomes. Certain 
oral pathogens possess a demonstrated ability to translocate and invade the amniotic 
tissues. Once in the amniotic environment, these opportunistic colonisers could then 
initiate or contribute to a perinatal infection, and in this way be involved in the 
complications. The overall aim of this study was to determine the presence, and 
confirm the origin, of suspected maternal oral microbiota in neonatal gastric 
aspirates (swallowed amniotic fluid) collected due to complications during 
pregnancy and/or evidence of neonatal sepsis. 
 
Non-cultural PCR-based methods directed to the ribosomal encoding genes (rDNA) 
were applied to analyse neonatal and maternal samples. The use of universal and 
species-specific primers that target the bacterial 16S rRNA gene allowed 
identification and quantification of broad-range and specific bacteria to the species 
level. Sequence comparative analysis of a more variable fragment, the intergenic 
spacer region located between the 16S and the 23S rDNA, was finally used to 
compare strains obtained from the neonates and their counterparts in the respective 
mother’s oral and vaginal samples.  
 
Data analysis allowed identification of a range of potential confounding factors for 
presence of bacteria in the infants, such as vaginal delivery and prolonged rupture of 
membranes. However, bacteria with a possible oral origin were mostly identified in 
the neonatal samples in low prevalence and not associated with any particular 
variable. Quantitative analysis of potential periodontal pathogens demonstrated the 
presence of Porphyromonas gingivalis (1%) and Fusobacterium nucleatum (16%) in 
the neonates. F. nucleatum was detected at relatively high levels (mean=4.41E+02 
cells/ml); representing up to 50% of the total bacterial load, which strongly supports 
its possible role in pregnancy complications. Also, F. nucleatum subspecies analysis 
and comparisons at the strain level suggest the oral cavity as the most likely origin of 
this infectious agent. This study supports the need for further studies.  
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1.1 OVERVIEW 
 
The oral cavity harbours one of the most complex microbial communities in the 
human body. Few of these microorganisms present the essential virulence factors 
that provide them with the ability to cause disease within and beyond the limits of the 
oral cavity. Periodontal disease (PD) is an inflammatory-based disease of the 
supporting structures of the teeth, usually as a result of bacterial infection. It refers to 
a broad group of pathological alterations of the periodontal tissues in which the 
periodontal vasculature proliferates and dilates, providing a greater surface area that 
facilitates the entry of microorganisms into the systemic circulation. Based upon 
these principles, PD (mainly periodontitis) has been previously associated with 
pregnancy complications in a number of case-control and cohort studies. However, 
the results from these studies are mixed and therefore controversial. The biological 
mechanisms of these associations can be explained by translocation of bacteria 
and/or their products and by the action of maternally produced inflammatory 
mediators. Nevertheless, to date, none of these theories have provided a clear 
evidence linking oral infection and adverse pregnancy outcomes (APO). 
 
Pregnancy complications may originate due to multiple causes and infection is one of 
the most important causes. Presence of bacteria in the amniotic cavity may lead to a 
diverse range of clinical manifestations such as preterm birth (PTB), spontaneous 
rupture of membranes, clinical chorioamnionitis, and other adverse perinatal 
outcomes. Likewise, a significant percentage of newborns develop infection during 
the first hours of life, representing a major cause of both neonatal death and 
subsequent disease. Even though the main source of intrauterine infection may 
originate from the maternal genito-urinary tract, many cases remain unexplained. 
Therefore, the oral infection theory may provide an alternative explanation. 
 
Animal studies and clinical findings have provided substantial evidence to support a 
possible oral-uterus translocation. It has been demonstrated that oral bacteria are able 
to translocate through the bloodstream, cross the placental membranes, and 
specifically invade the amniotic tissues resulting in an APO. Also, a number of 
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bacterial species with a possible oral origin have been found in the amniotic cavity 
associated with cases of PTB, chorioamnionitis, preterm labour (PTL), stillbirth, 
neonatal death and previous complications. Nevertheless, none of these studies has 
evaluated the precise origin of the pathogens. Microbiological similarities between 
the oral cavity and the female genital tract may be misleading the current evidence as 
to the origin of the infection. 
 
This PhD project focussed on the hypothesis of direct bacterial translocation to the 
intrauterine cavity. The overall aim of this study was to investigate, using molecular-
based techniques, the possibility that bacteria present in the amniotic environment 
may have originated from the maternal oral cavity in cases of APO. The use of 
neonatal gastric aspirates (NGA) was introduced in this study. These clinical samples 
are relatively easily available, avoid the need of invasive procedures, are routinely 
taken at hospitals from newborns that present with an adverse perinatal outcome, and 
have been demonstrated as an alternative to AF to investigate perinatal infection. 
Finally, this work is also supported by the use of novel and precise methods to 
compare bacterial species from two possible donor sites (maternal oral cavity and 
vagina) and the recipient site (NGA) at the subspecies, and strain levels. 
 
 
1.2 THE ORAL MICROBIOTA AND PERIODONTAL DISEASE 
 
1.2.1 The oral microbiota in health and disease. 
 
The oral cavity harbours one of the most complex microbial communities of the 
human body. This complexity is due to the large number of diverse surfaces, such as 
soft shedding tissues (buccal and vestibular mucosa, hard and soft palate, tongue, and 
floor of the mouth) and hard non-shedding surfaces (teeth) that allow a wide variety 
of complex biofilms to develop (Spratt and Pratten, 2003). Even biofilms associated 
with teeth are sub-divided, depending on their location; these include supragingival 
plaque (above the gingival margin often giving rise to caries), gingival margin 
plaque, subgingival plaque (below the gingival margin and associated with PD), and 
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approximal plaque (between teeth). The dorsum of the tongue, due to unique 
structural features, also allows a significant and characteristic microbiota to reside. 
Each surface provides a unique habitat for microbial colonization with variable 
gradients of nutrients, oxygen, redox potential, and pH. Moreover, the oral tissues are 
bathed in saliva, which provides physical cleansing by virtue of fluid flow and 
dilution effects, as well as host immune and non-immune defence factors that 
together have profound consequences for the microbial ecology of the oral cavity 
(Lamont et al., 2006).  
 
Also, different intraoral surfaces and bacterial species have different receptors and 
adhesion molecules that dictate the composition of biofilms on different oral surfaces 
(Mager et al., 2003), e.g. Actinomyces species colonize hard tissues at far higher 
proportions than soft tissues, while Prevotella melaninogenica, Veillonella parvula 
and Streptococcus mitis are found in higher proportions on soft tissue surfaces. 
Numbers of colonizers may also vary; in supragingival plaque the numbers of 
bacteria can exceed 109/mg on a single tooth surface, while counts in subgingival 
sites range from about 103 in healthy shallow sulci to more than 108 in deep 
periodontal pockets. Although the ecologic relationship between the microbiota and 
its host are usually benign, occasionally a subset of bacterial species either is 
introduced, overgrows or exhibits new properties that may lead to disease and the 
destruction of the oral tissues (Lindhe et al., 2008). 
 
With the advent of culture-independent molecular methods to characterize microbial 
communities, it has been estimated that more than 600 different species are capable 
of colonizing the mouth, and any individual may typically harbour 150 or more 
different species (Aas et al., 2005). With the understanding that essentially all the 
human oral surfaces are covered by complex microbial biofilms, infection is now 
recognized to be caused by a group of organisms rather than a single pathogen 
(Dewhirst et al., 2010). Several bacteria have been associated with a healthy oral 
cavity (Aas et al., 2005), while other bacteria have been implicated in oral diseases, 
such as caries (Chhour et al., 2005), periodontitis (Paster et al., 2001, Tanner et al., 
2006), and root canal infections (Munson et al., 2002, Sassone et al., 2008). 
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There is no bacterial species found exclusively in health or disease and the recent 
evidence, based on the latest methods, is changing previous beliefs that PD is 
initiated due to colonization by an stablished group of gram-negative anaerobes in 
the subgingival biofilm e.g., in a study looking for bacterial communities associated 
with periodontal status changes, increases in levels of Veillonella spp., a gram-
negative bacterium and the most common member of the subgingival bacterial 
community, were associated with periodontal health, while Filifactor alocis, a gram-
positive anaerobe, was found at higher levels in subjects with disease (Kumar et al., 
2006, Parahitiyawa et al., 2010). 
 
In addition, certain oral species have been implicated in several systemic diseases 
such as infective endocarditis, central nervous system infections, pneumonia, 
osteomyelitis, septicaemia, cardiovascular disease, and preterm and low birthweight 
(PT/LBW). Through a number of mechanisms, it is likely that bacteria from the oral 
cavity may gain access into the bloodstream and, in this way, reach distant body 
sites. Oral species associated with systemic infections include gram-positive and 
gram-negative bacteria (Table 1.1). 
 
Table 1.1 Bacteria previously associated with systemic infections.* 
 
GRAM-POSITIVE GRAM-NEGATIVE 
Streptococcus constellatus Aggregatibacter actinomycetemcomitans 
Streptococcus intermedius Agreggatibacter aphrophilus 
Streptococcus oralis Caphnocytophaga gingivalis 
Abiotrophia defectiva Dialister pneumosintes 
Actinomyces odontolyticus Fusobacterium nucleatum 
Solobacterium moorei Haemophilus aphrophilus 
Haemophilus paraphrophilus 
Kingella kingae 
Leptotrichia buccalis 
Leptotrichia trevisanii 
Neisseria meningiditis 
Porphyromonas gingivalis 
  Selenomonas spp.  
            Source: Parahitiyawa et al.  (2009). *The list is not exhaustive. 
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1.2.2 Periodontal disease. 
 
Periodontal disease refers to a broad group of pathological alterations of the 
periodontal tissues (the soft and hard tissues that support the teeth) and represents 
one of the most widespread infections of humans. The common forms of the disease 
are known as gingivitis and periodontitis. Gingival disease is manifested as a 
reversible inflammation of the marginal periodontal tissues and is most frequently 
associated with dental plaque (plaque-induced gingivitis). The severity and duration 
of gingivitis can be modified by factors that modulate bacterium-host interactions, 
including systemic factors (e.g. endocrine changes associated with puberty, 
pregnancy, and diabetes), medications, and malnutrition.  
 
Periodontitis is an inflammatory-based disease of the supporting structures of the 
teeth characterized by progressive destruction of the periodontal ligament and 
alveolar bone that may result in tooth loss (Lamont et al., 2006). The primary clinical 
features of periodontitis include clinical attachment loss, alveolar bone loss, 
periodontal pocketing and gingival inflammation (Figure 1.1). In addition, 
enlargement or recession of the gingivae, bleeding of the gingivae following 
application of pressure and increased mobility, drifting and/or tooth exfoliation may 
occur. The histopathological characteristics of periodontitis include periodontal 
pocketing, location of junctional epithelium apical to the cemento-enamel junction, 
loss of collagen fibers subjacent to the pocket epithelium, alveolar bone loss, 
numerous polymorphonuclear leukocytes in the junctional and pocket epithelium and 
a dense inflammatory cell infiltrate with plasma cells, lymphocytes and 
macrophages. 
 
The aetiology of PD implicates a bacterial infection as the primary cause of the 
disease. Several bacterial species residing in a biofilm on the tooth surface have been 
closely associated with periodontitis. It appears that various complexes of putative 
periodontal pathogens can initiate and perpetuate the disease in a susceptible host 
(Flemmig, 1999). Commonly species associated with chronic periodontitis are listed 
in Table 1.2. A. actinomycetemcomitans seems to be the prime candidate in the 
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aetiology of aggressive periodontitis. Therapy for infections like PD may consist of a 
combination of mechanical wound debridement and localize application of an 
antimicrobial agent (Christersson et al., 1991). 
 
 
Figure 1.1 Diagrammatic representation of the periodontium in health and disease. Source: 
American Academy of Periodontology (http://www.perio.org/consumer/graphics/toothdiagram.gif)  
 
 
Table 1.2 List of species commonly associated with chronic periodontitis.* 
 
GRAM-POSITIVE GRAM-NEGATIVE 
Streptococcus intermedius Porphyromonas gingivalis 
Parvimonas micra (formerly Prevotella intermedia 
Peptostreptococcus micros) Tannerella forsythia 
Eubacterium spp. Fusobacterium nucleatum 
Capnocytophaga spp. 
Eikenella corrodens 
Prevotella nigrescens 
Treponema denticola and 
other spirochetes 
   *The list is not exhaustive 
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1.2.3 The main microbial etiological agents of periodontal disease. 
 
The World Workshop in Periodontology (1996) designated A. 
actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythia as 
periodontal pathogens strongly associated with PD, disease progression, and 
unsuccessful therapy according to the criteria for defining pathogens of destructive 
PD, initially based on Koch’s postulates but amended and extended in later years. 
These criteria include association, elimination, host response, virulence factors, 
animal studies, and risk assessment (Lindhe et al., 2008). 
 
1.2.3.1 Aggregatibacter actinomycetemcomitans. 
 
Aggregatibacter actinomycetemcomitans (formerly Actinobacillus 
actinomycetemcomitans) is a small, non-motile, gram-negative, saccharolytic, 
capnophilic, rounded rod that forms small, convex colonies with a “star-shaped” 
centre when grown on blood agar (BA) plates (Figure 1.2). The most convincing 
correlation between the presence of A. actinomycetemcomitans and PD is found in 
young patients diagnosed with an aggressive form of the disease (localized 
aggressive periodontitis). Aggressive forms of PD are rapidly progressive and 
characteristically present with significant periodontal attachment loss at an early age, 
with a tendency for familiar clustering of cases (Henderson et al., 2010).The majority 
of subjects with aggressive periodontitis present an elevated serum antibody response 
to this species. Its elimination or suppression results in successful therapy, while 
recurrent lesions harboured the species (Listgarten et al., 1981, Haffajee et al., 1984). 
Potentially damaging metabolites include leukotoxin and a cytolethal distending 
toxin (Saiki et al., 2001). It also induces disease in experimental animals and has 
been found to invade epithelial and vascular endothelial cells in vitro (Schenkein et 
al., 2000), and buccal epithelial cells in vivo (Rudney et al., 2001). The species has 
also been shown to induce apoptotic cell death (Kato et al., 2000).  
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Figure 1.2 (A) Star-like morphologies of multiple colonies.  (B) A single colony of A. 
actinomycetemcomitans demonstrating a ‘crinkled-rough’ surface as well as the characteristic star 
shape  (photograph kindly provided by Dr Derren Ready, Eastman Dental Institute, UCL) 
 
 
Aggregatibacter actinomycetemcomitans has been implicated in chronic forms of 
destructive PD, but its role is less clear. It has been isolated from chronic 
periodontitis lesions, but less frequently and in lower numbers than from lesions in 
aggressive periodontitis subjects (Rodenburg et al., 1990). Antibody data from 
treatment of A. actinomycetemcomitans infected patients with chronic or refractory 
periodontitis provided evidence of a possible etiologic role in chronic forms of PD, 
with decrease in probing pocket depth and gain in attachment levels (van Winkelhoff 
et al., 1992). There appears to be at least six serotypes of A. actinomycetemcomitans 
(a, b, c, d, e, and f), and its predominance varies from different populations and 
forms of disease. 
 
It is suspected that A. actinomycetemcomitans initially colonizes the oral cavity by 
attachment to the surfaces of the oral epithelium through a specific protein adhesion, 
Aae (Fine et al., 2006), and then moves to the subgingival environment where it may 
attach to and invade the epithelial lining of the periodontal pocket and penetrate the 
underlying connective tissues (Rudney et al., 2001). Finally, A. 
actinomycetemcomitans has been cultured from atheromatous plaques and has been 
determined as causing or contributing to cause endocarditis (Paturel et al., 2004, 
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Kozarov et al., 2005). This pathogen is one of the most frequent oral species detected 
in cardiovascular disease specimens (Nakano et al., 2009, Wang et al., 2010). 
 
1.2.3.2 Porphyromonas gingivalis. 
 
Porphyromonas gingivalis is a gram-negative, anaerobic, non-motile, assaccharolytic 
rod that usually exhibits coccal to short-rod morphologies. P. gingivalis is a member 
of the “black-pigmented bacteria” characterised for their ability to form brown to 
black colonies on BA plates (Figure 1.3). P. gingivalis is considered the major 
etiological agent in the initiation and progression of chronic PD. This species is 
uncommon and present in low numbers in health or gingivitis but more frequently 
detected in destructive forms of disease (Haffajee and Socransky, 1994). In diseased 
subjects, there is a strong positive relationship with pocket depth and in sites 
exhibiting PD progression (Albandar et al., 1997, Kawada et al., 2004). P. gingivalis 
has been shown to be reduced in successfully treated sites but was commonly 
encountered in sites that exhibited recurrence of disease or persistence of deep 
periodontal pockets post-therapy (Kawada et al., 2004). It has been shown to induce 
elevated systemic and local immune responses in subjects with various forms of 
periodontitis (O'Brien-Simpson et al., 2000). P. gingivalis induces a chronic 
inflammatory response that, locally, results in inflammatory bone destruction which 
is manifested as PD, and systemically represents a contributory factor for several 
systemic diseases including diabetes, PTB, stroke, atherosclerosis and cardiovascular 
diseases (Hayashi et al., 2010).  
 
A variety of virulence factors have been attributed to P. gingivalis, including those 
associated with its cell surface, bioactive metabolic products, and proteolytic 
enzymes. The bacterial cell surface serves as a dynamic interface between the 
bacterium and the external environment, and facilitates growth, nutrient acquisition, 
colonization, biofilm formation and evasion of host defence (Yoshimura et al., 2009). 
P. gingivalis has been shown to be able to invade human gingival epithelial cells in 
vitro, buccal epithelial cells in vivo, and endothelial cells (Rudney et al., 2001, 
Takahashi et al., 2006). Attachment to and invasion of epithelial cells appears to be 
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mediated by adhesins known as fimbriae (Weinberg et al., 1997). The most potent 
virulence factors of P. gingivalis are the gingipains, which consist of three cysteine 
proteases that bind to and cleave a wide range of host proteins. Gingipains participate 
in sequential phases of disease progress including adherence and colonization, 
nutrient acquisition, neutralization of host defence, manipulation of the inflammatory 
response, tissue destruction, invasion and dissemination to systemic sites (Guo et al., 
2010). It has been shown that gingipains have inhibitory effects on host cell 
recognition by inactivation of Toll-like receptors that allow P. gingivalis to escape 
from the immune system (Kishimoto et al., 2006). Another important strategy used 
by this pathogen to evade the host immune response is based upon its ability to 
invade host cells, such as monocytes/macrophages or dendritic cells in inflamed oral 
mucosal lesions, to move from the initial colonization site, cross tissue barriers and 
disseminate in the circulation (blood or lymphatics) to other sites (Hayashi et al., 
2010).  
 
 
 
Figure 1.3 Black-pigmented colonies of P. gingivalis growing on agar supplemented with 
blood (photograph kindly provided by Dr Derren Ready, Eastman Dental Institute, UCL) 
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1.2.3.3 Tannerella forsythia. 
 
Tannerella forsythia (formerly T. forsythensis and Bacteroides forsythus) is a gram-
negative, anaerobic, spindle-shaped, highly pleomorphic rod. This pathogen has been 
classified into the group of red-complex bacteria together with P. gingivalis and 
Treponema denticola, which are also strongly implicated in the onset of periodontitis 
(Mineoka et al., 2008). T. forsythia is difficult to grow, often requiring 7-14 days for 
minute colonies to develop. The growth of the microorganism was shown to be 
enhanced by co-cultivation with F. nucleatum. The need for co-cultivation could be 
overcome by providing N-acetylmuramic acid (NAM) in the medium (Wyss, 1989). 
Inclusion of this factor markedly enhanced growth and the resulting cells were 
regularly shaped, short, gram-negative rods rather than the pleomorphic cells (Figure 
1.4). 
 
 
 
Figure 1.4 Small white colonies of T. forsythia growing on agar supplemented with blood and 
NAM (photograph kindly provided by Dr Derren Ready, Eastman Dental Institute, UCL) 
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Initially, this species was thought to be a relatively uncommon subgingival species. 
However, it has been demonstrated that the levels of T. forsythia are much higher in 
subgingival than supragingival plaque samples (Lai et al., 1987). This species was 
suggested to be the major species found at sites that converted from periodontal 
health to disease (Tanner et al., 1998). It was found in much higher counts, 
proportions, and prevalence in subjects with destructive PD, i.e. actively progressing 
periodontitis, and with greater risks for alveolar bone loss, attachment loss and tooth 
loss than in periodontally healthy subjects (Lai et al., 1987). T. forsythia has been 
shown to be decreased as regards frequency of detection and counts after successful 
periodontal therapy, including scaling and root planing, periodontal surgery, or 
systemically administered antibiotics (Haffajee et al., 2006). It was found at higher 
level at sites which showed breakdown after periodontal therapy than sites which 
remained stable or gained attachment (Shiloah et al., 1998). T. forsythia is also the 
most common species detected on or in epithelial cells recovered from periodontal 
pockets and is infrequently detected in epithelial cell samples from healthy subjects 
(Dibart et al., 1998).  
 
In spite of overwhelming evidence implicating T. forsythia in PD pathogenesis, the 
virulence mechanisms of this bacterium remain unclear. This is partly due to the 
fastidious growth requirements for cultivation as well as the difficulty to perform 
genetic manipulations of this microorganism (Sharma, 2010). Animal studies have 
demonstrated the virulence potential of T. forsythia. It has been shown that 
pathogenic potential of T. forsythia is enhanced in the presence of other bacteria, 
such as F. nucleatum and P. gingivalis, e.g. synergistically enhancing abscess 
formation in rabbits and mice (Sharma, 2010). Despite its ability to interact in 
biofilms with pathogens that have been shown to contribute to systemic diseases, no 
previous studies have associated T. forsythia to non-oral infections. 
 
1.2.3.4 Fusobacterium nucleatum. 
 
Fusobacterium nucleatum is a gram-negative, non-spore forming, non-motile, 
spindle-shaped rod (Figure 1.5). The bacterium is anaerobic but grows in the 
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presence of up to 6% oxygen.  This species is one of the most commonly occurring 
species in human gingival crevice (Moore and Moore, 1994). It increases in 
proportion as plaque forms and is highly prevalent in gingivitis in children and young 
adults. F. nucleatum is prevalent in subjects with periodontitis and periodontal 
abscesses and is reduced after successful periodontal treatment. 
 
 
 
Figure 1.5 Transmission electron microscopy picture of Fusobacterium nucleatum showing 
spindle rod shape. Source: http://www.icb.usp.br/mariojac/  
 
 
The pathogenic potential of F. nucleatum is based on its ability act as a bridge 
between early and late colonizers on the tooth surface and to form aggregates with 
other suspected pathogens in PD, increasing their pathogenicity in mixed infections 
(Jenkinson and Lamont, 2005). Its ability to obtain energy from fermentation of 
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simple carbohydrates or certain amino acids, as well as its aminopeptidase activity to 
metabolise small peptides when lacking fermentable carbohydrates, helps to explain 
its presence in both supra- and subgingival plaque and why it is often found together 
with organisms such as P. gingivalis which display powerful endopeptidase activities 
(Rogers, 1998). F. nucleatum is also capable of inhibiting the proliferation of human 
gingival fibroblasts, and may have the ability to penetrate the gingival epithelium 
(Bolstad et al., 1996). 
 
The heterogeneity of F. nucleatum on the basis of physiological, biochemical and 
molecular variability demonstrate that distinct subgroups exist within the species 
(Dzink et al., 1990, Gharbia and Shah, 1992). Five subspecies of F. nucleatum have 
been proposed as F. nucleatum subsp. polymorphum, F. nucleatum subsp. nucleatum, 
F. nucleatum subsp. vincentii, F. nucleatum subsp. animalis and F. nucleatum subsp. 
fusiforme. It was also suggested that some subgroups may be associated with disease 
and others may be associated with health (Gharbia et al., 1990). In the oral cavity, it 
was determined that F. nucleatum subsp. nucleatum was more prevalent in diseased 
sites, whereas isolates from healthy sites were identified as F. nucleatum subsp. 
polymorphum and subsp. fusiforme. However, other studies have not detected 
difference between isolates from periodontally healthy or diseased individuals 
(Berres et al., 2003).  
 
Of the microbial species associated with PD, F. nucleatum is the most common in 
clinical infections of other body sites. It has been isolated from several parts of the 
body and from infections including bacteraemia and liver abscesses (Crippin and 
Wang, 1992), intrauterine infections (Chaim and Mazor, 1992), bacterial vaginosis 
(BV) (Hillier et al., 1993), urinary tract infections (Ribot et al., 1981), infective 
endocarditis (Shammas et al., 1993), pericarditis (Truant et al., 1983), brain abscess  
(Kai et al., 2008), and lung infections (Bartlett, 1993). 
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1.3 SYSTEMIC TRANSLOCATION OF THE ORAL MICROBIOTA 
 
The exact mechanisms certain species use to translocate into the systemic circulation 
are still far from clear. Translocation may be due to a combination of variables, such 
as mechanical procedures or certain virulence attributes linked to vascular invasion 
(Parahitiyawa et al., 2009). 
 
1.3.1 Mechanical and triggering factors causing odontogenic 
bacteraemia. 
 
A feature that is unique to the oral cavity is the ability of dental biofilms, if left 
undisturbed, to establish themselves on non-shedding tooth surfaces. These biofilms, 
particularly the subgingival plaque, are in close proximity to a highly vascularised 
milieu, the gingival tissues. In common inflammatory conditions such as gingivitis 
and periodontitis, oral bacteria titers are dramatically increased and the periodontal 
vasculature proliferates and dilates thereby providing a greater surface area that 
facilitates the entry of microorganisms into the bloodstream. Indeed, oral microbes 
residing in saliva, dental plaque, mucous membranes and gingival crevice may 
translocate to the systemic compartment through inoculation when performing 
personal oral hygiene measures, chewing, and periodontal and endodontic procedures 
i.e. periodontal probing, scaling, root canal instrumentation, tooth extraction, 
resulting in bacteraemia  (Lamont et al., 2006, Parahitiyawa et al., 2009).  
 
Parahitiyawa et al. (2009) proposed two possible routes of bacterial entry from the 
teeth into the systemic circulation (Figure 1.6): 1. entry via the route canal or from 
periapical lesions into the alveolar vessels; 2. entry from the periodontum, where 
bacteria in the gingival crevices translocate to the capillaries in the gingival 
connective tissues, possibly through the junctional epithelium. Commensal oral 
bacteria which enter into the blood or other systemic compartments may then 
become pathogenic due to microbial virulence factors which are able to cause disease 
in a non-native environment. The new environmental stressors may influence the 
pattern of expressed genes to ensure survival in a non-oral site (Lamont et al., 2006). 
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Figure 1.6 Possible routes of bacterial entry from the teeth into the systemic circulation. E, 
enamel; D, dentin; G, gingival; L, periodontal ligament; AB, alveolar bone; RC, root canal; PA, 
periapical lesion; AW, alveolar blood vessels; GC, gingival crevice; JE, junctional epithelium; C, 
capillaries. (i) Schematic representation of the tooth in its alveolo; (ii) Schematic representation of the 
gingivae and JE; (iii) Microscopical view of a hystologic specimen of the gingival tissues stained with 
hematoxylin and eosin. Source: Parahitiyawa et al. (2009). 
 
 
1.3.2 Microbial virulence factors and systemic translocation. 
 
Innate microbial factors may play an important role as only a few species are usually 
detected and able to persist for a prolonged time during bacteraemia, despite the 
diversity of bacteria residing in the periodontal biofilm. Also, it is generally accepted 
that odontogenic bacteraemia is transient in nature with the duration of bacteraemia 
after an extraction having been calculated as approximately 11 minutes in healthy 
children (Roberts et al., 2006) before being eliminated by the innate and adaptative 
defence mechanisms. However, a few bacterial species may be able to persist and 
survive host defences. 
 
Species that are commonly found in the bloodstream have virulence attributes that 
could be linked to vascular invasion e.g. the endothelial adhesion of Streptococcus 
spp., degradation of intercellular matrices by P. gingivalis, and impedance of 
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phagocytic activity by A. actinomycetemcomitans and F. nucleatum (Parahitiyawa et 
al., 2009). The possible virulence properties linked to vascular invasion have been 
summarised previously for the most common oral species found in the bloodstream 
(Parahitiyawa et al., 2009) (Table 1.3). 
 
 
1.4 ADVERSE PREGNANCY OUTCOMES 
 
Adverse pregnancy outcomes denote those complications presented during 
pregnancy or immediately after birth that may cause the termination of the pregnancy 
and compromise the wellbeing of the fetus/neonate or the mother. Complications 
occur in 11% of pregnancies in the UK, and many of these are from unknown causes 
which represent a huge concern to both society and the healthcare system (Petrou, 
2003). 
 
1.4.1 Miscarriage and stillbirth. 
 
Miscarriage or spontaneous abortion refers to the end of the pregnancy at any stage 
between the first day of the last menstrual period and the 24th week of pregnancy. It 
is the most common complication of pregnancy with around 15% of known 
pregnancies resulting in miscarriage. The rate in women under 35 years of age is 6%, 
rising to about 25% for women over 40 due to a higher risk of chromosomal 
abnormality. Miscarriages occurring before 13 weeks of pregnancy are referred to  
as ‘early miscarriages’ and those which occur after 13 weeks are ‘late miscarriages’. 
Miscarriages may be associated to diverse causes: genetic, hormonal, structural 
(cervical incompetence, abnormal shaped uterus and uterine septum), resulting from 
blood clotting problems or from an infection. 
 
Stillbirth refers to the death of the fetus after the 24th week of pregnancy and before 
birth. The fetus may have died in the womb (intrauterine death) or during labour 
(intrapartum death). Stillbirths occur in 5.5 per 1000 of all births in England and 
Wales  (Office for National Statistics, 2005). The  rate  of  stillbirths is  higher in  
  
Table 1.3 Major bacterial species recovered from odontogenic bacteraemia and putative virulence factors thought to facilitate their entry and survival in 
blood.*  
 
Organism Factor, function, and/or characteristic Reference 
Streptococcus mutans Ability to switch peripheral blood monocytes to dendritic cells which exhibit large (Hahn et al., 2005) 
 numbers of adhesion molecules, such as ICAM-1, ICAM-2, and LFA-1,  
 contributing to adhesion to the injured endothelium and to fibrinogen in blood  
 clots  
Porphyromonas gingivalis Cysteine proteinase (gingipain); degrades extracellular matrix proteins, such as (Andrian et al., 2004) 
 laminin, fibronectin, and type IV collagen  
Abiotrophia defective Strains associated with endocarditis in humans show a higher fibronectin-binding (Senn et al., 2006) 
 ability than that of related species  
Aggregatibacter  Inhibits binding of chemotactic peptides to neutrophils (Van Dyke et al., 1982) 
actinomycetemcomitans   
and Fusobacterium 
nucleatum   
A. actinomycetemcomitans EmaA (extracellular matrix protein adhesin A); forms antenna-like protrusions (Ruiz et al., 2006) 
 associated with the surface and mediates adhesion to collagen  
Streptococcus intermedius Hyaluronidase and chondroitin sulphate depolymerase break the ground substance (Shain et al., 1996) 
 in connective tissues, facilitating spread  
Streptococcus anginosus Binds to the endothelium, the basement membrane, and collagen (Allen et al., 2002) 
Streptococcus sanguis Platelet aggregation-associated protein; enhances platelet accumulation (Hahn et al., 2005) 
Porphyromonas gingivalis Porin-like activity of the outer membrane molecules (probably (Novak and Cohen, 1991) 
 lipopolysaccharide) can depolarize neutrophils and immobilize  
 polymorphonuclear leukocyte responses  
Viridans streptococci Secreted factors could increase the production of interleukin-8, which is (Soto et al., 1998) 
 particularly important in lung pathology, such as acute respiratory distress  
  syndrome   
             Source: Parahitiyawa et al. (2009). *List is not exhaustive
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multiple  pregnancies, women  who smoke, women  over 35  years of age or  with a 
pre- existing medical condition, e.g. diabetes. Twelve percent of stillbirths are due to 
congenital malformations, 16% are caused by ante-partum haemorrhage (placenta 
previa), and 6% may be due to umbilical cord accidents or non-diagnosed ((Reddy et 
al., 2009)). Approximately 9% to 15% of stillbirths are caused by infections 
(Ahlenius et al., 1995). Infection is especially important as a cause of stillbirth 
occurring early in pregnancy (19% in less than 28 weeks) (Gibbs, 2002).  
 
Infection may  cause fetal death either indirectly due to a maternal infection leading 
to systemic illness or by direct infection of the placenta and later of the fetus 
(Goldenberg and Thompson, 2003). Recognized causes include syphilis, 
toxoplasmosis, parvovirus B-19, chorioamnionitis, and Listeria monocytogenes. 
Other organisms include Ureaplasma urealyticum, Mycoplasma hominis, Chlamydia 
trachomatis, HIV, and group B streptococci (GBS) (Gibbs, 2002). The patterns of 
infection vary between developed and developing countries and may originate due to 
a single microorganism or a variety of them. This is the case for ascending bacterial 
infections. Treatment of BV and sexually transmitted infections should prevent the 
occurrence of stillbirths or other pregnancy complications (miscarriage, PTB, 
preterm prelabour rupture of membranes [PPROM], and PTL), although the rates of 
stillbirths have not varied substantially in the last decade. In the UK, the exact cause 
of about 70% of stillbirth cases remains uncertain (Office for National Statistics, 
2005). 
 
1.4.2 Preterm birth. 
 
Preterm birth is a major clinical problem associated with perinatal mortality, serious 
neonatal morbidity and moderate to severe childhood disability in developed 
countries (McCormick, 1985, Lumley, 2003). As defined by the World Health 
Organization (WHO), PTB is when the delivery occurs before 37 completed weeks 
of gestation. Based upon lower survival rates and increased risk of medical and 
developmental problems, PTB have been classified as mild preterm (32-36 weeks), 
very preterm (28-31 weeks) and extremely preterm (<28 weeks). Around 7% of all 
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births in the UK are preterm (Office for National Statistics, 2005). Improvements in 
neonatal intensive care during the last 20 years have increased the survival of the 
most immature newborns at 23 weeks (6-9% survival), 27–28 weeks (90% survival) 
33 weeks (95% survival) (Ward and Beachy, 2003). Despite improvements in 
antenatal and neonatal care, the number of premature infants born each year has not 
significantly decreased since the 1960s.  
 
The majority of PTB occur without any obvious cause or known risk factors. Several 
aetiologies and/or risk factors have been reported for PTB including prior PTB, 
maternal age ≤17 and >35 years, low socio-economic status, maternal low body mass 
index, parity, alcohol and tobacco use, drug abuse, inadequate prenatal care, medical 
conditions, uterine and cervical anomalies, infections, multiple gestations, and stress 
(Mavalankar et al., 1992, Horta et al., 1997, Petridou et al., 2001, Moutquin, 2003a, 
Moutquin, 2003b). Nevertheless, none of these risk factors can completely explain 
all PTB, thus suggesting a multifactorial origin. PTB usually occurs subsequently to 
a number of diverse clinical presentations, including spontaneous PTL, PTL 
complicated by additional factors (e.g. antepartum haemorrhage), PPROM, or an 
elective preterm delivery indicated on maternal or fetal grounds, e.g. due to pre-
eclampsia (Lumley, 2003). 
 
1.4.3 Preterm labour. 
 
Labour is characterized by coordinated uterine contractions leading to cervical 
dilatation and finally the expulsion of the fetus (Williams et al., 2000). Spontaneous 
PTL precedes spontaneous PTB. Localized chronic inflammation as well as acute 
infections in an early stage of the pregnancy can cause production of 
autocrine/paracrine hormones and cytokines that then activate the myometrium 
causing PTL (Bryant-Greenwood and Millar, 2000). 
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1.4.4 Preterm prelabour rupture of membranes. 
 
Release of hormones and cytokines can also act via an alternative pathway increasing 
matrix degradation of the fetal membranes and cervix leading to myometrial 
activation (labour) and the rupture of fetal membranes (Bryant-Greenwood and 
Millar, 2000). Rupture of the membranes before the onset of labour and at less than 
37 weeks of gestation is defined as PPROM. Infection is usually regarded as the 
main cause of PPROM, although in some cases it is preceded by spontaneous PTL (a 
condition named preterm rupture of membranes [PROM]). Preterm rupture of 
membranes accounts for 25% of all PTB (7.1%–51.2%) (Moutquin, 2003a). 
 
1.4.5 Prolonged rupture of membranes. 
 
Prolonged rupture of membranes (pROM) is an event that occurs when the amniotic 
membranes, containing the fetus and the AF, ruptures prior to the start of labour and 
the amniotic cavity has been exposed to the external environment for more than 24 
hours (Linder et al., 1995, Mandel et al., 2005). This term should be differentiated 
from PPROM. As described, PPROM occurs when rupture of membranes occurs 
before 37 weeks of gestation, resulting in the birth of a preterm infant. On the other 
hand, pROM is related to the time of exposure rather than the gestational age. The 
causes of pROM have not been clearly identified. Some risk factors include smoking, 
multiple pregnancies, polyhydramnios (excess AF), amniocentesis or cervical 
cerclage. Complications that may follow this condition include PTL and delivery, 
chorioamnionitis, endometritis, neonatal sepsis, and compression of the umbilical 
cord. When pROM occurs at term, labour usually follows or is induced to avoid 
complications as there is an increased risk of infection. However, earlier in the 
pregnancy, delay of labour is preferred to avoid higher risks of complications in a 
preterm neonate. Treatment and prognosis may vary and depend on the maturity of 
the fetus and the development of infection.  
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1.4.6 Low birthweight and small for gestational age. 
 
Low birthweight (LBW) is defined by the WHO as weight at birth of less than 2.5 
kg. Eight percent of births in the UK are LBW (WHO, 2004). Low birthweight is 
closely associated with fetal and neonatal mortality and morbidity, inhibited growth 
and cognitive development, and chronic diseases later in life (Doyle and Anderson, 
2010). It is either the result of a short gestational period (preterm) or due to 
intrauterine growth restriction (IUGR). Low birthweight with a gestational age 
greater or equal to 37 weeks is defined as small for gestational age (SGA) (Williams 
et al., 2000). Birthweight is affected to a great extent by the maternal nutrition before 
and during pregnancy. Specific and non-specific infections also contribute to poor 
fetal growth (WHO, 2004). 
 
1.4.7 Neonatal infection. 
 
Neonatal infection is the colonisation of the neonate by an infectious agent. This is 
generally classified as early-onset and late-onset infection based on the initiation of 
bacterial colonisation (before or after delivery). Usually, the initial site of the 
infection is not always known since haematogenous dissemination to important 
organs occurs before diagnosis. Moreover, the clinical manifestations, whatever the 
source of infection, are frequently non-specific (tachycardia, tachypnea, abnormal 
temperature, leukocytosis) (Wynn et al., 2010). The multiplicity of associated risk 
factors and clinical manifestations makes it difficult to diagnose the infection. 
Despite advances in perinatal care, the prevalence of neonatal sepsis has not changed 
significantly over time. This represents a primary concern since, as indicated by the 
WHO data, 0.3% of pregnancies in England, Wales and Northern Ireland result in 
early neonatal death and 71.3% of these are classified as unexplained fetal death 
(WHO, 2008). The poor understanding of the events triggering these complications 
makes it difficult to prevent. 
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1.4.7.1 Early-onset neonatal infection. 
 
Early-onset neonatal infection occurs during the first hours of life. It is also known as 
congenital or fetal infection. The colonisation initiates before birth, with bacteria 
originating either from the maternal genital tract or via the placenta, followed by 
infection of the membranes, AF, and the fetus (Martius et al., 1999). The mortality 
rate of neonates with congenital neonatal sepsis ranges from 25 to 90% and depends 
on the gestational age  and the likelihood of survival (Romero et al., 2006). 
 
1.4.7.2 Late-onset neonatal infection. 
 
This occurs after the first 48 hours of life from microorganisms that may have been 
acquired from the mother and/or the immediate environment, e.g. hospital, 
breast/bottle feeding, mechanical ventilation. Organisms initially colonize superficial 
sites and the upper respiratory tract and infection may progress to cause widespread 
sepsis.  
 
 
1.5 MICROBIAL INVASION OF THE AMNIOTIC CAVITY 
 
The amniotic environment is normally sterile as less than 1% of women not in labour 
at term will present with bacteria in the AF. Detection of bacteria in the amniotic 
cavity is considered a pathological finding defined as microbial invasion of the 
amniotic cavity (MIAC) (Romero et al., 2006). Intra-amniotic infection is an 
important and frequent mechanism of obstetric complications. Women with MIAC 
are more likely to deliver preterm, have spontaneous rupture of membranes, develop 
clinical chorioamnionitis, and present with an adverse perinatal outcome (Romero et 
al., 2002). It has been associated with  25-40% of PTB (Goldenberg et al., 2000), 
which accounts for 75% of perinatal mortality and more than half of long-term 
morbidity cases (McCormick, 1985). Its prevalence varies according to the clinical 
manifestation and stage of the complication. The frequency of MIAC has been 
determined as 10-20% in women with PTL and intact membranes (Hill, 1998), 38% 
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in women with PTL and intact membranes who deliver preterm (Lettieri et al., 1993), 
32.4% at admission in women with PPROM and 75% at the time of onset of labour 
(Romero et al., 2006). Also, fetal bacteraemia has been detected in 30% of cases 
where PPROM and positive AF cultures were presented (Carroll et al., 1996). 
 
1.5.1 Pathways of intrauterine infection. 
 
Possible sources of microorganisms related to MIAC have been proposed as 
originating from: 1). the maternal genital tract via an ascending route; 2). via the 
haematogenous route (transplacental infection), with an infection originating from a 
distant part of the body, such as the oral cavity; 3). retrograde seeding from the 
peritoneal cavity through the fallopian tubes; 4). accidental introduction at the time 
of invasive procedures, such as amniocentesis, percutaneous fetal blood sampling, 
chorionic villous sampling or shunting (Romero et al., 2002). 
 
1.5.1.1 The ascending route. 
 
Historically, the most common pathway of intrauterine infection is the ascending 
route. The pathogens responsible for intrauterine infection generally reflect the 
predominant vaginal microbiota of pregnant women. Bacterial vaginosis, 
characterised by a decrease in the normal levels of Lactobacillus spp. and an increase 
in other organisms such as Gardnerella vaginalis, M. hominis, Prevotella spp., 
Bacteroides spp., Mobiluncus spp., has been associated with numerous adverse 
outcomes including miscarriage, PTL, PTB, IUGR, and postpartum endometritis 
(Kimberlin and Andrews, 1998). In addition, Streptococcus agalactiae (also called 
GBS) from a vaginal origin is the most frequent cause of early-onset neonatal 
infection (Ohlsson and Shah, 2009). Some clinical trials have shown that antibiotic 
treatment of BV in women at high risk of preterm delivery results in a reduction of 
PTB. Furthermore, bacteria identified in cases of congenital infections are similar to 
those found in the lower genital tract (Stoll et al., 1996). However, pregnancy 
complications do not develop in all cases where women have been diagnosed with 
BV or were GBS-positive, and not every APO is associated with a genitourinary tract 
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infection with many cases remaining unexplained. 
 
1.5.1.2 The transplacental route. 
 
Secondary pathways for MIAC have also been proposed. Systemic maternal 
infections. e.g. pneumonia, pyelonephritis, malaria, typhoid fever have been 
associated with PTL and PTB. However, many of these conditions are rare in 
developed countries. Thus, the risk attributable to systemic maternal infection for 
prematurity is considered to be low (Romero et al., 2002).  Nonetheless, recent 
evidence suggesting an association between PD or oral microorganisms with APO, 
has necessitated a re-examination of this possible route (Offenbacher et al., 1996, 
Jeffcoat et al., 2001, Offenbacher et al., 2001). Studies evaluating the simultaneous 
role of PD and BV as a risk factor for APO have shown that PD is significantly 
associated with APO, BV showed only a borderline significance, and the presence of 
both conditions appeared to increase the risks (Oittinen et al., 2005). These studies 
suggest that BV and PD are interrelated and increase the risk for APO through an 
additive effect. This could be explained particularly due to the microbiological 
similarities and common pathophysiology between the oral cavity and the female 
genital tract. 
 
1.5.2 Stages of intra-amniotic infection. 
 
The route of the infection has been found to be similar for the ascending and 
haematogenous route (Romero and Mazor, 1988, Han et al., 2004, Liu et al., 2007). 
Romero and Mazor (1988) described four stages of infection associated with the 
ascending route (Figure 1.7). Stage I consists of a change in the vaginal/cervical 
microbiota or the presence of pathologic organisms in the cervix. In stage II the 
microorganisms gain access to the intrauterine cavity and reside in the decidua. A 
localized inflammatory reaction leads to deciduitis. Microorganisms may then reside 
in the chorion and amnion. The infection may invade the fetal vessels 
(choriovasculitis) or proceed through the amnion (amnionitis) into the amniotic 
cavity, leading to MIAC (Stage III). Rupture of the membranes is not a prerequisite 
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for intra-amniotic infection, as microorganisms are capable of crossing intact 
membranes. Once in the amniotic cavity, the bacteria may gain access to the fetus 
through various ports of entry (Stage IV). Aspiration of the infected fluid by the fetus 
may lead to congenital pneumonia. Otitis, conjunctivitis and omphalitis may occur 
by direct spreading of microorganisms from infected AF. Seeding from any of these 
sites to the fetal circulation may result in fetal bacteraemia and sepsis. 
 
Han et al. (2004) demonstrated in pregnant mice that inoculation of F. nucleatum, 
directly into the bloodstream, resulted in an infection with a similar pattern to that 
observed in the ascending route, i.e., bacteria first colonised the decidua, followed by 
spread to the fetal membranes, AF and fetus.  
 
 
 
Figure 1.7 The stages of ascending infection. Source: Romero and Mazor (1988). Stage I, 
change in vaginal/cervical microbiota; Stage II, Invasion of the decidua, the chorion, and the amnion; 
Stage III, microbial invasion of the amniotic cavity; Stave IV, Invasion of the fetus. 
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1.5.3 Bacteria associated with microbial invasion of the amniotic cavity. 
 
1.5.3.1 Study of body fluids and superficial samples to 
investigate intra-amniotic infection. 
 
Isolation of microorganisms from body fluids such as blood and cerebrospinal, 
synovial, pleural, pericardial and peritoneal fluids remains the most valid method for 
the diagnosis of systemic bacterial infection in neonates. Surface culture obtained 
from skin or mucosal sites (axilla, external ear canal, umbilical stump, and aspirates 
from nasopharynx, endotracheal and gastric origin) are also used to evaluate suspect 
sepsis. Taking samples from surface body sites is based on the concept that 
colonization precedes infection; therefore, identification of potential pathogens in the 
surface sites may be predictive of those that later cause invasive disease (Evans et al., 
1988). Samples obtained from surface body sites, such as NGA, can be analysed to 
identify those bacteria associated with fetal colonization and the cause of early-onset 
neonatal infections. On the other hand, body fluids analysis will identify those 
infectious agents that have already initiated a serious blood-borne bacterial infection 
and sepsis in the infants. 
 
The gold standard for the investigation of MIAC has been through analysis of AF. 
Extraction of AF usually requires the need for an invasive amniocentesis procedure.  
Amniocentesis is performed by inserting a needle through the mother's abdominal 
walls into the amniotic sac and is normally used to investigate chromosomal 
abnormalities and,  less commonly, fetal infections. Obtaining AF presents the risk of 
accidentally introducing bacteria into the amniotic cavity (Romero and Mazor, 
1988). Also, there might be a very small risk of miscarriage or fetal death (Evans and 
Wapner, 2005).  
 
Neonatal gastric aspirates are a relatively easily available sample which avoids the 
need for invasive procedures. This sample is routinely taken at hospitals (Health 
Protection Agency, 2004).  In theory, this sample should contain swallowed AF to 
which the fetus has been exposed to in utero. NGA is acquired through aspiration 
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which involves inserting a sterile nasogastric tube into the stomach of the newborn 
during the first hours post-delivery and before feeding. Gastric aspirates contain 
bacteria from the AF and transient microorganisms derived from the birth canal. 
With the advent of molecular techniques, these samples have been suggested as an 
alternative to AF to investigate early-onset neonatal infections since positive 
bacterial 16S rRNA detection correlates 100% with the presence of chorioamnionitis 
in preterm infants (<33 weeks) and/or presentation of PROM (Miralles et al., 2005). 
Investigations that have evaluated the use of NGA as a tool to predict neonatal sepsis 
have been of mixed success (Leibovich et al., 1987, Evans et al., 1988, Puri et al., 
1995). These might be due to technique limitations and the limited knowledge as 
regards the associated pathogen(s) and their pathogenicity. 
 
1.5.3.2 Microbiology of the amniotic fluid. 
 
Using the culture approach, the most common microbial isolates from the amniotic 
cavity in women with PTL and intact membranes have been U. urealyticum, 
Fusobacterium spp. and M. hominis (Gonçalves et al., 2002). Other microorganisms 
that have been found in AF include S. agalactiae, Peptostreptococcus spp., 
Staphylococcus aureus, G. vaginalis, and Bacteroides spp. Occasionally, 
Lactobacillus spp., Escherichia coli, Enterococcus faecalis, Neisseria gonorrhoea 
and Peptostreptococcus spp. have been encountered. Haemophilus influenzae, 
Capnocytophaga spp., Stomatococcus spp. and Clostridium spp. were rarely 
identified in AF. 
 
Recently, with the introduction of molecular techniques, it has been shown that a 
higher frequency of microorganisms can be detected in the AF, particularly in 
women with evidence of intra-amniotic inflammation. Also, a broader range of 
species have been identified when investigating the microbiota associated with APO. 
Specific primers annealing to the 16S ribosomal RNA gene have been used for the 
identification of U. urealyticum, M. hominis, G. vaginalis, E. coli, Fusobacterium 
spp., Peptostreptococcus anaerobius, Bacteroides fragilis, C. trachomatis, H. 
influenza, N. gonorroea, and Streptococcus spp. Using a broad-range PCR technique, 
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an association between those cases of PTL and intact membranes, and a positive 
detection of bacteria was determined (Markenson et al., 1997, Oyarzún et al., 1998).  
 
Moreover, an association between intra-amniotic infections, as determined by 
culture-independent methods, and clinical events including early-onset neonatal 
sepsis, clinical and histological chorioamnionitis, and funisitis have recently been 
demonstrated (Kotecha et al., 2004, Miralles et al., 2005, Han et al., 2009). Han et al. 
(2009) showed that up to 67% (14/21) of the species detected in AF from cases of 
PTB were uncultivable and difficult-to-cultivate bacteria, including F. nucleatum, 
Leptotrichia (Sneathia) spp., Bergeyella sp., Peptostreptococcus sp., Bacteroides 
spp., and species of the order Clostridiales. Miralles et al. (2005) reported a similar 
range of species and also identified G. vaginalis and Streptococcus 
pneumoniae/milleri in AF. DiGullio et al. (2010a, 2010b, 2010c) also described the 
microbiology of AF associated with APO. They identified Ureaplasma sp. (21%), S. 
pneumoniae/mitis/oralis (3%), and F. nucleatum, Sneathia sanguinegens, S. 
agalactiae, and M. hominis (1%) as the most prevalent bacteria in the samples, and 
also identified several less prevalent species including G. vaginalis and species of the 
genera Prevotella, Bacteroides, Lactobacillus, Peptostreptococcus, Peptoniphilus, 
Staphylococcus and  Haemophilus. 
 
1.5.3.3 Microbiology of neonatal gastric aspirates. 
 
In terms of the microorganisms present, NGA should contain bacteria to which the 
fetus has been exposed to while in the uterus (swallowed AF), and transient 
microorganisms acquired during and immediately after birth. Any bacteria colonising 
the amniotic tissues before birth (early-onset neonatal infection) should be present in 
the samples. Hence, this relatively accessible sample is particularly useful to 
determine the potential pathogens associated with adverse perinatal outcomes. 
 
Previous studies have characterized NGA using both traditional and molecular 
methods. Using the culture approach, bacteria from 229 (21%) of 1084 NGA 
samples were isolated with only one species per sample in 85% of samples being 
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identified, and more than one potential pathogen in 15% of samples (Evans et al., 
1988). Microorganisms isolated by conventional culture techniques from these 
samples have to date been limited to a few species, including E. coli, H. influenzae, 
S. aureus, L. monocygenes, S. pneumoniae, GBS, and species of the genus 
Lactobacillus, Klebsiella, Enterobacter, Serratia, Enterococcus, Pseudomonas, and 
Corynebacteria (Evans et al., 1988, Thompson et al., 1992, Borderon et al., 1994, 
Hammoud et al., 2003). 
 
Molecular studies have also been performed to describe the microbiology of NGA. 
U. urealyticum, and M. hominis has also been detected in these samples with species-
specific primers (Egawa et al., 2007). Jones et al. (2010) recently demonstrated, 
using conventional and quantitative molecular methods, that culture analysis of NGA 
is only positive when bacterial DNA exceeds 4.50E+05 colony-forming units 
(CFU)/ml. They also showed that the bacterial load in these samples ranged from 
3.00E+03 to 1.74E+08 CFU/ml (average= 3.10E+05). In their study, they identified 
many potential pathogens including U. urealyticum, G. vaginalis, S. 
sanguinegens/ammionii, Lactobacillus spp., Veillonella spp., H. influenza and S. 
agalactiae. Nevertheless, the techniques used were based upon direct sequencing and 
did not allow a detailed description of the microbiology of NGA. 
 
Oue et al. (2009) identified 23 species in 42 gastric fluids positive for bacteria from a 
total of 103 specimens (41%) using nested PCR and clone analysis. The species of 
bacteria found in their study were as follows: U. urealyticum/parvum, M. hominis, E. 
coli, S. agalactiae, S. mitis, Streptococcus salivarius, Pseudomonas aeruginosa, 
Pseudomonas fluorescens, Staphylococcus epidermidis, Bacteroides spp., 
Lactobacillus crispatus, Peptoniphilus spp., Sphingomonas spp., F. nucleatum, 
Prevotella bivia, Propionibacterium acnes, and Corynebacterium spp. Recently,  
Payne et al. (2010) described the bacteria present in NGA using a combination of 
denaturing gradient gel electrophoresis (DGGE) and species-specific PCR for M. 
hominis and Ureaplasma spp. in preterm neonates. They demonstrated that the 
combined use of techniques identifies a higher diversity of species. Detection of M. 
hominis was increased from detection in one sample by DGGE to 11 (20%) using 
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species-specific PCR; similarly, Ureaplasma spp. identified in only two samples was 
then detected in 38% of the gastric fluids. 
 
 
1.6 THE ASSOCIATION BETWEEN ORAL BACTERIA AND ADVERSE 
PREGNANCY OUTCOMES 
 
1.6.1 Epidemiological and interventional studies. 
 
Based upon the underlying biological plausibility that oral/periodontal infection may 
contribute to an APO by translocation of bacteria and/or their products and by the 
action of maternally produced inflammatory mediators; it has previously been 
suggested that a possible association between PD and PT/LBW exist. Offenbacher et 
al. (1996) first demonstrated in a case-control study that women with PD were 7.5 
times more likely to present with a PT/LBW. Several other case-control and cohort 
studies have been performed since to investigate PD as a possible risk factor for 
APO, determining an association in some studies (Dasanayake, 1998, Jeffcoat et al., 
2001, López et al., 2002a, Mokeem et al., 2004, Goepfert et al., 2004, Offenbacher et 
al., 2006a, Agueda et al., 2008), and a lack of association in others (Mitchell-Lewis 
et al., 2001, Davenport et al., 2002, Moore et al., 2004, Bassani et al., 2007, Vettore 
et al., 2008).  
 
Similarly, few interventional studies have evaluated treatment of PD to reduce the 
incidence of PT/LBW. Some clinical trials report a significant effect of PD treatment 
on APO (López et al., 2002b, Sadatmansouri et al., 2006, Offenbacher et al., 2006b), 
while others did not find the same association (Michalowicz et al., 2006). Reasons 
for the inconsistencies include a genetic-environmental interaction effect (Romero et 
al., 2006, Pretorius et al., 2007), the population of study, variability among studies in 
definition of PD (Andriankaja et al., 2006, Manau et al., 2008) and APO, as well as 
inadequate control for confounding factors and possible effect modifiers for APO 
that make it difficult to draw meaningful conclusions (Wimmer and Pihlstrom, 
2008). Wimmer and Pihlstrom (2008) provided an extensive critical review of the 
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literature for studies investigating PD as a possible risk factor for APO, 
recommending that adequate large prospective cohort studies followed by 
multicentre randomized-controlled trials are needed to clarify the potential role of PD 
in APO, and of periodontal therapy in preventing APO. Interestingly, in a recent 
randomized clinical trial, no significant difference was observed between the control 
and the periodontal treatment groups; however, a strong significant association was 
demonstrated between a successful periodontal treatment (characterised by the 
resolution of gingival inflammation and by the lack of progression of attachment loss 
or periodontal probing pocket depth) and term birth (Jeffcoat et al., 2010). 
 
Recently, the hypothesis that destructive PD may not be strictly necessary for 
bacterial translocation to occur has been raised (Han et al., 2006, Han et al., 2010). It 
is likely that the sole presentation of gingival inflammation, as frequently observed in 
the common condition known as pregnancy gingivitis, in association with changes in 
the maternal immune system may suffice to allow opportunistic pathogens, which 
possess the required virulence factors, to translocate and invade the amniotic cavity. 
 
1.6.2 Possible biological mechanisms. 
 
1.6.2.1 Increased inflammatory mediators in periodontal 
disease. 
 
There is a possible common cellular and biochemical pathway that mediates the 
pathogenesis of PD and the normal physiological mediators of parturition. It is 
established that the physiological pathway that initiates parturition at term is 
mediated by inflammatory events (Norman et al., 2007); therefore, distant infections 
such as PD may well activate the host inflammatory response and the parturition 
cascade. Such early activation of the normal parturition process will thus produce a 
pregnancy complication as a result, manifested as one of many different clinical 
conditions including PTL, spontaneous rupture of membrane, PTB, or early-onset 
neonatal infection (Romero et al., 2006). 
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The infected periodontum is considered to act as a reservoir for both microbial 
products  (lipopolysaccharides, endotoxins) and inflammatory mediators such as 
prostaglandin E2 (PGE2) and tumour necrosis factor alpha (TNF-α) which have been 
shown to increase in PD. Prostaglandin E2 normally rises throughout pregnancy until 
a critical threshold is reached to induce labour, cervical dilatation and delivery. 
Pregnant women with elevated AF levels of PGE2, interleukin (IL)-6 and IL-8 and 
with periodontitis are at higher risk for PTB (Dörtbudak et al., 2005). Animal 
experiments with pregnant hamsters challenged with P. gingivalis showed a 
significant association between increasing levels of PGE2 and TNF-α, and fetal 
growth retardation (Collins et al., 1994). Therefore, it is plausible that PD may 
represent a risk factor for APO via an indirect mechanism. 
 
However, it remains unclear whether distant infections, such as PD, that result in 
elevated levels of circulatory inflammatory mediators, can influence parturition, as 
stated previously (Klebanoff and Searle, 2006), or if a more direct mechanism 
involving entry of the infectious agents into the amniotic cavity followed by a local 
elevation of mediators occurs regardless of the origin of the pathogen. 
 
1.6.2.2 Bacterial translocation. 
 
Translocation of bacteria represents another possible mechanism associated with the 
development of an APO. The mechanisms and virulence factors used by oral 
pathogens to translocate systemically have been explained previously (Section 1.2.3). 
Evidence of their translocation ability is described in following sections.  
 
1.6.3 Evidence of microbial translocation. 
 
A number of bacterial species with a possible oral origin have been found in the 
amniotic cavity in individuals with pregnancy complications. These microbiological 
findings have provided substantial evidence to suggest a possible oral-uterus 
translocation. Capnocytophaga sputigena was the first reported oral species 
recognized in the uterus from a preterm case with clinical chorioamnionitis and intact 
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membranes (Edwards et al., 1995, Douvier et al., 1999). F. nucleatum, a common 
oral species, is the most frequently detected oral species from AF cultures among 
women with PTL and intact membranes (Cahill et al., 2005, Hill, 1998).  
 
Previous studies (Bearfield et al., 2002) have determined the presence of bacteria, 
such as Streptococcus spp. and F. nucleatum, in the amniotic cavity of healthy 
women attending for elective Caesarean section. A significant association was found 
between detection of these bacterial species and complications in previous 
pregnancies, including miscarriage, intrauterine death, neonatal death, preterm 
delivery and PROM.  Eikenella corrodens, part of the normal flora in the human oral 
cavity, has been found to cause chorioamnionitis, PTB, and neonatal death (Andrés 
et al., 2002, Kostadinov and Pinar, 2005, Garnier et al., 2009). P. gingivalis has been 
detected in subgingival samples and the respective AF in women with a diagnosis of 
threatened PTL (León et al., 2007).  
 
Recently, the first unequivocal evidence that bacteria from the oral cavity may be 
linked with PTB has been obtained. Bergeyella spp., a reported uncultivable 
bacterium from the oral cavity, was detected in the uterus from a patient with clinical 
chorioamnionitis and genetic typing matched it exactly with the oral strain (Han et 
al., 2006). Moreover, uncultivable and difficult-to-cultivate species have been 
identified in AF associated with evidence of intra-amniotic inflammation, including 
oral species such as Bergeyella spp. and F. nucleatum (Han et al., 2009). Evidence 
that oral bacteria have been associated with fetal death has recently been published in 
a case report in which F. nucleatum was the cause of a 39th week stillbirth (Han et 
al., 2010). These findings strongly indicate that bacteria from the mouth may be 
involved in APO. 
 
1.6.4 Supporting evidence in animal experiments. 
 
Animal models have also been developed to understand the possible mechanisms 
behind the findings in humans. Studies with P. gingivalis (Lin et al., 2003a, Lin et 
al., 2003b, Boggess et al., 2005), F. nucleatum (Han et al., 2004, Liu et al., 2007) and 
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Campylobacter rectus (Yeo et al., 2005, Arce et al., 2010) confirmed translocation 
and transplacental passage of oral bacteria to placental and fetal tissues after 
inoculation into the maternal bloodstream at a site distant from the uterus. Studies 
with F. nucleatum demonstrated that this bacterium is able to translocate via the 
haematogenous route, specifically invade the amniotic tissues, and cause PTB, fetal 
grown restriction, stillbirths and miscarriage. 
 
Recently, Fardini et al. (2010) demonstrated, in a mouse model, that placental 
colonization with oral bacteria might be species-specific, since only a small 
proportion of the complex oral microbiota was found to be able to invade the murine 
placenta after bloodstream inoculation with samples of saliva and subgingival 
plaque. Interestingly, most of the oral bacteria able to cross the placental barriers are 
commensals in the oral cavity and show a relatively low virulence. However, once 
inside the uterus, they may stimulate the synthesis and release of proinflammatory 
cytokines, neutrophil infiltration and activation, and prostaglandin and 
metalloproteinase synthesis release, leading to cervical ripening, membrane 
weakening and rupture, uterine contractions and PTB. Some of these were observed 
to be enriched in the placenta, e.g. Granulicatella adiacens, Neisseria spp., S. mitis, 
Veillonella spp., F. nucleatum, and Aggregatibacter segnis. Also, a similar pattern 
has been reported to be associated with APO in humans (Romero et al., 1986, Barak 
et al., 2007, DiGiulio et al., 2008, Han et al., 2009, Han et al., 2010). 
 
 
1.7 MICROBIAL IDENTIFICATION TECHNIQUES 
 
1.7.1 Traditional microbial identification in clinical samples. 
 
Traditional methods for microbial identification require the isolation of pure cultures 
followed by a diverse and complex range of phenotypical and biochemical tests 
(Amann et al., 1995). Culture techniques are considered the gold standard in 
microbiology and remain to be an important diagnosis method to detect bacterial 
species in hospitals. However, these techniques present important limitations not 
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only because of the large number of bacteria not able to be cultured, but also due to 
the difficulty to detect those fastidious strains that require very specific 
environmental or nutritional requirements to grow. One major limitation of the 
phenotypical and biochemical tests is related to unreliability due to characteristics 
that do not fit into the patterns of any known genus and species (Woo et al., 2008). 
Even cultivable species may be difficult to recover when they are present in low 
numbers. Also, anaerobic pathogens could become non-viable after sampling, during 
transport and analysis, thereby underestimating their presence in the samples.  All 
these limitations together with the need for other requirements, such as experienced 
personnel, time and relatively high cost, have led to the need for non-cultural 
diagnostic methods, particularly nucleic acid-based detection methods. 
 
1.7.2 Molecular identification techniques to study complex microbial 
populations. 
 
Recently, improved methods based upon PCR and comparative DNA sequencing 
have made it possible to identify even extremely fastidious and uncultivable 
pathogenic bacteria in mixed species communities without the need for culture 
(Amann et al., 1995, Patel, 2001). Studies comparing traditional versus molecular 
techniques to define the bacterial content within a particular specimen have 
demonstrated the advantage of the molecular approach in detecting a broader range 
of species (Kroes et al., 1999). Molecular methods based on the analysis of the 
conserved small subunit 16S ribosomal RNA (rRNA) molecule have become very 
important in characterising complex microbial populations. The 16S rRNA gene has 
been proposed as the primarily tool for the identification and classification of 
bacteria (Rajendhran and Gunasekaran, 2010).  
 
To adequately study microbes in complex microbial communities, genomic DNA is 
extracted directly from the mixed sample without the need for cultivation. Gene 
libraries derived from amplification products of a defined fragment can be then 
sequenced. Bacterial taxa are identified based on the 16S rRNA sequence homology 
with existing sequences in the databases. A cloning and sequencing approach is 
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dependent upon the number of clones that can be processed and sequenced. This may 
be a very expensive and labour-intensive technique which limits the number of 
samples that can be evaluated. In addition to cloning and sequencing, DNA 
fingerprinting techniques based on the 16S rRNA gene have been proposed as this 
may be a more affordable option. Nevertheless, to date cloning and sequencing have 
proven to be accurate and reliable tools and are still broadly used techniques for 
exploring microbial diversity from complex communities. 
 
Currently developing technologies such as next-generation, high-throughput DNA 
sequencing offers a great leap forward in the ability to explore complex microbial 
ecosystems such as the oral microbiota by sequencing simultaneously thousands of 
isolates without amplification and cloning biases (Pozhitkov et al., 2011). The first 
paradigm shift in next-generation sequencing, to overcome the limitations of dideoxy 
chain termination sequencing, has been to create molecular clones in vitro by 
physically separating single template molecules and to replicate these in a physically 
isolated clonal population. The second shift has been to devise new sequencing 
chemistries enabling template sequence to be read as a series of discrete events in 
real time. These technologies are already being applied to the study of microbial 
community complexity (Nossa et al., 2010, Lazarevic et al., 2009). However, with 
such revolutionary advances in technology come new challenges in methodologies 
and informatics. Next-generation sequencing can produce terabytes of data that needs 
to be stored and analyzed. The biggest challenge will be this overwhelming 
production of data, requiring not only storage but also interpretation. In the future, 
next-generation sequencing will allow not only to catalogue the numbers and types 
of bacteria present but also to understand correlations with the function and fitness of 
a defined ecosystem. This will ultimately contribute to a more comprehensive 
understanding of human health, disease susceptibilities, and the pathophysiology of 
infectious and immune-mediated diseases (Snyder et al., 2009). 
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1.7.2.1 PCR and the16S ribosomal RNA gene.  
 
Polymerase chain reaction is a primer-mediated enzymatic amplification of specific 
target sequence from genomic DNA (Saiki et al., 1985a).  With this technique, a 
specific section of DNA can be copied multibillion-fold, allowing detailed molecular 
studies to be performed on as little as a single original cell. Briefly, PCR method was 
developed in 1985 (Saiki et al.). It relies on a thermal cycling consisting of cycles of 
repeated heating and cooling of the reaction producing DNA melting and enzymatic 
replication of the DNA. A high temperature (94 - 98 ⁰C) is necessary first to 
physically separate the two strands in a DNA double helix; as PCR progresses, the 
heat-stable DNA polymerase (Taq) enzymatically ensembles at a lower temperature 
a new complementary chain of nucleotides by using a single-stranded DNA as a 
template.  The fragment of DNA to be amplified is identified by a pair of specific 
oligonucleotides (primers) that designate the outer limits of the amplicon (Figure 
1.8).  
 
The 16S rRNA gene (Figure 1.9) has been selected as a candidate molecule for 
bacterial identification for several important reasons: 1. it is present in all bacteria 
and the RNA performs an important structural role as well as a crucial part in protein 
synthesis (as part of the ribosome); 2. it contains both highly conserved nucleotide 
sequences and hypervariable regions, thereby  allowing detection of a broad range of 
bacteria as well as specific bacterial species; 3. the 16S rRNA gene is of sufficient 
size  (ca. 1500 bases) to be easily sequenced and still contains sufficient information 
for identification and phylogenetic analysis (Clarridge, 2004). Generally, the 
comparison of 16S rRNA gene sequences allows differentiation between 
microorganisms at the genus level across all major phyla of bacteria.  In addition, it 
often allows classification of bacteria to the species level.  The occasional exceptions 
to the usefulness of 16S rRNA gene sequencing usually relates to several species that 
have the same or very similar sequences (Clarridge, 2004). The nucleotide sequence 
obtained by 16S rRNA-PCR can be compared to online databases which provide an 
increasing number of aligned 16S rRNA sequences and allows identification based 
upon similarity with the nearest neighbour. 
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Figure 1.8 Schematic representation of a PCR amplification sequence. Source: Gene cloning 
and DNA analysis: an introduction (Brown et al., 2006). 
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Figure 1.9 The 16S rRNA structure indicating (in black) the areas with the highest conserved 
regions which are the most common targets for the analysis of all (universal) bacteria. Source: Nucleic 
Acid Techniques in Bacterial Systematics (Stackebrandt and Goodfellow, 1991). 
 
 
A 97% similarity level has been proposed for bacterial identification using 16S 
rDNA sequences (Patel, 2001). However, other studies has suggested that a >0.5% 
difference may be indicative of a new species (Drancourt et al., 2000). It is not 
possible to determine a universal cut-off for bacterial genus and species delineation 
as different bacterial species are likely to evolve at different rates and the cut-offs for 
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species and genus identification should vary depending on the bacterial genus under 
investigation. Janda and Abbott (2007) suggested that a minimum of >99%, and 
ideally >99.5%, sequence similarity be used as the criteria for species identification. 
They also proposed that for matches with distance scores <0.5% to the next closest 
species, other properties, e.g. phenotype, should be considered in final species 
identification. However, using these criteria, it is difficult to determine the species 
identity with sequences that have very similar distances to the closest and next 
closest matches, especially those within 0.5–1%. 
 
1.7.2.2 Clone analysis and sequencing. 
 
Direct sequencing is not accurate when applied to mixed samples. Therefore, 
procedures to isolate individual species from complex communities are necessary. 
Microbial diversity assessment is generally based on: 
1. PCR amplification of 16S rRNA genes from genomic DNA. 
2.  Construction of 16S rRNA gene clone libraries. 
3.  Sequencing of randomly selected clones. 
4. Comparative sequence analysis.  
 
In gene cloning, a fragment of DNA is inserted into a circular DNA molecule called 
a vector to produce a recombinant DNA molecule (Figure 1.10). The vector 
transports the gene into a host cell, usually E. coli. Within the host cell the vector 
multiplies producing numerous identical copies of its genetic information including 
the inserted gene that it carries. When the host cell divides, the DNA recombinant is 
passed to the progeny. After a large number of cell divisions, each cell of a colony 
(or clone) will contain many copies of the gene of interest. Randomly selected 
colonies are picked and amplified by PCR for identification by sequencing (Brown et 
al., 2006).  
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Figure 1.10 Schematic representation of clone analysis. Source: Gene cloning and DNA 
analysis: an introduction (Brown et al., 2006). 
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1.7.2.3 DNA fingerprinting techniques. 
 
In addition to sequence analysis, DNA fingerprinting analysis based on 16S rRNA 
genes such as DGGE or temperature gradient gel electrophoresis, single-stranded 
conformation polymorphism, amplified ribosomal DNA restriction analysis and 
terminal restriction fragment polymorphism analysis are widely used to differentiate 
microorganisms (Bouchet et al., 2008).  
 
Denaturing gradient gel electrophoresis has rapidly become a valuable tool in the 
study of complex microbial populations. It consists of the electrophoretic separation 
in a polyacrylamide gel of PCR-amplified 16S rDNA fragments of the same length 
based upon their sequence difference (Muyzer et al., 1993). The polyacrylamide gel 
contains a linear gradient of DNA denaturants (urea and formamide), and 
electrophoresis is run at a constant temperature and voltage. When the DNA domain 
with the lowest melting temperature (MT) reaches its MT, a transition from helicoidal 
to a partially melted molecule causes it to cease migrating. Different sequences will 
stop migrating at different positions in the gel based upon their respective G+C 
content and MT (Figure 1.11). To increase specificity, the addition of a 30- to 50- 
nucleotide GC-clamp to the 5’-end of the DNA fragment is added during DGGE-
PCR to act as a high melting domain, preventing the two DNA strands from 
complete separation; the GC-clamp will be co-amplified and thus introduced into the 
amplified DNA fragment. 
 
The bands can then be observed with UV light after staining with ethidium bromide 
or an alternative dye (Muyzer and Smalla, 1998). The number of bands corresponds 
to the number of predominant members in the microbial community. However, bands 
at the same position in the gel do not necessarily belong to the same sequence. They 
merely have the same melting behaviour. Individual bands can be excised, eluted, re-
amplified, and sequenced to determine identity. Several samples run in the same gel 
allow a visual comparison between profiles. Limitations of this technique may be 
related to the separation of only small fragments of the gene, therefore limiting the 
sequence information for phylogenetic inferences. Also, co-migration of the 
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fragments, particularly, those samples with very low variability, may represent a 
problem. Li et al. (2007) determined that cloning of each band produced an average 
number of species detected of 2.7. This would indicate that the richness of the 
samples is probably much higher than suspected. Gafan and Spratt (2005) proposed 
the use of a more narrow gradient of denaturants to provide higher resolution in order 
to resolve the limitations of co-migration. 
 
 
 
Figure 1.11 Schematic representation of DGGE demonstrating the difference in electrophoretic 
mobility of two DNA fragments of equal size as a result of differences in their base-pair sequence.  
 
 
1.7.2.4 Quantitative PCR. 
 
Quantitative PCR (q-PCR) or real-time q-PCR is being used in a growing number of 
research applications, including pathogen detection. It was introduced to overcome 
the main limitation of the conventional (end-point) PCR in which the data is 
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collected after the amplification reaction has been completed, giving only a final 
qualitative result (Wang et al., 1989). Therefore, end-point PCR cannot calculate or 
differentiate between variable initial levels of template in the samples being 
analysed. With q-PCR, the number of DNA molecules of a particular sequence in a 
complex sample can be determined with high accuracy and sensitivity. A fluorescent 
reporter molecule is used to monitor the progress of the amplification reaction. This 
molecule could be either: 1). a sequence-specific probe comprised of an 
oligonucleotide labelled with a fluorescent dye plus a quencher; or, 2). a non-specific 
DNA binding dye (such as SYBR Green I) that fluoresces when bound to double-
stranded DNA. In each amplification cycle, the intensity of the fluorescence 
increases proportional to the increase in amplicon concentration. As PCR 
amplification is an exponential process, the extent of amplification (N) is given by 
the equation N = N0(l + E)n, where N0 is the initial amount of material, E is the 
efficiency, and n is the cycle number. Assuming a certain amplification efficiency, 
which typically is close to a doubling of the number of molecules per amplification 
cycle, it is possible to calculate the number of DNA molecules of the amplified 
sequence that were initially present in the sample (Kubista et al., 2006). 
 
Figure 1.12 represents the phases of amplification occurring during a q-PCR reaction 
and the response curves generated when plotting the cycle number against the 
fluorescence produced during each cycle. During the initial cycles the signal is weak 
and cannot be distinguished from the background. As the amount of product 
accumulates a signal develops and increases exponentially. Thereafter the signal 
levels saturate due to the reaction running out of some critical component e.g. 
primers, deoxyribonucleotide triphosphate (dNTP), polymerase in which case the 
exponential amplification switches to linear amplification. An end-point PCR 
experiment provides information on the resulting product at the plateau phase; hence, 
it only distinguishes a positive from a negative sample. In q-PCR, the response 
curves in the exponential growth phase of the reaction are separated based upon the 
initial amounts of template molecules. The number of cycles at which the 
fluorescence of a sample rises above the background fluorescence is called the 
crossing point (Cp) of the sample. This Cp value can be directly correlated to the 
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starting target concentration of the sample. The greater the amount of initial DNA 
template in the sample, the earlier the Cp value for that sample. 
 
 
Figure 1.12 Real-time PCR response curves. A threshold level is set sufficiently above 
background and the number of cycles required to reach threshold, CT are registered. CT=crossing 
point (Cp). Source: Kubista et al. (2006)  
 
 
There are two methods of PCR quantification: absolute and relative quantification.  
Absolute quantification allows measurement of the exact level of template in the 
samples. It uses a standard curve prepared from a dilution series of template of 
known concentration (Figure 1.13A). The standard curve is generated by plotting the 
logarithm of the initial copy number against the Cp generated for each dilution 
(Figure 1.13B). The plot of these points should be a linear regression line. 
Comparing the Cp values of the unknown samples to the ones produced by the 
standards allows the quantification of initial copy numbers. For this, a standard of 
known concentration should be included in every experiment. 
CHAPTER 1: INTRODUCTION 
 73
A linear standard curve also implies that the efficiency of amplification is consistent 
at varying template concentrations. The slope of the standard curve describes the 
kinetics of the PCR amplification, indicating how quickly the amount of the target 
molecule can be expected to increase with the amplification cycles. The efficiency 
can be calculated from the slope using the formula E=10-1/slope. Ideally, the slope 
should be near -3.3 (slope=-3.3 E=2 or double the amount of target with each 
cycle).  
 
 
Figure 1.13 Standard curves for q-PCR. A. Amplification curves of the standard dilution series 
plotting fluorescense vs. number of cycles. B. Logarithmic linear representation of standard curve 
plotting initial copy vs. Cp. 
 
 
The relative quantification is performed by measuring the relative concentration of 
the gene of interest in unknown samples compared to a calibrator, or control sample. 
Using this approach, differences in Cp value between an unknown sample and 
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calibrator are expressed as fold-changes (i.e., up- or down-regulated) relative to the 
calibrator sample. In addition to comparing the expression of the target gene in a 
control versus experimental sample, a normalizing reference gene or target, typically 
a gene whose expression is constant in both the control (calibrator) and experimental 
samples, can be added. 
 
1.7.3 The 16S-23S rDNA Intergenic Spacer Region. 
 
Typically, each ribosomal operon consists of the three genes encoding the structural 
rRNA molecules, 16S, 23S, and 5S. Among bacterial species, the average lengths of 
these genes are 1 522 bp, 2 971 bp, and 120 bp, respectively (Figure 1.14). The three 
rRNA genes are highly conserved within a bacterial species due to their fundamental 
role in protein synthesis. On the other hand, the 16S-23S rDNA intergenic spacer 
region (ISR) of the ribosomal operon is under minimal selective pressure during 
evolution and therefore contains more sequence variation than that of the 16S and 
23S rRNA coding regions. It has been found that bacteria contain multiple copies 
(between one and 15) of the ribosomal operon in each genome  (Lee et al., 2009). 
Moreover, the size of the ISR varies considerably for different species, and even 
among different operons within a single cell. It has been determined that the length 
of the 16S-23S rDNA ISR in bacteria varies between 164 bases in Bacillus subtilis 
(Green et al., 1985) and 1529 bases in Bartonella elizabethae (Roux and Raoult, 
1995). The variation in length of an amplified ISR is mainly due to the presence of 
various numbers and types of transfer RNA (tRNA) genes (Morgan et al., 1977). It 
has been suggested that the length and sequence polymorphisms in the ISR, which 
are detectable by ribotyping techniques, can be used to distinguish different bacterial 
species (Bouchet et al., 2008). However, while in some species the ISR length is 
variable within and between isolates, in others the ISR lengths are conserved and do 
not allow discrimination (Christensen et al., 1999). Thus, the most accurate 
techniques rely on sequencing. Sequencing of the amplified ISR has been suggested 
previously for species identification and subtyping (Whiley et al., 1995). 
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Figure 1.14 Ribosomal RNA map of F. nucleatum ATCC 25586- Operon 1. Source: Oral 
Pathogen Sequence Database, http://www.oralgen.lanl.gov  
 
 
1.8 AIMS OF THE STUDY 
 
TO INVESTIGATE THE MATERNAL ORAL CAVITY AS A POSSIBLE 
SOURCE OF PATHOGENS ASSOCIATED WITH COMPLICATED 
PREGNANCIES 
 
 To determine the microbiology of neonatal gastric aspirates obtained from 
complicated pregnancies using a combination of molecular techniques (clone 
analysis and DGGE) based upon the 16S rRNA gene. 
 
 To identify bacteria with a possible oral origin in samples of gastric aspirates. 
 
 To specifically detect and quantify periodontal pathogens from a possible oral 
origin in samples of gastric aspirates using a quantitative PCR approach. 
 
 To determine if any demographical or clinical variable might be 
independently associated with the presence of bacteria (including potential 
oral bacteria) in neonatal samples using a multivariable analysis approach. 
 
 To compare, at the subspecies and strain level, suspected oral bacteria 
observed in the neonatal samples with their respective counterparts in 
maternal oral and vaginal samples using the 16S rRNA gene and the 16S-23S 
intergenic region to evaluate them as the possible origin of these bacteria. 
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2.1 Study design. 
 
The following project is a laboratory-based analysis of clinical samples. Figure 2.1 
represents a simplified scheme of the protocol followed during the study. Ethical 
approval was obtained for this project from the Outer North East London Research 
Ethics Committee (Possible Association between the Oral Microflora and Adverse 
Pregnancy and/or Neonatal Outcomes, REC Ref. No. 08/H0701/61) (ANNEX 1), 
and was later amended to cover all the stages of the project. 
 
 
 
Figure 2.1 Schematic representation of the study design followed during this PhD project. 
NGA, neonatal gastric aspirates; SEND, Standarised Electronic Neonatal Database. 
 
 
The samples of NGA were identified and collected for this study at the Microbiology 
Department, Royal London Hospital, Barts and The London NHS Trust. These 
samples are routinely collected as part of the normal clinical care of the newborns for 
investigation of infection and were not collected specifically for this study.  
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Demographical and clinical data was obtained from the Standarised Electronic 
Neonatal Database (SEND) and from the maternity notes. Data included were 
maternal age, ethnic origin, gravidity (number of times a woman has been pregnant), 
parity (number of times a woman has given birth to a fetus at ≥ 24 weeks of 
gestation), mode of delivery, onset of labour, date and time of birth, complications 
during this and previous pregnancies (i.e. miscarriages, PTB, LBW, pROM), 
gestational age, birthweight, administration of intrapartum antibiotics (iATB), and 
smoking during pregnancy. Other information was also obtained from the 
Microbiology Department database such as date, time and place of collection of the 
sample, as well as results regarding gram staining and culture. 
 
Maternal samples from the oral cavity and the vagina were also collected for this 
study. Those mothers whose neonates had to provide NGA sample in the hospital 
were invited to participate in the study. Samples from neonatal and maternal origin 
obtained during the recruitment period were then analysed for the purposes of this 
study using the molecular techniques as explained in this and following chapters. 
 
2.2 Samples of neonatal gastric aspirates. 
 
Gastric aspirates are routinely taken at the Maternity and Neonatal Units, Royal 
London Hospital, Whitechapel under the ‘Standard operating procedure for the 
investigation of gastric aspirates and infection screen swabs from neonates’ 
Reference no. BSOP 23i4.1 (Health Protection Agency, 2004). These fluids are 
obtained from newborns that present with a clinical manifestation of neonatal sepsis 
(respiratory distress, unstable temperature and cardiovascular depression) or are at 
risk of developing an infection (congenital abnormalities, LBW, PTB, pROM, 
maternal fever, protracted and difficult births, respiratory distress syndrome, 
toxaemia of pregnancy, invasive procedure and devices, mother with previous infant 
affected by GBS sepsis). The samples are acquired through aspiration by inserting a 
tube in the newborn stomach at less than 4 hours post delivery and before feeding. 
These specimens are not normally taken from neonates that are not considered to be 
at risk of infection; therefore, healthy infants do not provide samples of NGA.  
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The samples of NGA were collected for this study on the following day, after being 
taken at the hospital and analysed at the Microbiology Department. The remaining 
volumes of those samples that contained at least 200 µl of non-diluted sample were 
obtained. Following collection, the samples were immediately aliquoted in 200 µl 
fractions. Two of the samples were immediately subjected to DNA extraction.  The 
remainder of the sample was stored at -80°C. 
 
2.3 Sample size. 
 
A total of 240 samples of NGA were collected during this project. The minimum 
number of NGA samples to be included in this study was calculated from 
preliminary data with the analysis of 50 samples of NGA. As observed, the 
transmission rate for the most common pathogens was likely to be at least 52%. With 
180 cases, it was expected to generate confidence intervals of about ±7%. Therefore, 
there was greater than 80% power to observe a difference between the presence and 
absence of bacteria for differences of 50 and 16%. 
 
2.4 Participants approach. 
 
Women attending the Royal London Hospital, who gave birth to a child with a 
suspected infection and were required to provide a NGA sample as part of the 
hospital’s routine care, were invited to participate in the study. Initial ethical 
approval was amended to identify and approach these women either at the hospital or 
by post (ANNEX 2).  The participants were requested to provide a sample of their 
oral cavity and a lower vaginal swab (LVS), and, they were also asked to sign a 
consent form (ANNEX 3) and complete a validated questionnaire (Davenport et al., 
2002) (ANNEX 4). The samples were obtained either at the labour ward, at the 
Neonatal Intensive Care Unit (NICU), or at The Dental Hospital, Barts and The 
London NHS Trust. The questionnaire provided included questions related to 
smoking and drinking habits, illness and medication during pregnancy, dental 
attendance, diet, antenatal care, education, paternal information, and sexual relations 
and oro-genital contact practice during pregnancy. 
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2.5 Samples from the maternal oral cavity and vagina. 
 
The oral samples consisted of a pool of saliva, supra- and subgingival plaque, and 
tongue surface scraping to ensure a representative sample of the diverse oral 
microbiota. A full-mouth periodontal examination (ANNEX 5) at six sites per tooth 
was performed in order to determine the periodontal status of the mothers and to 
identify those sites with deep pockets from which the subgingival samples were 
obtained. After completing the periodontal chart, a sample of saliva was obtained by 
asking the women to hold, and pass around the mouth, a sterile oral swab 
(Salimetrics Europe Ltd, Suffolk, UK) for 1-2 minutes. The Salimetric Oral Swab 
was then placed into a 7 ml bijou for transportation. A supragingival plaque sample 
was obtained from the gingival margins of 3-4 teeth using a sterile toothpick. This 
was then placed into a 0.5 ml tube containing 200 µl of phosphate buffered saline 
(PBS). After that, subgingival plaque was obtained from those sites with observed 
pockets (>4 mm) (if present) and/or from healthy sulci at the molar level. A validated 
paper point technique was used (Loomer, 2004, Jervøe-Storm et al., 2007) to collect 
subgingival plaque. Briefly, a paper point ISO#40 (SybronEndo, Kerr International, 
CA, USA) was inserted deeply into the pocket and held for 10 seconds. This was 
performed with five to 10 absorbent points and pooled into one 0.5 ml tube 
containing 200 µl of PBS. Finally, a tongue scraping sample was obtained with a 
nylon bristle brush (Cytosoft ™ Cytology Brush, CardinalHealth, Dublin) by making 
a few strokes on the tongue dorsum and placing it into a 1.5 ml tube containing 500 
µl of PBS. 
 
Lower vaginal swabs were asked to be self-collected by the mothers. This avoided 
requirement for medical staff or obstetricians to collect the samples. Previous studies 
support the use of self-collected low vaginal samples; it has been demonstrated that a 
substantial agreement exists between the vaginal microbiota when comparing 
physician-obtained speculum examination and self-obtained vaginal swabs (Strauss 
et al., 2005). Self-collected swabs have been shown to be well accepted by most 
women and the quality of the swabs to be satisfactory (Bresson et al., 2006). A card 
with instructions on how to obtain self-collected vaginal swabs was provided to the 
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women (ANNEX 6); this was modified from Rose et al. (2007). Once collected, the 
swabs were immediately placed in a 1.5 ml tube containing 600 µl of PBS.  
 
All the samples were finally transported to the laboratory. The saliva sample was 
immediately extracted from the oral swabs by placing it in a Swab storage tube 
(Salimetrics Europe Ltd, Suffolk, UK); this was followed by centrifugation at 13,000 
rpm for 1 minute as per manufacturer’s instructions. A pooled sample of the oral 
cavity was composed of the following: 300 µl of saliva, 150 µl of supragingival 
plaque, 150 µl of subgingival plaque, and 200 µl of the tongue scraping placed in the 
same tube. This was then divided into 200 µl aliquots. The sample of vagina was 
aliquoted in a 300 µl volume per tube. The samples were then stored at +4oC and, 
soon after, subjected to DNA extraction.  
 
2.6 Growth of bacterial strains. 
 
Reference strains, including recognised pathogens associated with PD, were grown 
in this study with two main purposes: for construction of standards for q-PCR (Table 
2.1), and for the analysis of the ISR of fusobacterial species (Table 2.2). All the 
bacterial strains were anaerobic or facultative anaerobic bacteria. The strains were 
grown in an anaerobic chamber (MACS 1000, Don Whitley Scientific Ltd, Shipley, 
UK) with an atmosphere containing 80% nitrogen, 10% hydrogen, and 10% carbon 
dioxide on solid media supplemented with 5% defibrinated horse blood (TCS 
Biosciences Ltd, Buckingham, UK) at a temperature of 37ºC. Unless specified, the 
bacteria were grown on BA (Oxoid, Basingstoke, UK) media (Table 2.1). Bacteria 
obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ) 
were supplied lyophilized and were reconstituted according to the manufacturer’s 
instructions. 
  
 
 
 
 
Table 2.1 Oral strains of bacteria grown in this study for constructions of standards for q-PCR analyses. 
 
    BACTERIUM STRAIN TYPE GROWTH CONDITIONS SOURCE REFERENCE 
1 
  
F. nucleatum NCTC 10562 
Grown anaerobically on BA for 3-5 
days. 
EDI MI 
3 
  
P. gingivalis  DSM 20709 
Grown anaerobically on BA for 3-5 
days. 
EDI MI 
4 
  
T. forsythia ATCC 43037 Grown anaerobically on FAA** for 
2 weeks. 
CID (Lee et al., 2006) 
5 
 
Granulicatella elegans DSM 11693 
Grown anaerobically on BA* for 24 
hours. 
DSMZ 
(Roggenkamp et al., 
1998) 
BA, blood agar; FAA, Fastidious Anaerobic Agar; * media supplemented with 0.01% L-cysteine hydrochloride + 5 µg/ml haemin (Sigma, Poole, UK)+ 
1µg/ml menadione (Sigma); ** media supplemented with 0.001% (w/v) filter-sterilized N-acetyl muramic acid (Sigma), 5 µg/ml haemin, and 1µg/ml 
menadione. MI, manufacturer’s instructions. 
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Table 2.2 Subspecies of F. nucleatum grown in this study for analysis of the ISR. 
 
BACTERIA* 
STRAIN 
TYPE SOURCE 
1 F. nucleatum subsp. polymorphum NCTC 10562 EDI 
2 F. nucleatum subsp. nucleatum ATCC 25586 CID 
3 F. nucleatum subsp. vincentii DSM 19507 DSMZ 
4 F. nucleatum subsp. fusiforme DSM 19508 DSMZ 
5 
 
F. nucleatum subsp. animalis 
 
DSM 19679 
 
DSMZ 
 
*All the strains were grown anaerobically on BA for 3 to 5 days.  
EDI, Eastman Dental Institute; CDI, Centre for Infectious Disease, Barts and The  
London, QMUL; DSMZ, German Collection of Microorganisms and Cell Cultures. 
 
 
2.7 Counts of bacteria and storage of stocks. 
 
Each strain was grown on multiple agar plates as specified above. Freshly collected 
colonies were transferred into sterile tubes containing 1.5 ml Brain Heart Infusion 
(BHI) broth + 10% sterile glycerol. The mixture was vortexed and the number of 
bacteria in the neat sample was quantified by a standard plate count method and 
spectrometric (turbidimetric) analysis. Briefly, the samples were serially diluted in 
BHI broth. Dilutions from 10-5 to 10-9 were plated in duplicate using two different 
amounts (10 and 100 µl) and those plates containing between 30 to 300 CFU were 
used to determine the number of bacteria in a given dilution (Figures 2.2 and 2.3). 
 
The concentration of bacteria in the neat suspension was calculated as CFU/ml using 
the following equation: 
 
 
Number of colonies (CFU) / dilution x amount plated = Number of bacteria/ml 
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Figure 2.2 Photograph of P. gingivalis pure culture grown in BA medium after 8 days 
incubation in an anaerobic cabinet (dilution 10-7 ,10 µl). 
 
 
The turbidity of the samples was calculated measuring the optical density (OD) at a 
wavelength of 600 nm (OD600). The OD600 of the neat sample, as well as the 
OD600 for the dilutions 1:2, 1:4, 1:8, 1:16 and 1:32, were determined for 
spectrometric analysis.  The number of bacteria in the neat and dilutions were plotted 
against absorbance using Microsoft Excel® software. The trend line and slope 
equation was used to determine the OD600 for the closest 10N dilution. Figure 2.4 
represents an example of the technique. 
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Figure 2.3 Serial dilutions of an unknown concentration of P. gingivalis (100 µl) on BA plates 
after 5 days incubation in an anaerobic cabinet. Dilutions are shown from the highest concentration 
(10-5) in the top left plate, to the lowest concentration (10-9) in the bottom plate. 
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Figure 2.4 Estimation of bacterial number as determined by the corresponding OD600 
(example represents data for A. actinomycetemcomitans). 
 
 
2.8 Genomic DNA extractions. 
 
Genomic DNA from the clinical samples and reference strains was extracted by 
using the ArchivePure DNA Purification Kit for Yeast and Gram -/+ (Flowgen 
Bioscience, Nottingham, UK). Due to the high viscosity, samples of NGA received 
pre-treatment with Dithiothreitol (Mucolyse, Pro-Lab Diagnostics, Cheshire, UK), a 
sputum liquefying agent, before DNA isolation. An aliquot of 200 µl of the sample 
was diluted with 200 µl of PBS solution and 10 µl of 5% mucolyse was added. The 
mixture was vortexed for 30 seconds and incubated at 37°C for 1 hour or until easily 
pipetted. No other sample (oral cavity, vaginal swab, or laboratory-cultured bacteria) 
required pre-treatment before DNA extraction. The DNA extraction protocol used in 
this study was optimised and is detailed below. 
 
The samples were pelleted by centrifugation at 13 000 x g in a bench top 
microcentrifuge for 20 minutes. The pellet was resuspended in 300 µl of Cell 
Suspension Solution and 1.5 µl of lytic enzyme was added. The samples tubes were 
inverted 25 times and incubated for 30 minutes at 37°C with occasional inverting. 
After incubation the cells were pelleted by centrifugation for 10 minutes and the 
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supernatant discarded. This was followed by resuspension of the pellets in 550 µl of 
Cell Lysis Solution and incubation at 80°C for 5 minutes in order to complete cell 
lysis. For a maximum yield of DNA, 1.5 µl of Proteinase K solution (20mg/ml, 
Flowgen Bioscience, Nottingham, UK) was added, mixed by inverting 25 times and 
incubated at 55°C overnight. After incubation, the cell lysate was treated with 3 µl of 
RNase solution, inverted 25 times and further incubation at 37°C for 15 minutes. 
Afterwards, the samples were cooled to room temperature (RT) and 100 µl of Protein 
Precipitation Solution was added to the lysate. Thorough mixing was then ensured by 
vortexing at high speed for 20 seconds.  Following this, the protein was pelleted by 
centrifugation for 10 minutes and the supernatant was poured into a tube containing 
300 µl of 100% isopropanol. The addition of 0.5 µl Glycogen Solution (20mg/ml, 
Bioline London, UK) for expected low DNA yields was included. This was mixed by 
inverting 50 times, centrifuged for 20 minutes and the supernatant discarded.  The 
DNA was then washed by adding 300 µl of 70% ethanol and inverting several times. 
The samples were then centrifuged for 10 minutes and the supernatant discarded.  
The DNA pellet was air dried for 10 minutes and then re-suspended in 20 µl of DNA 
Hydration Solution and left at RT overnight. Finally, the samples were stored at 4°C 
until the amplification step was performed or kept at -20°C for long term storage. 
 
2.9 16S rRNA gene PCR. 
 
In general, bacterial 16S rRNA genes were amplified from genomic DNA following 
a protocol previously described by Gafan et al. (2004). Briefly, a final reaction 
volume of 50 µl was prepared containing 1 X PCR buffer, 2.5 mM MgCl2, 0.2 mM 
of dNTPs, 0.2 µM of each primer, 0.15 U of BioTaq DNA polymerase (Bioline, 
London, UK), and either 5 µl of the extracted genomic DNA from clinical samples or 
2 µl of the extracted DNA from the reference strain. The PCR conditions used were: 
initial denaturation at 94°C for 5 minutes followed by 30 cycles of denaturation at 
94°C for 1 minute, annealing at 54°C for 1 minute, and elongation at 72°C for 1.5 
minutes, and a final 5-minute extension step at 72°C. 
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Primers used were either universal for conserved sequences of the gene (Table 2.3) 
or species-specific to amplify certain genera or species (Table 2.4). A modification 
of the commonly used 27F forward primer was used to analyse samples of NGA. 
This formulation was suggested by Frank et al. (2008) for the analysis of human 
vaginal samples to avoid problems with inefficient primer binding commonly 
observed for certain important species. The primer 27F-YM+3, which contained four 
parts of 27F-YM (Table 2.3), plus one part of each primer specific for 
Bifidobacteriaceae 27F-Bif 5’-AGGGTTCGATTCTGGCTCAG-‘3, Borrelia  27F-
Bor 5’-AGAGTTTGATCCTGGCTTAG-‘3, and Chlamydiales 27F-Chl 5’-
AGAATTTGATCTTGGTTCAG-‘3, together with the reverse primer 1492R (Table 
2.3) amplified most of the 16S rRNA gene, approximately 1500 bp length. 
 
The presence of the DNA fragment of interest was confirmed by electrophoresing 4 
µl of the PCR product mixed with 1 µl of loading buffer (New England Biolabs, 
Hitchin, UK) in an 1 – 2 % agarose gel using a size marker (HyperLadder I, Bioline, 
London, UK) to confirm the correct fragment size (Sambrook et al., 1989). DNA was 
stained with ethidium bromide (10 mg/ml) and visualized under UV light to confirm 
amplification. Few modifications due to variations in fragment size or primers used 
were performed accordingly. Techniques that imply a great variation from this 
protocol, such as touchdown-PCR and q-PCR, are explained in later sections. 
 
2.10 Cloning of bacterial 16S rRNA genes. 
 
Amplicons generated by end-point PCR and Taq DNA polymerase were cloned into 
E. coli by using the TOPO TA Cloning® kit (Invitrogen, Paisley, UK). Fresh PCR 
product (0.5 to 4 µl, depending on DNA concentration) was mixed gently with 1 µl 
salt solution, 1 µl of the TOPO vector plasmid and sterile water (final volume 6 µl).  
Incubation of the mixture at RT (22-23ºC) for 30 minutes allowed for ligation of 
PCR product to the plasmid.  A 2 µl volume of the reaction mixtures was then added 
to individual vials of One Shot® chemically competent TOP10 E. coli (provided 
with the kit), mixed gently and then incubated on ice for 30 minutes.  After 
incubation the cells were heat-shocked for 30 seconds in a 42ºC water bath.  
  
Table 2.3 Universal primers used in this study for amplification and sequencing of fragments within the 16S rRNA gene. 
 
PRIMER 
NAME 
Primer 
direction PRIMER SEQUENCE 
position in E. 
coli REFERENCE 
27F-YMa forward 5'-AGAGTTTGATYMTGGCTCAG-3' 8-27 
(Lane, 1991, Weisburg et al., 
1991) 
1492R reverse 5'-TACGGYTACCTTGTTACGACTT-3' 1506-1492 
357Fb forward 5'-CTCCTACGGGAGGCAGCAG-3' 341-357 
357R reverse 5'-CTGCTGCCTCCCGTAGGAG-3'  357-341 
518R reverse 5'-ATTACCGCGCTGGTGG-3' 534-518 (Muyzer et al., 1993) 
C11R reverse 5'-ACGTCATCCCCACCTTCCTC-3'  1246-1227 (Loy et al., 2008) 
      
a
 27F-YM+3 (Frank et al., 2008) was used for analysis of NGA (p.88) b 357F-GC was used for DGGE analysis (p. 90). Modifications are explained in the text. 
 
Table 2.4  Species-specific primers used in this study for amplification of a fragment within the 16S rRNA gene. 
 
TARGET BACTERIUM PRIMERS PRIMER SEQUENCE 
position in E. 
coli REFERENCE 
F. nucleatum Fn1F 
Fn2R 
5'-GACAGAGCTTTGCGTCC-3' 
5'-TGGGCGCTGAGGTTCGAC-3' 
 212-228 
 821-804 
(Nagano et al., 2007) 
A. actinomycetemcomitans AaF* 5'-ATTGGGGTTTAGCCCTGGTG-3' 889 - 911  (Tran and Rudney, 1999) 
P. gingivalis Pg2F 
Pg2R 
5'-GCGTATGCAACTTGCCTTAC-3' 
5'-GTTTCAACGGCAGGCTGAAC-3' 
89-108 
612-593  
(Wahlfors et al., 1995) 
T. forsythia Tf2F* 5'-GCGTATGTAACCTGCCCGCA-3'  120-140 (Sakamoto et al., 2001) 
G. elegans GeF* 5'-AGAAGGAAAAGAGGCTTCGG-3'   196 - 215 (Roggenkamp et al., 1998) 
* The following primers were complemented with a universal reverse primer for specific bacterial amplification (see Table 2.5).
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This was followed by the addition of 250 µl S.O.C. medium (Invitrogen) at RT.  The 
cells were then shaken horizontally at 37ºC for 1 hour and then 50 and 100 µl 
volumes were aliquoted onto pre-warmed Luria-Bertani agar supplemented with 50 
µg/ml kanamycin and finally incubated at 37ºC overnight. Colonies were then 
selected based upon the presence of an insert with X-gal (5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside). The presence of the insert was confirmed by PCR 
amplification of the white colonies using the same protocols as performed in the first 
amplification reaction. 
 
2.11 Denaturing gradient gel electrophoresis. 
 
2.11.1 DGGE profiling - Touchdown PCR. 
 
DGGE analysis was performed to identify the profile of bacteria present in samples 
of NGA. The V2-V3 region of the 16S rRNA gene was amplified using the PCR 
primers 357F-GC, which consisted of the 357F primer and a 40 bp GC clamp starting 
from the 5’ end, and the 518R (Table 2.3). The amplification reaction mixture 
contained 1 X PCR buffer, 2.5 mM MgCl2, 0.2 mM of dNTPs, 0.2 µM of each 
primer, 2.5 U of BioTaq DNA polymerase (Bioline, London, UK), and 5 µl of the 
genomic DNA. The cycling parameters for a touchdown PCR were as follows:  after 
pre-incubation at 94°C for 5 minutes, 34 cycles were performed at 94°C for 1 
minute, annealing temperature (TA) for 1 minute and 72°C for 1 minute.  The TA 
decreased step-wise by 1°C every 2 cycles from 65°C in the first cycle to 56°C in the 
20th cycle.  The TA for the last 14 cycles was 55°C.  Cycling was followed by 5 
minutes incubation at 72°C.  The expected product length (~235 bp) was confirmed 
by electrophoresis in a 2.6% agarose gel stained with ethidium bromide and run 
together with a size marker (HyperLadder V, Bioline, London, UK). 
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2.11.2 Casting parallel gels. 
 
Parallel gels containing 10% (w/v) polyacrylamide (37.5:1 
acrylamide:bisacrylamide) were cast using a DCode system (BioRad laboratories 
Inc., Hertfordshire, UK) (Figure 2.5).  The gels contained a linear gradient of the 
denaturants urea and formamide, increasing from 30% at the top of the gel to 60% at 
the bottom (with 100% denaturants corresponding to 7 M urea and 40% [v/v] 
deionised formamide).  PCR products (15 µl) and loading buffer (6 µl) were loaded 
onto the gels and run at 58 V for 17 hours at a constant temperature of 60°C in 7 
litres of 1 X TAE buffer (40 mM Tris base-acetic acid buffer and 1mM 
ethylenediaminetetraacetic acid pH 8.0) (Figure 2.6). Gels were stained for 20 
minutes in 1 X TAE containing 0.0001% SYBR® Gold Nucleic Acid Gel Stain 
(Molecular Probes, Paisley, UK) and photographed under UV light. 
 
2.11.3 DGGE band excision. 
 
Band excision was carried out using a sterile scalpel on a Syngene GVM20 
transilluminator (Synoptics Ltd, Cambridge, UK).  DNA fragments were then eluted 
into 20 µl of molecular grade water at 4ºC for 24 hours (Ampe et al., 1999). One 
microliter of the eluted DNA from each DGGE band was reamplified by using the 
same conditions described for the DGGE-PCR. To evaluate the success of this 
procedure and to verify whether single DGGE bands had been excised, 3 µl of the 
PCR reaction was electrophoresed through an identical DGGE gel. 
 
2.12 Purification of PCR products. 
 
All PCR products were purified before sequencing using the QIAquick PCR 
Purification kit (QIAGEN, Crawley, UK) as indicated by the manufacturer. 
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Figure 2.5 Casting stand and gradient delivery system for casting a parallel gradient gel for 
DGGE analysis. Source: Instruction Manual, DCode Universal Mutation Detection System, Bio-Rad 
Laboratories. 
 
 
 
 
Figure 2.6 DGGE-PCR products running in a gel containing a linear gradient of denaturants 
increasing from 30% at the top to 60% at the bottom. Electrophoresis was performed at 58 V at a 
constant temperature of 60°C in TAE buffer for 17 hours. 
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2.13 Quantitative PCR analysis. 
 
Quantitative PCR analyses were performed using the SYBR Green I method. 
Multiwell-96-plates were used, each well containing 4 µl of the 2 x LightCycler® 
FastStart DNA Mastermix (Roche Diagnostic, West Sussex, UK), 5 µM of each 
primer, 2 µl of the template and de-ionised H2O to a final reaction volume of 10 µl. 
All multiwell plates were sealed, centrifuged at 3000 g for 5 s, and then amplified in 
a LightCycler LC480 instrument, with activation of polymerase (95°C for 5 min), 
followed by 45 cycles of 10 s at 95°C, 6 s at the TA determined for each set of 
primers, and a predetermine extension time at 72°C.  
 
The set of primers used for the q-PCR analyses and the respective TA and extension 
times are detailed in Table 2.5. In general, the TA was calculated as 3 to 5°C below 
the MT of the primer with the lowest MT (Sambrook et al., 1989). Extension time was 
based upon the expected fragment length and was calculated as 1 second for every 25 
bp. The temperature transition rate was 4.4°C⁄ s for all steps. Double-stranded PCR 
product was measured at 76°C for 1 s by detection of fluorescence associated with 
the binding of SYBR Green I to the product. Fluorescence curves were analysed and 
the absolute amounts were determined by the LightCycler® software v. 1.5. Melting 
curve analysis was performed immediately after the amplification protocol under the 
following conditions: 30 s at 95°C, 30 s at 65°C and acquisition at 99°C. 
Temperature change rates were 4.4°C⁄ s, except in the final step, which was 0.1°C⁄ s. 
The melt peak generated represented the specific amplified product. Positive 
controls, comprising by a known dilution of the strain, were included in triplicate in 
all tests. Negative controls were also included, containing de-ionised H2O instead of 
the DNA template and no H2O/template.  All samples were initially processed in a 
single reaction and, when possible, confirmed in triplicate when a positive result was 
found.  
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Table 2.5 Primers used in this study for bacteria quantification and conditions for each set of 
primers.  
 
BACTERIAL 
TARGET 
PRIMER 
SET* 
Fragment 
length 
Annealing 
Temperature 
Extension 
Time 
General bacteria 
 
200 bp 58°C 10 sec 357F- 518R 
F. nucleatum 
 
609 bp 57°C 25 sec Fn1F- Fn2R 
A. 
actinomycetemcomitans 
 
 
360 bp 61°C 15 sec AaF- C11R 
P. gingivalis 
 
518 bp 59°C 21 sec Pg2F- Pg2R 
T. forsythia 
 
240 bp 62°C 11 sec Tf2F- 357R 
G. elegans 
 
160 bp 59°C 7 sec GeF- 357R 
 * Primer sequences are detailed in Tables 2.3 and 2.4. 
 
 
2.14 Primer set specificity test. 
 
Each set of primers used to amplify a specific genus or species were tested in this 
study for specificity using end-point PCR. The specificity of the primers were 
determined through the application of the following: (i) using probeCheck tool, 
Department of Microbial Ecology, University of Vienna (Loy et al., 2008); (ii) 
against genomic DNA extracted from a pure culture of the specific species; (iii) 
against several oral bacterial strains (Table 2.6); (iv) against 10 common strains 
determined as prevalent in the samples of NGA in this study (see Section 3.5.1 in 
Chapter 3, Construction of a standard for DGGE analysis). De-ionised H2O was 
included as a negative control in each experiment. Finally, the primers were also 
tested by sequencing the products as obtained from clinical samples in order to 
confirm its identity. 
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2.14.1 Oral bacterial strains to test primer specificity. 
 
The bacteria used in this study to test primer specificity consisted of a list of common 
oral species (Table 2.6). Genomic DNA was extracted from each strain as previously 
detailed. The quality and concentration of the extracted DNA was then measured 
using a Nanodrop®  ND-1000 Spectrophotometer (Thermo Scientific, East Sussex, 
UK), and stocks at approximately 50 ng/µl were prepared from each strain. 
 
Table 2.6 Oral strains of bacteria used for primer specificity test.  
 
    BACTERIUM STRAIN TYPE SOURCE 
1   A. actinomycetemcomitans  HK998 EDI 
2   Actinomyces naeslundii DSM 17233  EDI 
3   Fusobacterium nucleatum NCTC 10562  EDI 
5   Lactobacillus casei ATCC 334  EDI 
6   Neisseria subflava  DSM 17610 EDI 
7   Prevotella intermedia   DSM 20706 EDI 
8   Porphyromonas gingivalis   W50 EDI 
9   Pseudomonas aeuriginosa  PAO1 EDI 
10   Streptococcus anginosus  NCTC 10713 EDI 
11   Streptococcus gordonii  NCTC 7865 EDI 
12   Streptococcus mitis  NCTC 122 EDI 
13   Streptococcus mutans  ATCC 700610 EDI 
14   Streptococcus salivarius  NCTC 8618 EDI 
15   Streptococcus oralis  NCTC 11427 EDI 
16   Streptococcus sanguinis   NCTC 02863 EDI 
17   Staphylococcus aureus  8325-4 EDI 
18   Tanerella forsythia ATCC 43037 CID 
19   Veillonella dispar  NCTC11831 EDI 
EDI, Eastman Dental Institute, UCL; CID, Centre for Infectious Disease, Barts 
and the London SMD, QMUL. 
 
 
2.15 Specific amplification of the 16S-23S rDNA intergenic spacer region. 
 
A forward primer within the 16S rRNA gene specific for the genus Fusobacterium 
(Fn1F, Table 2.3), and a universal primer within the 23S rRNA gene, either 456R or 
the 129R (Table 2.7), were used to amplify the complete ISR from any component of 
 CHAPTER 2: MATERIALS AND METHODS 
 
 
96 
 
the genus. PCR reaction conditions used to amplify this considerably longer 
fragment of DNA were a modification of the method previously described. A final 
reaction volume of 50 µl contained 1X PCR buffer, 4 mM MgCl2, 0.4 mM of dNTPs, 
0.2 µM of each primer, 0.5 U of BIO-X-ACT™ Long DNA Polymerase (Bioline, 
London UK), and either 2 µl of the extracted DNA from the reference strain, or 5 µl 
of the extracted genomic DNA obtained from the clinical samples. The PCR cycle 
was identical to the one previously described (Section 2.9) except for the extension 
time that was increased to 3.5 minutes. 
 
2.16 Extended agarose gel analysis. 
 
An extended agarose gel analysis was used to confirm amplification of the ISR, and 
in order to discriminate even small variations of the fragment sizes in the gel. The 
amplified products of ca. 2000 bp were resolved on a 0.8% agarose gel in TAE 
electrophoresis buffer at 65V using a size marker HyperLadder I (Bioline, London, 
UK). An extended electrophoresis time of 4 hours was determined in this study as the 
most efficient time to resolve the bands. 
 
2.17 Sequencing. 
 
All sequencing was carried out at the Genome Centre, Barts and The London using 
BigDye 3.1 chemistry with visualization on an ABI 3700 automated DNA sequencer.  
The primers used in the sequencing reactions varied according to the technique. The 
357F primer (Table 2.3) was used for sequencing the fragments obtained from 
neonatal samples. The species-specific forward primers described in Table 2.4 were 
used to amplify fragments of specific bacterial species. A list of the primers used for 
sequencing of the ISR is detailed in Table 2.7.  
 
Usually, sequencing produced an 800 bp sequence length (whereas DGGE analysis 
produced 150bp fragments). The quality of the sequences was checked using the 
Chromas software package (http://www.technelysium.com.au/chromas.html). 
Sequences of the ISR products amplified using both a forward and a reverse primer 
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were aligned and corrected using Multalign, a multiple sequence alignment tool 
(Corpet, 1988) and Chromas. 
 
Table 2.7 Primers used in this study for the amplification and sequencing of fragments of the 
16S-23S rDNA ISR. 
 
PRIMER 
NAME* PRIMER SEQUENCE 
position in 
E. coli REFERENCE 
1114F 5'-GCAACGAGCGCAACCC-3' 1114-1130 
(Stackebrandt and 
Goodfellow, 1991) 
129R 5'-GGTTBCCCCATTCRG-3' 129-114 (Hunt et al., 2006) 
456R 5'-CCTTTCCCTCACGGTACT-3' 456-438 (Hunt et al., 2006) 
* Primer FnF1 was also used for the amplification of the ISR. Sequence details in Table 2.4. 
 
 
2.18 Sequence comparative analysis. 
 
Bacterial sequences were identified by comparison with libraries of sequences based 
upon ≥97% similarity with the closest relative (Patel, 2001). The on-line libraries 
used comprised thousands deposit bacterial 16S rRNA gene sequences from the 
Ribosomal Database Project (RDP) (Cole et al., 2007), the Human Oral Microbiome 
Database (HOMD) (Chen et al., 2010), and the Basic Local Alignment Search Tool 
(BLAST) of the National Center for Biotechnology Information 
(http://blast.ncbi.nlm.nih.gov/Blast). 
 
2.19 Phylogenetic analysis. 
 
Phylogenetic analysis was used to determined evolutionary relationships between 
strains of F. nucleatum. Multiple alignments of the sequence data were performed 
using the AlignX tool of the VectorNTI software (Advance 11.5 version; Invitrogen). 
Phylogenetic trees corresponding to the alignments were created using the ClustalW 
algorithm (pairwise alignments). Evolutionary history was inferred using the 
Neighbour-Joining method (Saitou and Nei, 1987) based upon the principle of 
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minimum evolution, which defines the topology of a tree by successively finding and 
joining pairs of neighbours. The method provides also the branch length determined 
from a matrix of distances between all pairs of sequence. These distances are related 
to the degree of divergence between the sequences which determined the alignments 
of the tree. 
 
2.20 Statistical analyses and data presentation. 
 
Data was summarized in tables organised by counts, mean, or median, depending on 
the type of data. In general, counts or prevalence were used to describe qualitative 
data. Mean was used for quantitative data that was normally distributed and median 
was used for quantitative data that did not present this characteristic. 
 
All the graphs were performed using the IBM®SPSS® Statistical 19 software (IBM 
UK Ltd, Middlesex, UK). Clustered bar charts were used for qualitative data, usually 
when a significant statistical difference between two variables was observed. To 
illustrate quantitative data, i.e. the absolute and relative levels of bacteria, box-plots 
were constructed. Simple and clustered boxplots with interquartile range and outliers 
were used. The bottom and top of the box corresponded to the 25th and 75th 
percentiles, the band near the middle of the box represented the median (the 50th 
percentile). The results that substantially differed from the rest of the data, the 
outliers, were also included in the diagrams as small circles (mild outliers) or stars 
(extreme outliers). The addition of outliers in the box-plots was particularly useful to 
observe cases with high levels of bacteria and/or in high percentage. The data is 
presented on either logarithmic or linear scale, depending on the levels observed in 
the samples. 
 
Statistical analyses were performed to compare prevalence, levels, and percentage of 
general and specific bacteria in NGA with important demographical and clinical 
data, as well as characteristics of sample collection. Presence of bacteria was treated 
as a binomial variable: present or absent. The 2-sided Fisher’s exact test was used to 
compare detection of bacteria with the binomial covariates included in this study. 
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One-way ANOVA was applied to compare presence of bacteria with those variables 
with more than two categories, i.e. type of PTB and LBW. The independent t-tests 
were used when analysing parametric data to compare prevalence of bacteria with 
variables presented as quantitative data, i.e. gestational age and birthweight. Finally, 
the non-parametric Mann-Whitney U Test was used to compare quantitative levels of 
bacteria with the demographical/clinical variables. A p-value of <0.05 was 
considered to indicate statistical significance. 
 
Finally, multivariate analyses were performed to control for the effect of those 
important variables in the occurrence of broad or specific bacteria in samples of 
NGA. The odds ratio (OR) and confidence intervals were reported. All statistical 
analyses were performed using the IBM® SPSS® Statistics Software, version 19.0. 
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3.1 Introduction. 
 
It is likely that the bacteria causing an infection in the fetus and/or neonate may have 
originated from a maternal site harbouring a complex community (e.g. the vagina, 
the gut, or the oral cavity), and that more than one single pathogen may have 
translocated from the contributor site to the amniotic environment. Few studies have 
fully characterized the bacterial diversity associated with APO.  The lack of this 
information is due to the techniques traditionally used (i.e. culture or species-specific 
molecular analysis), which usually identify only one or a few pathogens (Evans et 
al., 1988). As a consequence, the use of routine techniques would not allow 
identification of the bacterial complexity possibly associated with the complications.  
 
The overall aim of this project was to evaluate whether oral bacteria may have 
successfully translocated from the oral cavity to the amniotic environment. It is 
therefore important to have knowledge of the range of bacteria associated with cases 
of intrauterine infection, and which are possibly involved with APO. In addition, in 
order to identify the broader range of bacteria, including those present in low 
prevalence and low levels, improved and more sensitive protocols were necessary. 
 
Another limitating factor to the understanding of the potential pathogens associated 
with APO is related to the suitability of the sample investigated. The analysis of AF 
has been considered the ‘gold standard’ for investigating bacteria associated with 
intra-amniotic infection. However, samples of AF are usually obtained from healthy 
mothers/infants at 16-20 weeks of gestation for genetic testing.  Obtaining AF 
samples requires an invasive procedure, making it sometimes difficult to get the 
participant’s consent and ethical approval. Moreover, contrary to the reasons for 
these studies, this procedure presents the risk of accidentally introducing bacteria 
into the amniotic cavity (Romero and Mazor, 1988). Therefore, these samples would 
not provide be of great predictive value when compared to samples obtained from 
disease-associated cases. 
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In this study, the analysis of NGA has been proposed. It has been suggested that 
“surface body samples”, such as NGA, should contain the bacteria that reached and 
colonised the amniotic cavity before birth and therefore include those potential 
pathogens that possibly initiated an early-onset infections in neonates (Evans et al., 
1988). Historically, investigations that have evaluated the use of NGA as a tool to 
predict neonatal sepsis were of mixed success (Leibovich et al., 1987, Evans et al., 
1988, Puri et al., 1995). This may have been due to technique limitations (use of 
culture analysis) and the limited knowledge of the truly associated pathogen(s). As 
recently demonstrated, molecular detection of bacteria in NGA correlated with 
presence of chorioamnionitis and/or pROM (Miralles et al., 2005). Therefore, the 
study of NGA obtained from complicated pregnancies should provide a new insight 
into the investigation of the species of bacteria possibly associated with APO. 
 
In this chapter, the array of microorganisms present in samples of NGA obtained 
from neonates that were born from complicated pregnancies was determined. A 
combination of clone analysis and DGGE was applied in order to increase the 
probability of identifying the less prevalent species, including the bacteria present at 
low prevalence/levels. Furthermore, a detailed analysis of possible oral bacteria in 
the samples was introduced. 
 
3.2 Routine analysis of neonatal gastric aspirates as determined at the 
Microbiology Department, Barts and The London NHS Trust. 
 
The neonatal samples analyzed in this study were obtained as a surplus to the NGA 
routinely obtained under the regulations of the UK’s National Standard Methods. In 
accordance with these regulations, the samples were investigated using minimal 
microbiology standards, which consist of gram staining and basic microbial culture. 
These are the primary diagnostic methods used to date in most hospitals to determine 
the microorganisms present in a specific sample. Gram stain smears will not give a 
definite diagnosis; their purpose in medical settings is to allow rapid identification of 
bacteria to aid treatment and prognosis. Microbial culture allows growth and 
isolation of microorganisms using predetermined media under controlled laboratory 
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conditions. Culture particularly focuses on the range of bacteria that have been 
historically associated with neonatal sepsis (Table 3.1). All these procedures may 
take as long as 72 hours and are usually followed by further antibiotic susceptibility 
testing (Health Protection Agency, 2004). 
 
Table 3.1  Summary of the routine culture procedures performed under the “Standard 
Operating Procedure for the investigation of gastric aspirates and infection screen swabs from 
neonates” (BSOP23).  Source: Health Protection Agency (2004). 
 
Clinical 
details/ 
conditions 
Standard 
media 
Incubation 
Cultures 
read Target organism(s)* 
Temp 
⁰C Atmos Time 
Prolonged 
rupture of 
membranes 
Blood 
agar 35-37 5-10% 40-48 h daily 
Any of the following: 
β-haemolytic 
streptococci 
Possible 
sepsis Coagulase-negative 
staphylococci 
Enterococci 
 
CLED 
agar 35-37 air 16-24 h ≥ 16 h 
Enterobacteriacea 
L. monocytogenes 
Pseudomonas 
S. aureus 
Yeasts 
Pure growth of any 
  other organisms 
* Other organisms for consideration: N. gonorrhoeae, C. trachomatis, Mycoplasma species and U. 
urealyticum 
 
 
The analyses routinely performed at the hospital determined that 25.8% (62/240) of 
the NGA samples included in this study were positive using the gram staining 
technique; similarly, 25% (60/240) were positive with the culture analyses. This 
information was not produced in this study but data was obtained from the 
Microbiology Department’s database and is summarized in Tables 3.2 and 3.3. 
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Table 3.2 Number and percentage of samples of NGA positive with the gram staining 
technique as observed at the Microbiology Department, Royal London Hospital, Barts and The 
London NHS Trust. A total of 240 samples were analysed. 
 
Gram result # % 
G(+) cocci (total)  43 17.9 
 G(+) cocci pairs 5 2.1 
 G(+) cocci chains 8 3.3 
 G(+) cocci clusters 3 1.3 
G(+) rods 15 6.3 
G(-) cocci 3 1.3 
G(-) rods 21 8.8 
G(-) bacillus 2 0.8 
 
 
Table 3.3  Number and percentage of samples of NGA positive with the culture technique as 
observed at the Microbiology Department, Royal London Hospital, Barts and The London NHS Trust. 
A total of 62 samples were positive by culture. 
 
Culture result # % 
α-haemolytic streptococcus (including 
‘viridans’ streptococci) 7 
 
11.7 
group B streptococcus (GBS) 9 15.0 
Streptococcus spp. (S. bovis) 2 3.3 
coagulase-negative staphylococcus 7 11.7 
Staphylococcus aureus 1 1.7 
Corynebacterium spp. 2 3.3 
Enterococcus spp. 2 3.3 
E. coli 4 6.7 
Klebsiella pneumoniae 1 1.7 
coliform group bacteria 5 8.3 
‘skin flora’ 11 18.3 
‘mouth flora’ 3 5.0 
Bacillus spp. 1 1.7 
Gardnerella vaginalis 1 1.7 
‘anaerobes’ 4 6.7 
Candida albicans 4 6.7 
yeast 1 1.7 
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3.3 Molecular detection of bacteria in neonatal gastric aspirates.  
 
Samples of NGA were analysed in this study using clone analysis and DGGE 
approaches. Detection of bacteria in the samples was defined as clone analysis-PCR 
and/or DGGE-PCR positive as confirmed using 1% and 2.6% agarose gel 
electrophoresis, respectively.  With the clone analysis-PCR approach, 77 of the 240 
samples analysed (32.1%) were positive. Due to limited amount of the samples, only 
227 samples were available for the DGGE analysis of which 92 samples (40.5%) 
were positive. The percentage of positive samples with clone analysis when 
including only the 227 samples used for DGGE was 76 (33.5%). This excluded a 
smaller sample size as the reason for the higher detection rate with DGGE. Positive 
samples were then analysed in order to identify the bacterial species. Figure 3.1 
illustrates a comparison of the same set of samples (N=240) analysed for the 
presence of bacteria using different detection techniques. 
 
 
Figure 3.1 Clustered bar graph representing number of positive and negative samples for 
presence and absence of bacteria using different detection techniques. The percentage of positive 
samples out of the total evaluated are indicated on top of the positive bars. 
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3.4 Clone analysis. 
 
The number of clones analysed per sample was initially 10 due to a low expected 
richness of the samples based upon previous studies (Evans et al., 1988). 
Nevertheless, it was observed in a preliminary analysis in 50 samples that some 
samples showed a richness of as many as seven different species in 10 clones 
analysed. Therefore, the following experiment was performed to determine the 
appropriate number of clones to be evaluated from each sample. 
 
3.4.1 Richness of the samples and number of clones to evaluate. 
 
Table 3.4 summarises the findings when evaluating as many as 47 clones from rich 
and less rich samples. The samples included in this experiment were randomly 
selected from different richness as observed in the initial 10 clones. It could be observed 
that in the 20 first clones selected, the number of taxa gradually increased for all the 
samples including the least rich, less rich, rich, and richest samples. After 20 clones, 
the number of taxa detected only increased significantly for the richest sample. 
Therefore, it was decided to analyse 20 clones of each sample and, if necessary, 
include the analysis of a further 10 clones depending on the richness. 
 
Table 3.4 Number of taxa (richness) in NGA samples determined by cloning and sequencing. 
 
Test 
Sample 
Richness* 
No. of clones evaluated 
10 20 30 40 47 
T1 LEAST 
RICH 
1 1 2 3 3 
T2 1 2 2 2 2 
T3 LESS RICH 3 4 4 --- --- 
T4 RICH 5 6 6 8 --- 
T5 RICHEST 7 12 14 15 18 
       * Richness of the samples were determined from the analysis of the first 10 clones.  
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3.4.2 Taxa identified with clone analysis. 
 
Due to technique-sensitive protocols and limited amounts of the samples, bacteria 
were identified in 33 (43%)  of the 77 PCR-positive samples. A total of 932 clones 
were selected and sequenced for identification. Forty-two taxa were detected using 
this approach (Table 3.5), and the number of taxa per sample ranged between one 
and 11 with an average (mean±SD) of 2.4±2.1. To identify the species, the fragments 
of 16S rRNA gene were sequenced using the 357F primer and analysed by sequence 
comparison with both the RDP and the HOMD databases. 
 
3.5 Denaturing Gradient Gel Electrophoresis. 
 
3.5.1 Construction of a standard for DGGE analysis. 
 
The most prevalent bacteria, identified by clone analysis in this study, were used to 
construct a standard for DGGE in order to facilitate the analysis of the gel bands. 
Purified PCR products from clones containing the inserts that were identified as 
originating from a range of taxa (E. coli, G. vaginalis, L. crispatus, L. iners, S. 
agalactiae, Streptococcus pneumoniae/mitis/oralis/infantis, Sneathia 
sanguinegens/amnionii, U. urealyticum/parvum, V. montpellierensis, and V. parvula) 
were subjected to a nested DGGE-PCR. The amplifications were performed 
separately for each species, and also in the same reaction to confirm that each species 
arrested at different levels in the gel (Figure 3.2). The identity of the bands was 
confirmed after band excision and sequencing. The DGGE standard was run together 
with the samples positive for the DGGE-PCR primers. 
 
3.5.2 Taxa identified with DGGE. 
 
Forty-one percent (92/227) of the samples available for DGGE-PCR were positive, 
detecting a total of 37 operational taxonomic units in the 59/92 positive samples 
(64%) that were successfully characterized with this technique. A number of bands 
(n=372) were excised from the polyacrylamide gels and identified by sequencing.  
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Table 3.5 Bacteria identified in NGA samples using a 16S rRNA gene PCR, cloning, and 
sequencing approach (in 33 of the 77 PCR-positive samples). 
 
 
SPECIES IDENTIFIED BY CLONE ANALYSIS No. %^ 
1 Streptococcus pneumoniae/mitis/oralis/infantis* ¶ 16 48.5 
2 Escherichia coli ¶ 11 33.3 
3 Gardnerella vaginalis ¶ 8 24.2 
4 Ureaplasma urealyticum/parvum* ¶ 7 21.2 
5 Streptococcus sanguinis/gordonii* ¶  6 18.2 
6 Lactobacillus crispatus ¶ 5 15.2 
7 Lactobacillus iners ¶ 5 15.2 
8 Streptococcus agalactiae ¶ 5 15.2 
9 Sneathia sanguinegens/amnionii* ¶ 5 15.2 
10 Veillonella montpellierensis (V. atypica/parvula)* ¶ 4 12.1 
11 Aerococcus christensenii ¶ 3 9.1 
12 Peptoniphilus spp.¶  3 9.1 
13 Brevundimonas diminuta ¶ 3 9.1 
14 Staphylococcus epidermidis ¶ 2 6.1 
15 Streptococcus constellatus/intermedius/anginosus* ¶ 2 6.1 
16 Streptococcus salivarius/vestibularis* ¶  2 6.1 
17 Peptostreptococcus anaerobius ¶ 2 6.1 
18 Hyphomicrobium zavarzinii 2 6.1 
19 Sphingomonas spp.¶  2 6.1 
20 Propionibacterium acnes ¶  1 3.0 
21 Corynebacterium riegelii 1 3.0 
22 Bifidobacterium spp. 1 3.0 
23 Atopobium minutum 1 3.0 
24 Bacteroides spp. 1 3.0 
25 Prevotella spp.¶  1 3.0 
26 Staphylococcus spp. 1 3.0 
27 Granulicatella elegans¶  1 3.0 
28 Enterococcus faecalis 1 3.0 
29 Clostridium perfringens 1 3.0 
30 Anaerococcus vaginalis 1 3.0 
31 Faecalibacterium prausnitzii 1 3.0 
32 Veillonella parvula/dispar* ¶  1 3.0 
33 Fusobacterium necrophorum 1 3.0 
34 Fusobacterium nucleatum ¶ 1 3.0 
35 Fusobacterium periodonticum 1 3.0 
36 Sphingopyxis alaskensis ¶  1 3.0 
37 Caldimonas taiwanensis 1 3.0 
38 Haemophilus influenzae ¶ 1 3.0 
39 Moraxella osloensis ¶  1 3.0 
40 Pseudomonas aeruginosa/otitidis* ¶  1 3.0 
41 Pseudomonas fluorescens ¶  2 6.1 
42 Silanimonas lenta 1 3.0 
^ Determined as percentage of the samples positive to the universal bacterial 16S rDNA primers 
used analysed with this technique (out of 33) 
* Species considered in a same group due to difficulty in differentiating by 16S rRNA gene 
sequencing. 
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          1      2    3       4      5     6     7      8      9     10   A      B      C     x      y      z      
 
 
Figure  3.2 Negative image of a DGGE gel containing PCR products used for the construction 
of the standard for DGGE. Bacteria were run independently (1-10), in groups of 3-4 (x, y, z), and all 
together (A,B,C). Coloured dots indicate the levels at which each band arrested. Blue dots, single 
bacteria; green dots, groups of 3-4; red dots, all the bacteria. 1, E. coli; 2. G. vaginalis; 3, L. crispatus; 
4, L. iners; 5, S. agalactiae; 6, S. mitis group; 7, S. sanguinegens; 8, U. urealyticum/parvum; 9, V. 
montpellierensis; 10, V. parvula; A-C contain all bacteria in different amounts; A, 10 µl; B, 15 µl; C, 
20 µl. x, S. sanguinegens, L. iners, E. coli; y, U. urealyticum/parvum, S. agalactiae, V. parvula, G. 
vaginalis; z, L. crispatus, S. mitis group, V. montpellierensis. 
 
 
Twenty bands were identified by comparison with the standard and/or a band 
sequenced from a nearby sample that arrested at the same level (Figure 3.3). This 
was kept to a minimum since different species were observed to provide more than 
one consecutive band in the gel. This varied between samples and might occur due to 
high levels of a specific species in the sample. Therefore, excision and sequencing of 
the bands was considered the more reliable technique. The number of taxa identified 
per sample using a DGGE approach ranged from one to seven with an average of 
1.9±1.3. Table 3.6 summarizes bacteria species identified by DGGE in the samples 
of NGA. 
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Figure 3.3 Negative image of a DGGE profile of ~235 bp 16S rDNA fragments extracted from 
samples of NGA. Samples (1-8) were run in separate lanes between standards (S) originating from the 
following taxa: a. U. urealyticum/parvum*, b. S. sanguinegens/amnionii*, c. L. crispatus, d. S. 
agalactiae, e. L. iners, f. S. pneumoniae/mitis/oralis/infantis*, g. V. montpellierensis, h. E. coli, i. V. 
parvula/dispar*, j. G. vaginalis. Arrows indicate an example of bands arresting at the same level of 
the polyacrylamide gel and identified as U. urealyticum/parvum* as compared with standards and 
sequence of the PCR product. Sample 2 shows an example of multiple consecutives bands for U. 
urealyticum/parvum. * Species considered in a same group due to difficulty to differentiate by 16S 
rRNA approach. 
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Table 3.6 Bacteria identified in NGA samples using a DGGE-PCR and band sequencing 
approach (in 59 positive samples). 
 
 
SPECIES IDENTIFIED BY DGGE ANALYSIS No. %^ 
1 Streptococcus pneumoniae/mitis/oralis/infantis* ¶ 20 33.9 
2 Ureaplasma urealyticum/parvum* ¶ 16 27.1 
3 Lactobacillus iners ¶ 10 16.9 
4 Sneathia sanguinegens/amnionii* ¶ 8 13.6 
5 Streptococcus agalactiae ¶ 8 13.6 
6 Lactobacillus crispatus ¶ 7 11.9 
7 Pseudomonas aeruginosa/otitidis* ¶  7 11.9 
8 Gardnerella vaginalis ¶ 6 10.2 
9 Staphylococcus epidermidis ¶ 5 8.5 
10 Escherichia coli ¶ 5 8.5 
11 Haemophilus influenzae ¶ 4 6.8 
12 Prevotella bivia 3 5.1 
13 Streptococcus sinensis/parasanguis* 3 5.1 
14 Peptoniphilus spp.¶  3 5.1 
15 Veillonella montpellierensis (V. atypica/parvula)* ¶ 3 5.1 
16 Pseudomonas fluorescens ¶  3 5.1 
17 Aerococcus christensenii ¶ 2 3.4 
18 Streptococcus constellatus/intermedius/anginosus* ¶ 2 3.4 
19 Streptococcus salivarius/vestibularis* ¶  2 3.4 
20 Peptostreptococcus anaerobius ¶ 2 3.4 
21 Fusobacterium nucleatum ¶ 2 3.4 
22 Brevundimonas diminuta ¶ 2 3.4 
23 Propionibacterium acnes ¶  1 1.7 
24 Prevotella sp.¶  1 1.7 
25 Granulicatella elegans¶  1 1.7 
26 Lactobacillus gasseri 1 1.7 
27 Streptococcus sanguinis/gordonii* ¶  1 1.7 
28 Megasphaera sp. 1 1.7 
29 Veillonella parvula/dispar* ¶  1 1.7 
30 Sphingopyxis alaskensis ¶  1 1.7 
31 Sphingomonas spp.¶  1 1.7 
32 Massilia sp. 1 1.7 
33 Klebsiella pneumoniae 1 1.7 
34 Proteus mirabilis 1 1.7 
35 Acinetobacter baumannii 1 1.7 
36 Moraxella osloensis ¶  1 1.7 
37 Mycoplasma hominis 1 1.7 
^ Determined as percentage of the samples positive to the universal bacterial 16S rDNA 
primers used analysed with this technique (out of 59). 
* Species considered in a same group due to difficulty to differentiate by 16S rDNA approach 
¶ Species detected by 16S rRNA gene cloning and sequencing and DGGE. 
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3.6 The combined molecular approach to determine the microbiology of neonatal 
gastric aspirates. 
 
When comparing the results obtained with the cloning and the DGGE analyses, it 
was observed that they differed greatly as regards the prevalence of bacteria 
described. Forty-two species were identified with cloning, while 37 bacteria could be 
identified with DGGE. However, bacteria observed only matched for 28 species 
(55%) out of the 51 observed with both techniques. This difference observed 
between the techniques was basically due to those less prevalent taxa. When the 
bacteria observed only once were not included, 30 and 29 species were identified for 
cloning and DGGE respectively matching in 90% (28 of 31) of cases. Clone analysis 
used in isolation identified most of the bacteria observed only once (n=22). 
 
The results obtained from both techniques were combined in order to describe the 
microbiology of NGA. With the combined molecular approach 142 (59%) of the 240 
samples were negative with the molecular techniques used. In the 98 (40.8%) 
samples positive, the total number of taxa detected was 51. The taxa identified in the 
NGA fell into six different phyla, namely Actinobacteria, Bacteroides, Firmicutes, 
Fusobacteria, Proteobacteria and Tenericutes. Table 3.7 summarizes the bacteria 
identified in the samples as organized by phylum, class, order, family, genus, and 
species. 
 
Bacteria most prevalent (% out of 98 positive samples) were: S. 
pneumoniae/mitis/oralis/infantis (28%), U. urealyticum/parvum (18%), 
Lactobacillus spp. (18%), E. coli (14%), Pseudomonas spp. (12%), S. agalactiae 
(11%), G. vaginalis (10%), and S. sanguinegens/amnionii (9%). 
 
 
 
 
 
   
 
 
Table 3.7 Taxonomic classification of the bacteria identified in NGA using clone analysis and DGGE in a combined molecular approach. 
 
 
PHYLUM CLASS ORDER FAMILY GENUS SPECIES No. %^ 
1 
Actinobacteria Actinobacteria 
Actinomycetales Corynebacteriaceae Propionibacterium Propionibacterium acnes ¶  2 2.0 2 Propionibacteriaceae Corynebacterium Corynebacterium riegelii a 1 1.0 
3 Bifidobacteriales  Bifidobacteriaceae Bifidobacterium Bifidobacterium sp.
a
 1 1.0 
4 Gardnerella Gardnerella vaginalis ¶ 10 10.2 
5 Coriobacteriales Coriobacteriaceae Atopobium Atopobium minutum a 1 1.0 
6 
Bacteroidetes Bacteroidia Bacteroidales  
Bacteroidaceae  Bacteroides Bacteroides sp.a 1 1.0 
7 Prevotellaceae Prevotella Prevotella bivia 
b
 3 3.1 
8 Prevotella sp.¶  2 2.0 
9 
Firmicutes I Bacilli 
Bacillales Staphylococcaceae Staphylococcus Staphylococcus epidermidis ¶ 6 6.1 10 Staphylococcus sp.a 1 1.0 
11 
Lactobacillales 
Aerococcaceae Aerococcus Aerococcus christensenii ¶ 4 4.1 
12 Carnobacteriaceae Granulicatella Granulicatella elegans¶  2 2.0 
13 Enterococcaceae Enterococcus Enterococcus faecalis a 1 1.0 
14 
Lactobacillaceae Lactobacillus 
Lactobacillus crispatus ¶ 8 8.2 
15 Lactobacillus gasseri b 1 1.0 
16 Lactobacillus iners ¶ 13 13.3 
17 
Streptococcaceae Streptococcus 
Streptococcus agalactiae ¶ 11 11.2 
18 
Streptococcus 
constellatus/intermedius/anginosus* ¶ 2 2.0 
19 Streptococcus salivarius/vestibularis* ¶  4 4.1 
20 Streptococcus sanguinis/gordonii* ¶  7 7.1 
21 Streptococcus sinensis/parasanguis* b 3 3.1 
22 
Streptococcus 
pneumoniae/mitis/oralis/infantis* ¶ 27 27.6 
^ Determined as percentage of the samples positive to the universal bacterial 16S rDNA primers used (out of 98); ¶ Species detected with both molecular 
techniques;  
a
 Species identified with cloning analysis only; b Species identified with DGGE approach only     continue on following page 
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Table 3.7              (cont.) 
23 
Firmicutes II Clostridia Clostridiales 
Clostridiaceae Clostridium Clostridium perfringens a 1 1.0 
24 Incertae Sedis XI Anaerococcus Anaerococcus vaginalis 
a
 1 1.0 
25 Peptoniphilus Peptoniphilus spp.¶  6 6.1 
26 Peptostreptococcaceae Peptostreptococcus Peptostreptococcus anaerobius ¶ 3 3.1 
27 Ruminococcaceae Faecalibacterium  Faecalibacterium prausnitzii a 1 1.0 
28 
Veillonellaceae 
Megasphaera Megasphaera sp.b 1 1.0 
29 Veillonella 
Veillonella montpellierensis (V. 
atypica/parvula)* ¶ 5 5.1 
30 Veillonella parvula/dispar* ¶  2 2.0 
31 
Fusobacteria Fusobacteria Fusobacteriales Fusobacteriaceae Fusobacterium 
Fusobacterium necrophorum a 1 1.0 
32 Fusobacterium nucleatum ¶ 2 2.0 
33 Fusobacterium periodonticum a 1 1.0 
34 Leptotrichiaceae Sneathia Sneathia sanguinegens/amnionii* ¶ 9 9.2 
35 
Proteobacteria 
Alphaproteobacteria 
Caulobacterales Caulobacteraceae Brevundimonas Brevundimonas diminuta ¶ 4 4.1 
36 Rhizobiales Hyphomicrobiaceae Hyphomicrobium Hyphomicrobium zavarzinii a 2 2.0 
37 Sphingomonadales Sphingomonadaceae Sphingopyxis Sphingopyxis alaskensis ¶  2 2.0 38 Sphingomonas Sphingomonas spp.¶  3 3.1 
39 Betaproteobacteria Burkholderiales Comamonadaceae  Caldimonas Caldimonas taiwanensis
 a
 1 1.0 
40 Oxalobacteraceae Massilia Massilia sp.b 2 2.0 
41 
Gammaproteobacteria 
Enterobacteriales Enterobacteriaceae 
Escherichia/Shigella Escherichia coli ¶ 14 14.3 
42 Klebsiella Klebsiella pneumoniae b 1 1.0 
43 Proteus Proteus mirabilis b 1 1.0 
44 Pasteurellales Pasteurellaceae Haemophilus Haemophilus influenzae ¶ 4 4.1 
45 
Pseudomonadales 
Moraxellaceae Acinetobacter Acinetobacter baumannii 
b
 2 2.0 
46 Enhydrobacter Moraxella osloensis ¶  2 2.0 
47 Pseudomonadaceae Pseudomonas Pseudomonas aeruginosa/otitidis* ¶  8 8.2 48 Pseudomonas fluorescens ¶  5 5.1 
49 Xanthomonadales Xanthomonadaceae Silanimonas Silanimonas lenta a 1 1.0 
50 Tenericutes Mollicutes Mycoplasmatales Mycoplasmataceae Mycoplasma Mycoplasma hominis 
b
 1 1.0 
51 Ureaplasma  Ureaplasma urealyticum/parvum* ¶ 18 18.4 
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3.7 Bacteria from a possible oral origin. 
 
Extensive lists of bacteria characterized from a diverse range of healthy and/or 
diseased sites in the oral cavity have been published in a number of studies. The 
species identified in samples of NGA were compared with those studies that have 
used non-specific molecular approaches to characterise oral bacteria (Dymock et al., 
1996, Kroes et al., 1999, Paster et al., 2001, Munson et al., 2002, Paster et al., 2002, 
Hutter et al., 2003, Kazor et al., 2003, Aas et al., 2005, Kumar et al., 2005, Chhour et 
al., 2005, Paster et al., 2006, Tanner et al., 2006, de Lillo et al., 2006, Diaz et al., 
2006, Sakamoto et al., 2006, Ledder et al., 2007, Siqueira et al., 2007, Riggio et al., 
2007, Riggio et al., 2008, Faveri et al., 2008, Siqueira and Rôças, 2009, Kanasi et al., 
2010). This was followed by an exhaustive search in Medline specific to the bacteria 
of interest to determine those species that are also resident in other non-oral sites.  
 
In this study, 15 of the species detected in the samples of NGA have been selected as 
potential oral pathogens due to a demonstrated association in the previous literature 
with the oral cavity either in health or disease (Figure 3.4). The oral cavity can act as 
the portal of entry of many bacteria from the external environment, and is also in 
close proximity with the nasopharynx and laryngopharynx microbiota. As a 
consequence, many of the microorganisms normally present in these non-oral sites 
might have been inevitably detected in the oral cavity in this and other studies. 
Therefore, to avoid selection of possible transient species, the species were further 
investigated to determine their relevance to the oral cavity (Table 3.8). Species such 
as A. baumannii (Paster et al., 2001) and P. bivia (Dymock et al., 1996) were 
excluded as previous studies did not provide conclusive evidence of the association 
with their oral cavity. Other bacteria known to be prevalent in the oral cavity but 
were not identified at the species level in this study were also excluded (Bacteroides 
spp., Bifidobacterium spp., and Megasphera spp.).  
 
 
   
 
 
Figure 3.4 Pie chart representing prevalence and percentage of the bacteria observed in samples of NGA using a combined molecular approach.  Those 
species from possible oral origin are highlighted in red. 
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 associations with pregnancy complications.
BACTERIA Association with pregnancy
(prevalence in NGA)#  complications
PTB, Chorioamnionitis,
Escherichia coli periodontitis, dentoalveolar GUT, GIT, genito-urinary tract stillbirth, pROM, meningitis Bhola et al ., 2008, 
(14%) absess, halitosis and relate infections in neonates, early onset Kuhn et al ., 2010
neonatal infection, PPROM
Bearfield et al ., 2002, 
Wilson 2008 Barak et al ., 2007, 
Fusobacterium     health, periodontitis, caries, A, B, C, D, E, F, GUT, GIT, genito-urinary tract, Truant et al ., 1983, PTB, stillbirth, preeclampsia, Hill 1993,
 nucleatum (2%) /  dentoalveolar absess, H, I, J, K, L, M, pericarditis, IE, brain abscess, UTI, Shammas et al ., 1993, chrorioamnionitis, previous Madianos et al ., 2001, 
periodonticum (1%) endodontic infection, N, O, P, R AF  Kai et al ., 2008, complications, pROM, AF, Han et al ., 2010, 
halitosis Ribot et al ., 1981  PROM Han et al ., 2009,
Cahill et al ., 2005, 
Jalava et al ., 1996
health, periodontitis, caries, Sato et al ., 1999, 
Granulicatella elegans dentoalveolar absess, Ohara-Nemoto  et al ., 2005, 
(2%) endodontic infection, Casalta et al ., 2002
halitosis
respiratory tract, genito-urinary tract, maternal sepsis, PTB, PTL, Warren et al ., 2010, 
Haemophilus nasal cavity, oropharinx,  eyes, Okuda et al ., 2005, chorioamnionitis, neonatal Gill et al ., 1995, 
influenzae (4%) pneumonia Wilson 2008  infections, PPROM Takala et al ., 1991, 
Jalava et al ., 1996
Wilson 2008, 
Truant et al ., 1983, 
Peptostreptococcus periodontitis, dento alveolar A, D, E, F, K, GUT, GIT, genito-urinary tract,  liver Shammas et al ., 1993,  BV in pregnant women, Hillier et al ., 1993, 
anaerobius (3%) absess, endodontic infection O, S absess, BV Kai et al ., 2008, endometriosis, AF Thadepalli et al ., 1978
Ribot et al ., 1981, 
Pybus and Onderdonk, 1998
health, periodontitis, Wilson 2008, intrauterine infection, BV, Gibbs et al ., 2004,
dentoalveolar absess, A, B, D, E, F, respiratory tract, GUT, GIT, vagina Persson et al ., 2009 chorioamnionitis (P. bivia) Hecht et al ., 2008
endodontic infection, caries  I, P
Table 3.8          Bacteria from a possible oral origin identified in NGA as previously determined using broad-range molecular techniques; their presence in non-oral sites, and 
5
6
1
2
3
4
REFERENCES^
Prevotella sp. (2%)
A, D, H Wilson 2008
A, B, E, G, H, L IE n/a n/a
health, periodontitis A, E, L
Presence in the oral cavity REFERENCES^,* Presence in non-oral sites REFERENCES^
Table 3.8             (cont.)
GUT, GIT, genituurinary tract, skin, 
endocarditis, endophthalmitis, 
Propionibacterium endodontic infection, Noma F, R osteomyelitis, joint, CNS, cranial Sasaki et al., 1980, placentitis and abortion
acnes (2%) neurosurgery infections, implanted Wilson 2008 in animals
biomaterial contamination
periodontitis, periodontitis, GUT, GIT, respiratory tract, 
Pseudomonas endodontic infection, dermatitis, soft tissue infection, Okuda et al., 2005, intraamniotic infection, 
aeruginosa (8%) immunocompromised bacteremia, bone and joint Wilson 2008 neonatal death
subjects infections, pneumonia
Staphylococcus skin and mucous membranes, 
epidermidis (6%) frequent hospital infections
Streptococcus health, periodontitis, ANUG, A, B, E, F, J, K, GUT, genito-urinary tract,  chorioamnionitis, BV McDonald and Chambers, 2000,
constellatus/inter  endodontic infection, absess  L, M, S, T respiratory tract, cardiovascular Wilson 2008 in pregnant women  Rabe et al., 1988
medius/anginosus (2%) disease, abdominal infection, CNS
Streptococcus health,  periodontitis, ANUG, A, B, C, E, F, H, GUT, genito-urinary tract, Wilson 2008, breast milk, PTB, PPROM, Martín et al., 2007, 
 mitis/oralis (27%)  endodontic infection, I, J, K, L, M, P,  respiratory tract, IE Aoyagi et al., 2005 neonatal meningitis DiGiulio et al., 2008, 
halitosis, caries Q, R, T Bignardi and Isaacs, 1989,
Streptococcus salivarius health, ANUG, uterine pathology in animals McDougall, 2005
/vestibularis (4%) halitosis
Streptococcus health, ANUG, periodontitis, A, B, C, E, G, H, Kassis et al., 2010, 
sanguinis/gordonii/   halitosis, caries  I, J, K, L, M, P, brain absess, IE Turner et al., 2009,
parasanguis (3%) Q Xiong et al., 2008
Streptococcus Woo et al., 2002, 
sinensis (3%) Faibis et al., 2008
Veillonella health, periodontitis, ANUG, A, B, C, E, F, G, GUT, GIT, genito-urinary tract, IE, Bhatti and Frank, 2000,
parvula/dispar endodontic infection, H, I, K, L, M, P, meningitis, osteomielitis Boo et al., 2005, PTB, PPROM Romero et al.,  1986
(2%) halitosis, caries Q, T Singh and Yu, 1992
GUT, genitourinary tract; GIT, gastrointestinal tract; UTI, urinary tract infection; IE, infective endocarditis; CNS, central nervous system; ANUG, acute necrotizing ulcerative gingivitis
#
 Percentage of the samples positive to the universal bacterial 16S rDNA primers used (out of 98)
* Legend for the reference for oral cavity studies are detail below.
REFERENCES: A, Paster et al ., 2001; B, Aas et al .,2005, C, Kroes et al ., 1999; D, Dymock et al ., 1996; E, Kumar et al ., 2005; F, Munson et al ., 2002; G, Kanasi et al ., 2010; H, Riggio et al ., 2008; 
I, Ledder et al ., 2007; J, Tanner et al ., 2006; K, de Lillo et al ., 2006; L, Diaz et al ., 2006; M, Hutter et al ., 2003; N, Sakamoto et al ., 2006; O, Siqueira and Rôças, 2009; P, Chhour et al ., 2005; 
Q, Kazor et al ., 2003; R, Paster et al ., 2002; S, Riggio et al ., 2007; T, Faveri et al ., 2008.
Oláh 2004
Lyons et al., 2009
A, B, C, H, J, L Wilson 2008
A
genito-urinary tract, GIT
n/a
endodontic infection, Noma F, R Otto, 2009 neonatal infection Nelson et al., 2009
13
15
14 health E, K IE n/a n/a
n/a
9
10
11
12
7
8
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Table 3.8 presents a description of those potential oral bacteria observed in NGA. 
The first column of this table summarizes those studies that have previously detected 
microorganisms as potential oral species using broad-range molecular techniques. 
The second column denotes the presence of these oral soecies in non-oral sites. Most 
of these pathogens are also normally found in non-oral sites such as the genitourinary 
tract, gastrointestinal tract, respiratory tract, and genito-urinary tract. Wilson (2008) 
provided an extensive overview of the distribution of microbial communities 
inhabitating humans that was used as a main reference source for this study. Also, a 
Medline search was performed to determine bacteria frequently found in other non-
oral sites in disease. A few exceptions, namely G. elegans, S. 
sanguinis/gordonii/parasanguis and Streptococcus sinensis, have only been found 
within the oral cavity and not at any other body site. Interestingly, they have been 
associated previously with infection in other body sites, including infective 
endocarditis and brain abscesses. 
 
Finally, a Medline search using “(the specific bacteria name)” AND “pregnancy” 
was performed to identified those microorganisms that have been previously 
associated with pregnancy complications. Again, most of the species have been 
associated previously with pregnancy complications, with the exception of G. 
elegans, S. sanguinis/gordonii/parasanguis and S. sinensis. Most of the studies that 
have identified F. nucleatum in association to an APO have also proposed the oral 
cavity as the source of the infection (Han et al., 2009, Han et al., 2010); other 
bacteria have been associated with the vagina or from diverse sources of 
contamination. 
 
3.8 Discussion. 
 
This chapter introduces a detailed description of the bacterial species contained in 
samples of NGA using molecular techniques. The specimens analysed were obtained 
from newborns that presented with an APO and/or were suspected to have an 
infection. Hence, the bacteria identified in the samples may be associated with the 
complications.  
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No healthy neonates could be sampled for NGA due to the invasiveness of the 
procedure. It could be anticipated that gastric fluids in newborn infants should be 
sterile since a healthy fetus is thought to develop in a bacteria-free environment and 
presence of bacteria in the amniotic cavity is considered a pathological finding 
(Romero et al., 2007). However, bacteria acquired during labour, at the time of 
delivery, or through other sources of contaminations may be present in these 
samples. Previous work have determined that presence of bacteria increased in 
labour from 3.5% to 13% when cervical dilatation increases from less than 4 cm to 
more than 4 cm (Seong et al., 2008). This has been explained by a suction-like effect 
during uterine contractions (Zervomanolakis et al., 2007). The microorganisms were 
more likely to originate from vaginal fluid aspirates since only few of these cases 
showed signs of chorioamnionitis and funisitis (umbilical cord infection). 
 
Also, a recent study has demonstrated that the initial microbiota in healthy neonates, 
as determined in multiple body habitats (skin, oral mucosa, and nasopharyngeal 
aspirate), reflects the mother’s vaginal  bacteria (Lactobacillus spp., Prevotella spp., 
and Sneathia spp.) in the case of vagina delivery, and the skin microbiota 
(Staphylococcus spp., Corynebacterium spp., and Propionibacterium spp.) if 
delivered by Caesarean section (Dominguez-Bello et al., 2010). However, in the 
study mentioned, the samples were obtained within 5 minutes of delivery, from more 
superficial sites (in comparison to NGA), and before removing the vernix caseosa. 
The vernix is the waxy ‘cheese-like’ film that covers the fetus during the last 
trimester. Its function is to act as a barrier to protect the newborn from bacterial 
infection. It is in direct contact with the maternal vagina and skin at the time of 
delivery, therefore presence of certain levels of vaginal and skin bacteria is expected. 
No other study reporting first colonisers in healthy neonates has been reported. In 
this report, a high percentage of samples (59%; 142/240) were negative for detection 
of bacteria which supports the assumption that either no bacteria, or low levels of 
vaginal and skin contaminants should be present in the gastric fluids from healthy 
infants. 
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The laboratory methods used in this study consisted of a combination of two broad-
coverage molecular techniques namely 16S rRNA gene sequencing (clone analysis) 
and DGGE profiling. A combination of methods to improve detection of microbial 
prevalence, diversity and abundance has been previously suggested (DiGiulio et al., 
2008, Payne et al., 2010). In this study, the use of a combined approach was 
introduced in order to benefit from the inherent positive aspects of each method and 
to overcome their limitations. The initial PCR varied for each technique in the 
fragment size amplified, the set of primers, and the conditions used (Muyzer et al., 
1993, Frank et al., 2008). This could explain the detection variations observed 
between both techniques i.e., 42 samples were positive with cloning-PCR, 38 
samples were positive with DGGE-PCR, and only in 28 did these methods coincide. 
At first glance, the techniques show great variability; nonetheless, the results 
demonstrated that both techniques have shown to be efficient in detecting the most 
prevalent bacteria. The combined approach therefore showed great advantage also 
detecting less prevalent species. This feature is important for the aims of this study 
since potential oral pathogens may be present in low prevalence and perhaps at a low 
numbers. 
 
Previous studies have investigated NGA using both traditional and molecular 
methods. Using the culture approach, microorganisms isolated have been limited to a 
few species, including E. coli, H. influenzae, S. aureus, L. monocygenes, S. 
pneumoniae, GBS, and species of the genus Lactobacillus, Klebsiella, Enterobacter, 
Serratia, Enterococcus, Pseudomonas, and Corynebacteria (Evans et al., 1988, 
Thompson et al., 1992, Borderon et al., 1994, Hammoud et al., 2003). Recently, 
Jones et al. (2010) demonstrated, using a q-PCR approach, that culture analysis of 
NGA was only positive when bacterial numbers exceeded 4.50E+05 CFU/ml (mean: 
3.10E+05; range: 3.00E+03- 1.74E+08). Therefore, routine analysis may 
underestimate the number of samples containing microbes. In this study 41% of the 
samples (98/240) were positive with the combined molecular approach compared to 
only 26% (60/240) culture-positive as determined at the Microbiology Department, 
Royal London Hospital. More importantly, culture-dependent methods may severely 
underestimate bacterial richness (Amann et al., 1995) usually reporting only one 
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single microorganism, while the results in this study describe up to 11 different 
species per sample (mean±SD: 2.2±2.2). This study supports the statement that 
routine culture analysis may represent a practical tool in the hospital to guide 
treatment in already established infections but is not useful to identify those unusual 
pathogens involved in fetal colonization and early-onset neonatal infections. 
 
Other studies have given an insight into the microbiota associated with APO. In fact,  
as determined by 16S rRNA gene PCR techniques, an association between intra-
amniotic infections and clinical events including early-onset neonatal sepsis, clinical 
and histological chorioamnionitis, and funisitis was demonstrated (Kotecha et al., 
2004, Miralles et al., 2005, Han et al., 2009). In these studies, species detected in the 
AF of women who present with an APO, were observed as Ureaplasma spp., M. 
hominis, G. vaginalis, F. nucleatum, S. sanguinegens, S. agalactiae, S. 
pneumoniae/mitis/oralis, and species of the genus Bergeyella, Prevotella, 
Bacteroides, Lactobacillus, Peptostreptococcus, Peptoniphilus, Staphylococcus and 
Haemophilus (Miralles et al., 2005, Han et al., 2009, Digiulio et al., 2010a, Digiulio 
et al., 2010b, Digiulio et al., 2010c). In general, the microbiota this study has 
identified in the NGA resembles those bacteria described in the mentioned AF 
studies. This observation supports the ability of NGA to be used as an alternative to 
AF to investigate the infections associated with APO. In addition, results from the 
study published by Miralles et al. (2005) contribute to this assumption as NGA 
showed an exact correlation with chorioamnionitis and/or pROM.  
 
Jones et al. (2010) identified many potential pathogens in NGA including U. 
urealyticum, G. vaginalis, S. sanguinegens/ammionii, Lactobacillus spp., Veillonella 
spp., H. influenza and S. agalactiae. However, the techniques they used were based 
upon direct sequencing and may not allow a detailed description of the microbiology 
of NGA. Also, Oue et al. (2009) identified 23 species that were also observed in this 
study. However, an additional 31 species were also identified using the combined 
molecular approach, including the more prevalent species G. vaginalis, L. iners, S. 
sanguinegens/amnionii, S. sanguinis/gordonii, V. montpellierensis, and A. 
christensenii, and some less prevalent taxa e.g. G. elegans, S.  
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constellatus/intermedius/anginosus, P. anaerobius, H. influenzae, B. diminuta, M. 
micronuciformis, S. sinensis/parasanguis, P. bivia, and V. parvula, most of which 
have not previously been detected in NGA. 
 
Finally, bacteria from a possible oral origin have been found in samples of NGA in 
this study. G. elegans, S. sanguinis/gordonii/parasanguis and S. sinensis unlike the 
other possible oral species, have only been described as inhabitants of the oral cavity 
and not at any other body site, therefore it is quite possible that these bacteria may 
have originated from the oral cavity. These species require particular attention as 
they are known to become blood-borne and have been associated with other systemic 
disease such as infective endocarditis (Roggenkamp et al., 1998, Ohara-Nemoto et 
al., 2005, Faibis et al., 2008, Woo et al., 2008, Xiong et al., 2008, Kassis et al., 
2010). The potential of these possible oral species to translocate via the bloodstream 
is supported by a number of studies (Soto et al., 1998, Allen et al., 2002, Turner et 
al., 2009). Interestingly, G. elegans was initially described as a member of the 
nutritionally variant streptococci (NVS) (Roggenkamp et al., 1998), which may 
explain shared virulence characteristics with the Streptococcus spp., the most 
commonly cause of endocarditis. These bacteria may have originated from the oral 
cavity, although it remains to determine whether they possess the ability to cross and 
invade the placental tissue.  
 
Species such as F. nucleatum/periodonticum, P. anaerobius, Prevotella spp., V. 
parvula, and members of the Streptococcus mitis, anginosus and salivarius groups 
found in this study are recognised as common oral bacteria as shown to be present in 
most of the broad-range molecular studies (Table 3.8). However many of these 
species are also common to the genito-urinary and gastrointestinal tracts (Srinivasan 
et al., 2009). Although in low prevalence (2%), special attention should be given to 
F. nucleatum. This is, in fact, the most common species isolated from AF in cases of 
PTL and intact membranes (Hill, 1998).  
 
Recently, the first evidence of F. nucleatum as the etiological cause of a stillbirth 
was reported (Han et al., 2010). Similarly to the findings reported in this study, Oue 
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et al. (2009) identified F. nucleatum in two (5%) of 42 bacteria-positive samples of 
NGA, whereas Han et al. (2009) detected the same species in 33.3% of AF positive 
samples. One reason for low detection may be due to the associated PCR 
amplification bias, which may preferentially amplify certain species (Kraytsberg and 
Khrapko, 2005). In this report, the use of a special set of primers including broad-
range segments for normally vaginal strains  may have contributed to the preferential 
amplification of other species over fusobacteria (Frank et al., 2008). With the use of 
species-specific primers, Bearfield et al. (2002) amplified F. nucleatum from 15% of 
AF samples and found a significant association with previous pregnancy 
complications. Further evidence regarding the potential ability of F. nucleatum to 
cross the placental tissues has been demonstrated in animal studies. Indeed, this 
microorganism has been observed to specifically invade the murine uterus without 
spreading systemically, resulting in preterm delivery, stillbirths and non-sustained 
live births (Han et al., 2004). Also, other work has been performed to evaluate the 
potential mechanisms used by F. nucleatum to colonise the placenta. It has been 
shown that the adhesin fadA may be involved in the attachment and invasion of 
placental tissue using in vitro and in vivo models (Han et al., 2005, Ikegami et al., 
2009).  Most of the studies usually imply F. nucleatum has an oral origin, although 
there is no conclusive evidence to support this. Other possible means whereby an 
oral pathogen might be transferred to the samples, need to be evaluated such as from 
medical staff during delivery and earlier colonization through oral-genital 
transmission from the partner followed by subsequent spread through the ascending 
route (Saini et al., 2010). Whether the bacteria have originated from the oral cavity or 
the vagina will be further analysed in the following chapters. 
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4.1 Introduction. 
 
Adverse pregnancy outcomes can occur in a range of clinical presentations and may 
be due to multiple causes. Intrauterine infection is a frequent and important 
mechanism for pregnancy complications. The causal link of infection leading to a 
diversity of clinical outcomes including fetal loss, preterm delivery, PROM, SGA 
infant, PTL, and neonatal morbidity and mortality has been well established (Gomez 
et al., 1995, Romero et al., 2002, Goldenberg and Thompson, 2003). The diagnosis 
of infection is not always performed since it could remain clinically silent for weeks 
or even months before it is manifested as one of many obstetric disorders (Gray et 
al., 1992). The predisposition to one of these presentations might be influenced by a 
gene-environment interaction and/or a gene-gene interaction involving maternal and 
fetal genotype (Romero et al., 2006). Also, several risk factors for the presentation of 
an APO have been suggested, including non-white ethnicity, low socio-economic 
status, low pre-pregnancy weight (41-45 Kg) or low BMI (body mass index), 
smoking and drinking habits, previous LBW or PTB, uterine and cervical anomalies, 
multiple pregnancies, maternal medical complications, gestational bleeding, 
urogenital infection and social isolation (Mavalankar et al., 1992). Other factors such 
as maternal age, parity, anxiety-stress during pregnancy, drug abuse, strenuous 
physical work-load, sexual activities, inadequate or no pre-natal care have also been 
proposed (Petridou et al., 2001, Moutquin, 2003a).  
 
In this study, prevalence of bacteria in NGA was investigated and is detailed in 
Chapter 3. However, multiple aetiology and the complex nature of pregnancy 
complications should be carefully considered at the time of interpretation of the data 
together with other considerations. For example, the presence of bacteria could 
indicate colonisation rather than infection. The term ‘colonisation’ refers to the 
persistent presence of indigenous bacteria in a commensal relationship with the host 
without causing any harm. Alternatively, the successful multiplication of a pathogen 
within, and at the expense of, a host is defined as an infection (Finlay and Falkow, 
1989). Infection does not always result in disease and, conversely, colonisation may 
sometimes lead to an opportunistic infectious disease (Asikainen and Chen, 1999). 
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Opportunistic species may proliferate as a result of the disease, but not necessarily be 
the cause of the disease. These opportunists may proliferate in numbers 
concomitantly with or after the true pathogens, thus making it difficult to determine 
the true pathogens involved with the complications. 
 
Another limitation when using NGA as a sample for analysis was the number of 
potential transient microorganisms that could be present in the samples. These are: a) 
bacteria from the maternal vagina and skin acquired during delivery (Dominguez-
Bello et al., 2010); b) possible bacterial contaminants from the hospital environment 
and personnel that may have reached the samples during delivery, collection and 
transportation of the sample. Finally, the routine administration of intrapartum 
antibiotic as a preventive strategy, which could have altered the microbiota in 
mothers and neonates, may have influenced the bacterial content in the samples. 
 
Therefore, a diverse range of demographical, clinical and outcome characteristics of 
the mother and infant, as well as the time and place of sample collection, were 
analysed in this study using a bivariate analysis (the analysis of two variables 
simultaneously) followed by a multivariable analysis (the analysis of multiple 
variables simultaneously). 
 
4.2 Demographical and clinical data. 
 
Demographical and clinical characteristics were obtained from all the cases 
evaluated in this study and are detailed in Tables 4.1 and 4.2. 
 
4.3 Comparisons between detection of bacteria and demographical/clinical data. 
 
Detection of general bacteria with the combined molecular approach showed 
significant association with both vaginal delivery (p= 0.001) and pROM (p<0.001) 
using the bivariate Fisher’s exact test (Table 4.3). Clustered bars representing the 
comparisons for these variables are shown in Figures 4.1 and 4.2. The p-value was 
placed to indicate differences between the groups. 
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Table 4.1 Demographical data. 
DEMOGRAPHICAL DATA TOTAL (%) 
NEONATE GENDERa 
  
Female (n) (%) 104 (43.5) 
Male (n) (%) 135 (56.5) 
MATERNAL AGEb; mean (SD), range 28.6 (5.8), 17- 46 
MATERNAL ETHNIC ORIGINa 
Asian-Bangladeshi/Indian/Pakistani (n) (%) 117 (49.0) 
Asian-other (n) (%) 16 (6.7) 
Black African/Caribbean/other (n) (%) 30 (12.6) 
White British/Irish/other (n) (%) 68 (28.5) 
Other-mixed (n) (%) 8 (3.3) 
a data only known for a239 cases, b 237 cases 
 
 
Table 4.2 Clinical characteristics of the pregnancy, and place and time of collection of the 
samples of neonatal gastric aspirates. 
CLINICAL CHARACTERISTICS TOTAL (%) 
Multiple delivery (n) (%) 19 (7.9) 
Vaginal deliverya (n) (%) 117 (49.6) 
Caesarean sectiona (n) (%) 119 (50.4) 
Primiparousb (n) (%) 120 (54.8) 
Parity (median) (range) 1 (0- 13) 
Previous complicationsc (n) (%) 63 (56.3) 
Gestational age (wk); mean, (SD) 34.9, (4.9) 
Preterm birth (n) (%) 140 (58.3) 
Birthweight (g)d; mean (SD) 2322.1 (962.9) 
Low birthweightd (n) (%) 131 (54.8) 
Time of ROM (h)e (median) (range) 3 (0- 2184) 
Prolonged ROM (>24h)e (n) (%) 39 (21.8) 
Intrapartum antibioticsf (n) (%) 35 (17.4) 
Smoking during pregnancyg (n) (%) 16 (8.4) 
SAMPLE COLLECTIONh   
At the maternal ward (no neonatal ward) 58 (24.2) 
Samples collected within 12 hours of birth 189 (80.4) 
data only known for: a236 cases, b217 cases, c112cases, d239 case,  
e112 cases, f201 cases, g190 cases,  h237cases.  
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Table 4.3 Comparisons between detection of broad-range bacteria and demographical, clinical 
and sample’s data.  
 
MOLECULAR DETECTION OF 
BACTERIA 
DEMOGRAPHICAL DATA 
positive (n=98) negative (n=142) 
p-
values* 
NEONATE'S GENDER     
Female (n) (%) 48 (49.0) 56 (39.7)a 0.185 
Male (n) (%) 50 (51.0) 85 (60.3)a 
MATERNAL AGEb; mean (SD) range 28.5 (5.8)b 28.7 (5.8)c 0.822 
MATERNAL ETHNIC ORIGIN 
   Asian-Bangladeshi/Indian/Pakistani (n) (%) 47 (48.5)b 70 (49.3) 1.000 
Asian-other (n) (%) 7 (7.2)b 9 (6.3) 0.798 
Black African/Caribbean/other (n) (%) 11 (11.3)b 19 (13.4) 0.695 
White British/Irish/other (n) (%) 26 (26.8)b 42 (29.6) 0.664 
Other-mixed (n) (%) 6 (6.2)b 2 (1.4) 0.065 
CLINICAL CHARACTERISTICS       
Multiple delivery (n) (%) 5 (5.1) 14 (9.9) 0.227 
Vaginal delivery/ non-Caesarean (n) (%) 62 (63.3) 55 (39.9)d 0.001** 
Primiparous (n) (%) 47 (52.2)e 73 (56.6)f 0.582 
Parity (median) (range) 1 (0- 8) 1 (0- 13) 0.577 
Previous complications (n) (%) 22 (48.9)g 41 (61.2)h 0.245 
Gestational age (wk); mean (SD) 35.3 (5.1) 34.6 (4.8) 0.308 
Preterm birth (n) (%) 53 (54.1) 87 (61.3) 0.288 
Birthweight (g); mean (SD) 2405.1 (944.4)b 2265.3 (973.0) 0.271 
Low birthweight (n) (%) 47 (48.5)b 84 (59.2) 0.113 
Time of ROM (h) (median) (range) 11 (0- 2184)i 1 (0- 720)j 0.111 
Prolonged ROM (>24h) (n) (%) 26 (34.7)i 13 (12.5)j <0.001** 
Intrapartum antibiotics (n) (%) 16 (20.3)k 19 (15.6)l 0.448 
Smoking during pregnancy (n) (%) 9 (12.3)g 7 (6.0)m 0.178 
SAMPLE COLLECTION     
At the maternal ward (no neonatal ward) 27 (27.6)b 31 (21.8)c 0.358 
Samples collected within 12 hours of birth 77 (81.1) 112 (80.0) 0.869 
data only known for: a141 cases, b97 cases, c140 cases, d138 cases, e90cases, f127 cases, 
g73 cases, h39 cases, i75 cases, j105 cases, k79 cases, l122 cases, m122 cases.  
*p-values determined using Fisher's Exact test for qualitative variables and 2-tailed  
Independent-samples T-test for quantitative variables. 
** Significant difference as determined by p<0.005. 
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Figure 4.1 Clustered bar diagram representing prevalence of bacteria comparing Caesarean 
section and vaginal delivery. 
 
 
Figure 4.2 Clustered bar diagram representing prevalence of bacteria comparing presence and 
absence of pROM (>24h). 
 
CHAPTER 4: ASSOCIATIONS BETWEEN BACTERIAL PRESENCE AND VARIABLES 
131 
 
4.4 Comparisons between detection of most prevalent bacteria and 
demographical/clinical data. 
 
Interestingly, when the presence of specific bacteria was compared with 
demographical characteristics (Table 4.4), S. mitis group members were less 
prevalent in mothers originally from South Asian countries (Bangladesh, India and 
Pakistan) (p= 0.024) and of Black ethnic origin (p= 0.031). Also, an inverse 
association between U. urealyticum/parvum and other-mixed ethnic origin (p= 0.016) 
was observed. 
 
Presence of the most prevalent species was also compared with vaginal delivery, 
primiparity, history of previous complications, PTB, LBW, presence of pROM, 
administration of iATB, smoking during pregnancy, collection of the samples at the 
maternal wards and samples collected within 12 hours post-delivery (Table 4.5). 
Bivariate analysis showed associations between vaginal delivery and presence of S. 
pneumoniae/mitis/oralis/infantis (p= 0.025), U. urealyticum/parvum (p= 0.003), 
Lactobacillus spp. (p= 0.014), E. coli (p= 0.001) and S. sanguinegens/amnionii (p= 
0.018). Also, presence of Lactobacillus spp. was significantly higher in term 
deliveries (≥37 weeks)  (p= 0.011); and Lactobacillus spp. (p= 0.006) and G. 
vaginalis (p= 0.046) were more prevalent in non-low birthweight. Moreover, women 
that presented with pROM were more likely to present members of the S. mitis group 
(p= 0.046) and E. coli (p= 0.006). It was also observed that women who received 
antibiotics during delivery presented with a significantly higher prevalence of S. 
agalactiae (p= 0.009). Similarly, presence of U. urealyticum/parvum (p= 0.018), 
Lactobacillus spp. (p= 0.018), G. vaginalis (p= 0.002) and S. sanguinegens/amnionii 
(p= 0.040) was associated with collection of the samples at a maternal ward rather 
than during neonate hospitalization in the neonatal wards. Finally, an association was 
shown between Pseudomonas spp. and samples collected more than 12 hours post-
delivery (p= 0.042). Comparisons of variables that showed associations are 
represented in clustered bar diagrams in Figure 4.3. 
 
 
  
 
 
 
Table 4.4 Comparisons between presence of specific bacteria and demographical characteristics (p-values). 
 
 
DEMOGRAPHICAL DATA 
GENERAL 
BACTERIA 
S. mitis 
group 
Ureaplasma 
spp. 
Lactobacillus 
spp. 
E. 
coli 
Pseudomonas 
spp. 
S. 
agalactiae 
(GBS) 
G. 
vaginalis 
Sneathia 
spp. 
NEONATE'S GENDER 
(male or female)a 0.185 0.306 1.000 0.807 1.000 0.135 1.000 0.338 0.735 
MATERNAL AGEb 0.822 0.159 0.181 0.514 0.442 0.809 0.981 0.829 0.075 
MATERNAL ETHNIC ORIGINa 
Asian-Bangladeshi/Indian/ 
Pakistani 
1.000 0.024**α 0.808 1.000 0.279 0.564 0.765 1.000 0.500 
Asian-other 0.798 1.000 1.000 1.000 1.000 0.573 0.541 0.507 1.000 
Black African/Caribbean/other 0.695 0.031**α 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
White British/Irish/other 0.664 0.825 0.786 1.000 0.122 0.517 0.733 0.729 0.123 
Other-mixed 0.065 0.602 0.016**α 0.471 0.073 0.342 0.318 0.293 1.000 
a data not known for 1 case, b data not known for 3 cases;  p-values determined using Fisher's Exact test; **Significant difference as determined by p<0.05.    
α Prevalence associated with no observation of the clinical variable. 
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Table 4.5 Most prevalent bacteria in NGA and associations with clinical variables. 
 
 
Bacteria most 
prevalent in NGA 
No. COMPARISONS with clinical variables (p-values)* 
(%)^ 
vaginal 
delivery 
pROM primi- 
parous 
previous 
complic. 
PTB LBW iATB smoking maternal 
ward 
collected 
more 12h 
post-delivery 
1 
Streptococcus 
pneumoniae/mitis/ 
oralis/infantis 
27 (28) 0.025** 0.046** 0.672 0.360 0.148 0.064 0.376 1.000 0.814 0.287 
2 Ureaplasma 
urealyticum/parvum 
18 (18) 0.003** 0.106 0.804 1.000 1.000 1.000 0.410 1.000 0.018** 1.000 
3 Lactobacillus spp. 18 (18) 0.014** 0.647 0.629 1.000 0.011**α 0.006**α 0.192 1.000 0.018** 0.208 
4 Escherichia coli 14 (14) 0.001** 0.006** 0.259 0.084 0.269 0.053 1.000 0.414 0.109 0.723 
5 Pseudomonas spp. 12 (12) 0.251 0.613 0.772 0.166 1.000 0.773 0.351 0.465 0.168 0.042** 
6 Streptococcus 
agalactiae  
11 (11) 0.539 1.000 0.352 0.384 0.056 0.070 0.009** 1.000 0.305 0.454 
7 Gardnerella vaginalis 10 (10) 0.058 0.389 1.000 1.000 0.098 0.046**α 0.008 1.000 0.002** 0.690 
8 Sneathia 
sanguinegens/amnionii 
9 (9) 0.018** 0.176 0.473 1.000 0.739 0.518 0.608 0.465 0.040** 1.000 
^ Determined as percentage of the samples positive to the universal bacterial 16S rDNA primers used (out of 98).  NGA, Neonatal gastric aspirates; pROM, Prolonged rupture 
of membranes; PTB, Preterm birth; LBW, Low birthweight; iATB, intrapartum antibiotics.  *p-values determined using Fisher's Exact test, **Significant difference as 
determined by p<0.05. α Prevalence associated with no observation of the clinical variable.  
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Figure 4.3 Clustered bar charts representing associations between most prevalent bacteria in NGA and clinical variables (only those showing significant 
associations are represented here). Strepmitis, Streptococcus pneumoniae/mitis/oralis/infantis; Ureaplasma, Ureaplasma urealyticum/parvum; Lactobacillus, 
Lactobacillus spp.; Ecoli, Escherichia coli; Sneathia, Sneathia sanguinegens/amnionii. 
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Figure 4.3 (cont.)  Lactobacillus, Lactobacillus spp.; gardenella, Gardnerella vaginalis; GBS, Streptococcus agalactiae; pseudomonas, Pseudomonas spp.; 
Ureaplasma, Ureaplasma urealyticum/parvum; Sneathia, Sneathia sanguinegens/amnionii. 
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4.5 Multivariate analyses. 
 
When analyzing demographical and clinical variables using a multivariate logistic 
regression, few of the associations observed with the bivariate analyses remained. A 
non-white variable was included in the logistic regression model. Gestational age 
was also included in this model, instead of PTB, since this variable also showed 
association with the S. mitis group not observed with the binomial PTB; and also, to 
avoid conflicts with LBW because most of the LBW may also be PTB. Tables 4.6 
and 4.7 summarize the results of the multivariate logistic regression including in the 
model those variables that showed associations with the bivariate tests. 
 
The multivariate analysis confirmed the associations observed for molecular 
detection of broad-range bacteria in NGA. Detection positive showed a significant 
association with both vaginal delivery (OR= 2.3, 95% CI:1.2- 4.5) and pROM 
(OR=4.3, 95% CI: 1.7- 10.3) (Table 4.6; Figure 4.4).  
 
Due to the low number of cases for each specific bacterium, only certain species 
could be analyzed by logistic regression (Table 4.7). Associations were observed 
between vaginal delivery and pROM and presence of S. 
pneumoniae/mitis/oralis/infantis (OR=3.23, 95% CI: 1.0- 10.3 and OR=5.17, 95% 
CI: 1.6- 16.8 respectively) (Figure 4.5). Also, administration of iATB was predictive 
for detection of S. agalactiae in the samples (OR=7.27, 95% CI: 1.6- 32.7). Finally, 
even not statistically significant (p= 0.062), U. urealyticum/parvum was eight times 
more likely to be observed in neonates that were delivered vaginally (95% CI: 0.9- 
73.2). 
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Table 4.6 Multivariate logistic regression for detection of bacteria in NGA using broad-range 
molecular techniques. 
 
DETECTION OF BACTERIA 
VARIABLES p-value OR 95% C.I. 
Lower Upper 
non-white 0.275 0.66 0.31 1.39 
vaginal delivery 0.015** 2.31 1.17 4.55 
gestational age 
(wk) 0.360 1.06 0.94 1.19 
LBW 0.825 0.88 0.29 2.69 
pROM 0.002** 4.23 1.73 10.34 
iATB 0.543 1.30 0.56 3.03 
maternal ward 0.256 0.53 0.18 1.59 
sampled>12h 0.601 0.79 0.32 1.92 
OR= odds ratio; LBW, Low birthweight; pROM, prolongued of membranes; 
iATB, intrapartum antibiotics. **Significant difference as determined by 
p<0.05. 
  
 
 
Figure  4.4 Clustered bar chart representing prevalence of bacteria using molecular techniques 
comparing mode of delivery and presence of pROM. 
 
.
  
 
 
 
 
Table 4.7 Multivariate logistic regression for identification of species-specific bacteria in NGA. 
 
 
S. mitis group U. urealyticum/parvum S. agalactiae 
VARIABLES p-
values OR 
95% C.I. p-
values OR 
95% C.I. p-
values OR 
95% C.I. 
Lower Upper Lower Upper Lower Upper 
non-white 0.880 0.91 0.28 2.99 
 
0.776 1.29 0.23 7.26 
 
0.271 0.42 0.09 1.95 
vaginal 0.048** 3.23 1.01 10.35 
 
0.062 8.11 0.90 73.16 
 
0.327 0.46 0.10 2.15 
gestational age (wk) 0.180 1.15 0.94 1.42 
 
0.881 0.98 0.78 1.24 
 
0.712 1.06 0.76 1.48 
LBW 0.801 1.26 0.21 7.68 
 
0.645 1.81 0.14 22.90 
 
0.611 0.46 0.02 9.29 
pROM 0.006** 5.17 1.58 16.85 
 
0.890 1.14 0.18 7.08 
 
0.727 0.71 0.11 4.72 
iATB 0.280 1.96 0.58 6.66 
 
0.545 1.71 0.30 9.69 
 
0.010** 7.27 1.62 32.66 
maternal ward 0.170 0.21 0.02 1.95 
 
0.323 2.84 0.36 22.44 
 
0.528 1.79 0.29 11.04 
sampled>12h 0.822 1.16 0.31 4.33 
 
0.507 1.83 0.31 10.79 
 
0.676 0.61 0.06 6.27 
OR= odds ratio; LBW, Low birthweight; pROM, prolonged rupture of membranes; iATB, intrapartum antibiotics  
**Significant difference as determined by p<0.05. 
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Figure  4.5 Clustered bar chart representing prevalence of S. mitis group comparing mode of 
delivery and presence of pROM. 
 
 
4.6 Discussion. 
 
The bivariate comparative analysis performed between prevalence of the broad range 
of bacteria present in the samples and the clinical and non-clinical variables 
supported the hypothesis that many of the samples may contain transient bacteria 
probably acquired from the birth canal during vaginal delivery or as a result of the 
prolonged exposure to the external environment. Nevertheless, even though bacteria 
were more prevalent in vaginal deliveries, most of the species identified in this study 
have also been observed in Caesarean sections, the only exceptions being S. 
epidermidis (n=6) and A. christensenii (n=4), which are frequent colonizers of the 
female genito-urinary tract (Collins et al., 1999). Similarly, few bacteria were 
observed only in cases of pROM (S. constellatus/intermedius/anginosus and P. 
aeruginosa/otitidis), while the opposite was observed for S. epidermidis, 
Peptoniphilus sp., P. fluorescens, S. salivarius/vestibularis and F. nucleatum which 
were only present when rupture of membranes occurred at less than 24 hours before 
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delivery. The former contradicts the observation made by Cahill et al. (2005) who 
reported a high prevalence of F. nucleatum in cases of pROM. However, due to their 
low prevalence in the samples, it is not possible to make any accurate conclusion. 
 
Further analysis was also performed to compare prevalence of specific bacteria with 
the clinical observations and sample characteristics. Numerous bacteria showed 
association with vaginal delivery when using the bivariate analysis. However, similar 
species were also prevalent in the samples collected at the maternal ward, indicating 
possible contamination due to the difficulty of achieving sterile conditions during 
sample collection at these wards. After adjusting for a range of variables, statistical 
associations with vaginal delivery and pROM could only be confirmed for the 
members of the S. pneumoniae/mitis/oralis/infantis. Also, although not statistically 
significant, U. urealyticum was observed to be eight times more prevalent in vaginal 
deliveries.  
 
In this study, S. pneumoniae/mitis/oralis/infantis were the most prevalent bacteria 
(28%) in samples of NGA. Unfortunately, members of the S. mitis group are 
genetically closely related to each other and they were not able to be differentiated in 
this study. Although ‘viridans’ streptococci (S. mitis and S. oralis) are of low 
pathogenity, S. mitis has been reported to cause early-onset neonatal infection and 
neonatal death as a result of its resistance to antibiotics (Adams and Faix, 1994). 
High prevalence of S. mitis group components associated with the female genito-
urinary tract, the amniotic environment, or early-onset neonatal infections has not 
been reported before. On the other hand, S. pneumoniae is one of the major bacterial 
pathogens worldwide causing bacteraemia and community-acquired infections in 
infants (Selva et al., 2010). U. urealyticum has been previously implicated in several 
forms of APO (Waites et al., 2005). However, carriage of U. urealyticum in the 
women’s genitourinary tract will not necessarily trigger an APO (Waites et al., 2005, 
Govender et al., 2009), nor will treatment of the infection alter the occurrence of 
prematurity (Romero et al., 1989a). Prevalence of Ureaplasma species in NGA is 
likely to derive from the birth canal during delivery. Although these bacteria may 
originate from the vagina, their possible contribution to neonatal infections should be 
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further analyzed. Interestingly, the non-white ethnic origin group showed a 
protective effect for presence of S. pneumoniae/mitis/oralis/infantis and U. 
urealyticum, as most individuals presenting these pathogens were from white ethnic 
origin. 
 
Also, a significantly higher prevalence of S. agalactiae (GBS) was observed in 
relation to the administration of iATB. Logistic regression analysis confirmed this 
observation (OR=7.3; 95% C.I.: 1.6- 32.7). One explanation might be that samples of 
NGA are routinely taken from those cases with a history of infection with GBS. 
Intrapartum antibiotic prophylaxis has been instituted as a routine hospital procedure 
since the mid-1990s, successfully decreasing the incidence of early-onset GBS 
septicaemia in more than 65% of neonates (Schrag et al., 2000, Ohlsson and Shah, 
2009). However, iATB administration may disrupt the perinatal microbiota, allowing 
S. agalactiae antibiotic-resistant strains and other pathogenic bacteria to proliferate. 
 
Another interesting observation was the presence of Lactobacillus spp. in association 
with neonates delivered at term and presenting a birthweight ≥ 2500 g. Lactobacillus 
spp. are usually observed dominating the microbiota in the vagina and cervix of the 
healthy female reproductive system and may prevent colonization of more 
pathogenic species (Boris and Barbés, 2000, Wilson, 2008). Similarly, significantly 
higher presence of G. vaginalis was observed when the birthweight was ≥ 2500 g and 
in samples collected at the maternal ward. Unfortunately, these associations were not 
able to be analyzed in a multivariate analysis due to the low number of positive 
samples. 
 
Moreover, the most common pathogens recognized as causing nosocomial 
bloodstream infection in NICU (E. coli, Staphylococcus spp., A. baumannii, K. 
pneumoniae, and P. aeruginosa) have also been identified in the samples. E. coli was 
associated with both vaginal delivery and pROM. It is one of the most common 
bacterial species responsible for neonatal infections and is increasingly implicated in 
nosocomial outbreaks in NICU due to multidrug-resistant strains. Finally, an 
association between Pseudomonas spp. in NGA samples collected >12 hours post-
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delivery was observed. 
 
Although no associations were observed between general or specific infection and 
PTB, LBW, or previous complications, identification of the bacteria in the samples 
may still indicate colonization of the amniotic cavity and fetus, and therefore identify 
a potential infectious agent. In general, the observations in this study agree with the 
ones previously reported, which contributes to the plausibility that the samples of 
NGA could represent a valuable specimen in well-controlled studies. In particular, 
these samples may be suitable to investigate the presence of potential oral pathogens 
in association with perinatal infections and APO. However, clinical observations 
should be carefully considered when analysing the results. 
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5.1 Introduction. 
 
Maternal periodontal infection has been associated with APO in several 
epidemiological and interventional studies (Offenbacher et al., 1996, Dasanayake, 
1998, Jeffcoat et al., 2001, López et al., 2002a, Offenbacher et al., 2006a, Jeffcoat et 
al., 2010). Clinical findings have also reported presence of possible oral bacteria in 
the amniotic environment of women who present with an APO, suggesting the 
possibility of an oral-uterine translocation (Douvier et al., 1999, Andrés et al., 2002, 
Cahill et al., 2005, León et al., 2007, Han et al., 2010). However, this area remains 
controversial since other studies have not found the same association (Mitchell-
Lewis et al., 2001, Davenport et al., 2002, Michalowicz et al., 2006). The reasons for 
this variability may to be due to the great differences between study designs and the 
definitions used for PD and APO (Manau et al., 2008). Undoubtedly, the strongest 
evidence supporting the possible association between oral bacteria and APO has been 
provided by animal studies in which oral bacteria were shown to be able to 
translocate via bloodstream, cross the placental membranes, and specifically invade 
the amniotic cavity resulting in preterm delivery, fetal growth restriction, and fetal 
death (Collins et al., 1994, Han et al., 2004, Liu et al., 2007, Fardini et al., 2010). 
 
Periodontitis is a common inflammatory disease initiated primarily by a small subset 
of opportunistic gram-negative pathogen inhabitants of the subgingival plaque. The 
microorganisms implicated in PD possess numerous potent virulence factors that 
may allow them to survive, translocate, and colonise distant non-oral sites. Oral 
pathogens that are able to translocate and invade the amniotic cavity may be present 
in the samples of NGA investigated in this study. Hence, a quantitative analysis of 
selected periodontal bacteria was performed. The quantitative-PCR analysis ensures 
a higher sensitivity which can detect even those species present in low levels. 
Moreover, the levels of bacteria would provide an estimate of the clinical relevance 
regarding their presence in the samples. 
 
The main periodontal pathogens that have been associated with severity and 
progression of PD, as defined by the World Workshop in Clinical Periodontics 
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(1996), were included in the analysis (A. actinomycetemcomitans, P. gingivalis, and 
T. forsythia). These species have shown mechanisms of invasion and translocation 
that may facilitate spread through the bloodstream. Besides, they may be able to 
avoid the immune response, and/or have been detected in sites distant from the oral 
cavity. For example, A. actinomycetemcomitans has been implicated in the aetiology 
of infective endocarditis,  and translocation may occur due to its ability to attach to 
collagen  (Tang et al., 2008).  P. gingivalis has been involved in cardiovascular 
diseases and is able to inactivate Toll-like receptors by the release of gingipains 
which inhibit the host cell recognition (Kishimoto et al., 2006).  
 
Also, quantification of potential oral pathogens that have been identified in this study 
in the samples of NGA (F. nucleatum and G. elegans) is reported here. F. nucleatum 
is one of the most prevalent species in the oral cavity in health and disease.  This 
pathogen is also one of the most common bacterial species isolated from AF in cases 
of PTL and intact membranes, which explains the great interest this microorganism 
have received in several studies investigating its contribution to preterm delivery and 
other APO (Hill, 1998, Madianos et al., 2001, Han et al., 2004, Liu et al., 2007, Han 
et al., 2009). G. elegans was detected in the samples of NGA in this study. This 
bacterium is a member of the human oral microbiota and also thought to be a potent 
pathogen in endocarditis (Ohara-Nemoto et al., 2005). Moreover, G. elegans has 
shown to inhibit proliferation of human peripheral blood mononuclear cells and this 
mechanism appears to enable the microorganism to cause infective endocarditis 
(Kanamoto et al., 2007). 
 
5.2 Selection of species-specific primers for q-PCR analysis. 
 
Species-specific forward and reverse primers were used if possible, although in some 
cases a combination of specific and universal primer was preferred to ensure 
technique efficiency by amplifying short length fragments. In all the cases, 
specificity and sensitivity of each set of primers was confirmed against a list of 
pathogens as previously detailed (Section 2.14). The set of primers used for universal 
amplification have a demonstrated advantage over other possible options as shown in 
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a previous study (Yu and Morrison, 2004). Also, in this study, it was demonstrated 
that the primer set 357F-518R was more efficient than the primer set 27F-357R. 
 
5.3 Growth of bacteria, identification, counts and determination of culture 
absorbance, and DNA extraction. 
 
A. actinomycetemcomitans, P. gingivalis, T. forsythia, F. nucleatum, and G. elegans 
were grown in this study as previously described (Section 2.6). A colony obtained 
from the pure culture was subjected to end-point PCR using the set of primers 
detailed in Table 2.5 (Chapter 2) and successfully identified using direct sequencing. 
The bacterial counts and culture absorbance were determined in order to obtain a 
stock of cells from known concentration.  Table 5.1 shows the OD600 corresponding 
to a pre-determined bacterial count (in CFU/ml) for each strain. DNA extraction was 
then performed on one aliquot containing 200 µl of the stock using the same protocol 
described for the samples without the need for mucolyse digestion. Remaining stocks 
were stored frozen at -70ºC.  
 
Table 5.1 Bacteria grown in this study and corresponding OD600 values for predetermined 
CFU/ml. 
 
Bacterial strains CFU/ml OD600 
 
F. nucleatum 109 1.756 
A. actinomycetemcomitans 109 0.237 
P. gingivalis 1010 0.287 
T. forsythia 109 1.510 
G. elegans 108 0.368 
  CFU, colony-forming units; OD600, optical density at a  
wavelength of 600 nm. 
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5.4 Dilution series of template and construction of standard curves for q-PCR. 
 
Standard curves for absolute quantification were prepared from a dilution series of 
template of known concentration. Genomic DNA from each target bacteria was used 
as a template for the construction of standard curves. The standards were run 
following the protocol described below for q-PCR analysis (Chapter 2). For the 
construction of standard curves the LightCycler® 480 software was used. All the 
standard curves included dilutions from 102 to 107. In all cases the slopes were within 
the acceptable range (between -3.0 and -3.6; –3.3 for 100% PCR efficiency 
(Efficiency = [10(-1/slope)] – 1)). Standard curves characteristics are detailed in 
Table 5.2. 
 
One difficulty to accurately determine the levels of general bacteria in the samples 
was related to the differences in numbers of rrn operons per bacteria. The number of 
operons per bacterial genome has been demonstrated to vary from one to 15, and this 
value is only known for a few species (Lee et al., 2009). This limitation could be 
successfully avoided by constructing standard curves using known concentration of 
bacteria grown in pure culture to calculate levels of specific bacteria. However, it 
was not possible to calculate the levels of general bacteria due to the diversity of the 
samples (unknown numbers of species and their relative abundance). In this study, in 
order to overcome this limitation, an average number of five copies of the gene were 
allocated to calculate general bacteria numbers in the samples. This was calculated as 
the average copy number of rrn encoding-genes in the range of bacteria observed in 
NGA (only the bacteria with known operon number were included). The operon copy 
number was obtained from The Ribosomal RNA Operon Copy Number Database 
(Lee et al., 2009) and varied between one and 10. 
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Table 5.2 Characteristics of the standard curves constructed in this study for quantitative 
analysis of oral bacteria. 
 
BACTERIA PRIMERS Efficiency Slope Error 
General bacteria 357F-518R 1.964 -3.411 0.0233 
F. nucleatum Fn1F-Fn2R  1.951 -3.445  0.0119  
A. actinomycetemcomitans AaF-C11R 1.989 -3.348 0.0069 
P. gingivalis Pg2F-Pg2R  1.944  -3.465 0.0166 
T. forsythia Tf2F-357R  1.938  -3.480 0.0100  
G. elegans GeF-357R 1.959   -3.424 0.0467 
 
 
5.5 Absolute amounts of general bacteria and specific periodontal pathogens 
using q-PCR. 
 
A total of 201 samples of NGA were included. The number of samples analysed per 
bacterium targeted varied mainly due to availability of the sample. One hundred and 
seventy-five samples were analysed with the universal primer set, 10 of which did 
not produce a result. Samples consistently not producing a result after three 
repetitions were considered negative and were not included in the analysis.  
Similarly, the number of samples evaluated for each specific bacterium was as 
follows (the numbers of negative samples is shown in brackets): F. nucleatum, 191 
(28); A. actinomycetemcomitans, 101 (4); P. gingivalis, 145 (45); T. forsythia, 99 
(34); G. elegans, 102 (44). 
 
Figure 5.1 illustrates absolute levels of the bacteria in the samples of NGA. The 
levels of general bacteria ranged between 4.15E-01 and 5.18E+06 cells/ml; the mean 
level was calculated as 1.04E+05 cells/ml (median= 1.51E+03). It could be observed 
that in all the cases, levels of general bacteria were higher than the levels of each 
specific bacterium tested. A. actinomycetemcomitans and T. forsythia were observed 
at very low levels in the samples evaluated, reaching a maximum of 4.65E+01 and 
1.57E+01 cells/ml respectively. These levels may represent the background of the 
reaction since similar levels were also observed in the controls (both H2O and PCR 
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mix only). P. gingivalis (mean= 9.33E+00, median= 5.22E-02) was also present at 
low levels, although two of the samples produced high detection levels of the 
bacteria in the sample (2.98E+02 and 1.75E+02 cells/ml). Interestingly, the sample 
that contained the highest level of P. gingivalis also harboured similar levels of F. 
nucleatum (1.51E+02 cells/ml). Overall, the samples analysed with primers specific 
for F. nucleatum contained high levels of these bacteria, reaching up to 2.32E+03 
cells/ml.  The mean level of F. nucleatum was determined as 1.09E+01 cells/ml 
(median= 2.17E+01). Also, few samples contained high levels of G. elegans, with a 
maximum of 5.83E+02 cells/ml (mean= 4.04E+01; median=5.48E+00) being 
observed. Bacterial identity was confirmed using direct sequencing of the end-point 
PCR products for F. nucleatum, P. gingivalis and G. elegans.  
 
 
BACTERIA DETECTED 
 
Figure 5.1 Box-plots representing absolute levels of universal and specific bacteria in neonatal 
gastric aspirates as determined using q-PCR analysis.  
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5.6 Relative amounts of potential oral bacteria in neonatal gastric aspirates. 
 
Levels of general (universal) bacteria were used to determine relative amounts of 
specific bacteria in the samples. Relative amount was calculated as a percentage of 
the specific bacteria out of the total bacterial load. Percentage of F. nucleatum ranged 
from less than 0.01 to 49.5% of the total bacterial load (mean= 5.1%; median= 
1.2%). P. gingivalis was observed in high proportion in two samples representing 
11.7% and 20.3%; the percentage of P. gingivalis in the remainder of the samples 
analysed ranged from <0.01% (in 48 samples) to 4.5% with a mean value of 0.6% 
(median= <0.01%). One of the samples of NGA contained a relatively high 
percentage of A. actinomycetemcomitans, representing 3.9% of the total bacterial 
load compared to the rest of the samples whose relative amounts were not higher 
than 0.2%. Percentages of T. forsythia, however, were always <0.01%.  Finally, the 
percentage of G. elegans in the samples was determined as being up to 34.8% 
(mean= 3.0%; median= 0.3%) (Figure 5.2).  
 
 
BACTERIA DETECTED 
 
Figure 5.2 Box-plots representing relative amount of periodontal bacteria in NGA calculated as 
percentage of the total bacterial load in the samples. 
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5.7 Prevalence of potential oral bacteria in neonatal gastric aspirates using q-
PCR analysis. 
 
Prevalence was determined using a designated detection limit, which was determined 
by comparisons with the end-point PCR results. Determination of prevalence should 
allow confirmation of the associations observed with the initial PCR analysis using a 
more sensitive technique. It was mainly performed in order to identify those cases to 
be included in downstream analysis, in which end-point PCR was necessary. 
 
Prevalence was determined based upon detection limits observed with the end-point 
PCR results. In general, end-point PCR was positive when samples contained more 
than 100 cells/ml of a specific bacterium by q-PCR. A sensitivity and specificity test 
demonstrated that presence of F. nucleatum was, respectively, 90% and 91% 
accurate when using the end-point PCR results as the gold standard. One hundred 
bacterial cells has also been determined previously as the detection limit for 
identification of periodontal bacteria by real-time PCR (meridol®Perio Diagnostics) 
(Jervøe-Storm et al., 2005). Therefore, samples that contained levels higher than 100 
cells/ml were considered positive in this study. Nevertheless, the same consistency 
was not observed with the results obtained with the universal primers. This may be 
due to the higher sensitivity inherent to the q-PCR technique compared to the end-
point PCR method; and also because of the limitation derived from the rrn operon 
number. In this study, detection limit was selected as 500 cells/ml since the highest 
sensitivity (87.8%) was observed when comparing the data with the end-point PCR 
results as the gold standard (specificity was 17.6%).  
 
Using this criterion, general bacteria were considered to be present in 140 of 175 
(80%) samples. An average of 1.23E+05 cells/ml (median= 1.87E+03) was observed 
in the positive samples, compared to 2.03E+02 cells/ml (median= 1.31E+02) in the 
negative samples. Specific bacteria that were considered positive using the 100 
cells/ml detection limit were F. nucleatum, P. gingivalis and G. elegans. Twenty-six 
samples out of 163 (15.9%) were positive for F. nucleatum (mean= 4.41E+02; 
median= 2.51E+02). Two samples out of 100 (2.0%) were positive for P. gingivalis 
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(mean= 2.37E+02; median= 2.37E+02) and five samples out of 58 (8.6%) were 
positive for G. elegans (mean= 3.46E+02; median= 2.63E+02). Levels of bacteria 
have been illustrated by prevalence in Figure 5.3. 
 
 
BACTERIA DETECTED 
 
Figure 5.3 Clustered box-plot representing levels of bacteria in positive and negative samples 
as determined by the detection limit set in this study. 
 
 
5.8 Statistical analyses. 
 
The following tables and figures summarize the statistical analyses performed with 
the data obtained with the quantitative analysis. Comparisons between prevalence of 
bacteria and demographical and clinical data were only available for general bacteria 
and F. nucleatum when using the q-PCR analysis (Table 5.3). Interestingly, 
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associations with presence of general bacteria (> 500 cells/ml) were observed with 
both PTB (p= 0.002) and LBW (p= 0.004) (Table 5.3 and Figure 5.4). This was 
confirmed with an inverse association when comparisons were made with gestational 
age (p= 0.001) and birthweight (p= 0.006). The Fisher’s exact test and the 
independent t-test were used to analyse the qualitative and the quantitative data 
respectively (Table 5.3). Furthermore, associations were performed for the type of 
PTB and LBW presented. Type of complication was evaluated using ANOVA 
followed by Tuckey analyses. Preterm birth was classified as mild PTB (32-36 
weeks), very PTB (28-31 weeks), and extremely PTB (< 28 weeks). Low birthweight 
was classified as mild LBW (1500-2499 g), very LBW (1000-1499 g) and extremely 
LBW (< 1000 g) (Figure 5.4). Associations were observed only between term 
delivery and very PTB (p= 0.050); and term delivery and extremely PTB (p= 0.010). 
These results demonstrate that term and mild preterm neonates present higher 
prevalence of bacteria compared to the very preterm and term neonates.  
 
Contrary to the observations made with the broad-range PCR analyses, associations 
between prevalence of general bacteria and mode of delivery or pROM were not 
observed with the q-PCR analysis (Table 5.3). However, when absolute levels of 
general bacteria rather than prevalence was evaluated a significant association with 
vaginal delivery (p = 0.037) could be observed but not with pROM. Finally, a 
multivariate analysis including gestational age and LBW and other important 
variables, confirmed association between presence of bacteria using q-PCR approach 
and gestational age (p= 0.009; OR=1.17; 95% C.I.: 1.0-1.3) (Table 5.4).  
 
Associations between prevalence of F. nucleatum in the samples and clinical and 
non-clinical variables are detailed in Table 5.3. An association with multiple 
deliveries (twins) was observed (p= 0.037). Interestingly, associations with non-
white origin (p= 0.062) and LBW (p= 0.065) were close to significance; these are 
represented in Figure 5.5. However, none of these was maintained using a 
multivariable approach. Absolute and relative levels of F. nucleatum in NGA also 
showed few associations using the bivariate analyses.  Absolute amounts were 
associated with twin delivery (p= 0.019) and samples collected at the maternal ward 
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(p= 0.033), and relative amounts were associated with women presenting pROM (p= 
0.001) (Tables 5.5 -5.6). 
 
 
Table 5.3  Comparisons between prevalence of general bacteria and F. nucleatum in NGA as 
determined by q-PCR analysis with demographical and clinical data. 
 
COMPARISONS BETWEEN PREVALENCE AND VARIABLES  
(p-values)* 
DEMOGRAPHICAL DATA 
GENERAL 
BACTERIA            
(> 500 cells/ml) 
F. nucleatum 
(>100 cells/ml) 
Neonate's gender (M or F)a 0.791 0.531 
Maternal age at risk (<18 and >35 years)b 0.566 0.762 
Non-white maternal's ethnic origina 0.194 0.062 
CLINICAL CHARACTERISTICS 
 
Multiple delivery 0.340 0.037** 
Vaginal delivery/ non-Caesarean sectionc 0.432 0.407 
Primiparousd 0.891 1.000 
Previous complicationse 0.702 0.746 
Gestational age (wk)¶ 0.001** α 0.461 
Preterm birth 0.002** 0.412 
Birthweight (g)¶a 0.006** α 0.642 
Low birthweighta 0.004** 0.065 
Prolonged ROM (>24h)f 0.471 1.000 
Intrapartum antibioticsg 0.714 0.311 
Smoking during pregnancyh 0.431 1.000 
SAMPLE COLLECTIONb 
At the maternal ward (or neonatal ward) 0.359 0.091 
Samples collected within 12 hours of birth 0.620 1.000 
data not known for: a1 case, b3cases, c4 cases, d23 cases, ; data only known for e112cases, 
f112 cases, g201 cases, h190 cases. * p-values determined using Fisher's Exact test for 
qualitative variables and 2-tailed Independent T-test for quantitative data (¶). ** Significant 
difference as determined by p<0.005. α Inverse association with the clinical variable. 
 
 
 
 
Finally, even though very low amounts of A. actinomycetemcomitans, P. gingivalis, 
T. forsythia, and G. elegans were observed in the samples, few associations were 
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found with certain demographical and clinical data as observed in Tables 5.5 and 5.6 
and represented in Figures 5.6 and 5.7.  
 
5.9 Discussion. 
 
The use of species-specific primers has been demonstrated to be a more sensitive 
technique to identify bacteria in a defined sample compared to traditional (Jervøe-
Storm et al., 2005, Melendez et al., 2010) and broad-range techniques (Payne et al., 
2010). In this study, this was clearly conducted for F. nucleatum, which allowed 
identification of a high prevalence of this species in the samples. F. nucleatum was 
detected in 26 (15.9%) of the NGA analysed, compare to its presence in only two 
samples (2.0%) using end-point PCR. G. elegans was also identified at a higher 
prevalence (5 samples; 8.6%) compared to the initial approach (2 samples; 2%). 
Also, these methods allowed identification of P. gingivalis, which was not detected 
previously with the other techniques. 
 
This is the first time a study has used a predetermined detection limit to indicate 
prevalence in the samples. The main reason for using this approach was to avoid 
false positives (type I error), which represent a common drawback inherent in the use 
of SYBR-Green based detection chemistry.  SYBR-Green binds to any double 
stranded DNA, including non-specific reaction products, which may result in an 
overestimation of the target concentration. This was also applied for general bacteria 
using a detection limit of 500 cels/ml. Contrary to the results obtained with the 
broad-range techniques, associations were not observed with vaginal delivery and 
pROM. On the other hand, a strong inverse association with PTB and LBW could be 
observed with the bivariate analysis. Significantly higher levels of bacteria were also 
observed using as the variables the qualitative measures of gestational age and 
birthweight.  
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Figure 5.4 Clustered bar charts of the associations observed between prevalence of general 
bacteria and preterm birth (PT) and low birthweight (LBW). Fisher’s Exact test and ANOVA 
followed by Tuckey HDS statistical analyses were performed to determine associations. MPT, mild 
PTB; VPT, very PTB; EPT, extremely PTB; BW, birthweight; MBW, mild LBW, VLBW, very LBW; 
ELBW, extremely low LBW. 
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Table  5.4 Multivariable analysis model to determine associations between prevalence of 
general bacteria using q-PCR analyses and demographical and clinical characteristics. 
 
Prevalence of bacteria using q-PCR 
VARIABLES p-
values OR 
95% C.I. 
Lower Upper 
non-white 0.320 1.48 0.68 3.21 
vaginal 0.151 1.65 0.83 3.26 
pROM 0.677 0.84 0.36 1.95 
gestational age (wk) 0.009** 1.17 1.04 1.32 
LBW 0.186 2.12 0.70 6.48 
smoking 0.856 0.89 0.26 3.03 
iATB 0.936 1.04 0.45 2.41 
sampled>12h 0.100 0.47 0.19 1.16 
OR= odds ratio; LBW, Low birthweight; pROM, prolonged rupture 
of membranes; iATB, intrapartum antibiotics. ** Significant difference as 
determined by p<0.05. 
 
 
Interestingly, the association with gestational age remained after adjusting for 
important clinical factors such as maternal origin, mode of delivery, smoking, 
pROM, iATB and samples taken more than 12 hours post-delivery. It has been 
suggested that uterine contractions may exert a suction-like effect where vaginal 
fluid is introduced into the uterine cavity (Seong et al., 2008). Contractions occur in 
higher intensity as the infant is ready to be delivered at term, and also an increased 
cervical dilatation is required for delivery of a larger infant. This may explain the 
higher rates of bacteria at term observed in this study. Conversely, when analyzing 
results using the absolute levels of bacteria, an association with vaginal delivery was 
observed. The use of a detection limit may have avoided detection of those transient 
low levels of bacteria acquired from the birth canal during delivery. It is likely that 
the higher levels of bacteria in the samples originated from vaginal fluids aspired 
during labour.  
  
 
 
Table 5.5  Comparisons between absolute amounts of periodontal bacteria in NGA determined by q-PCR analysis with demographical and clinical data. 
COMPARISONS BETWEEN ABSOLUTE AMOUNTS (cells/ml) OF BACTERIA 
AND DEMOGRAPHICAL AND CLINICAL VARIABLES (p-values*) 
DEMOGRAPHICAL DATA 
General 
Bacteria F. nucleatum 
A. actinomyce-
temcomitans P. gingivalis T. forsythia G. elegans 
Neonate's gender (M or F)a 0.449 0.342 0.141 0.611 0.131 0.587 
Maternal age at risk (<18 and >35 years)b 0.441 0.386 0.061 0.766 0.167 0.768 
Non-white maternal's ethnic origina 0.582 0.190 0.597 0.742 0.734 0.907 
CLINICAL CHARACTERISTICS 
Multiple delivery 0.396 0.019** 0.161 0.913 0.921 0.155 
Vaginal delivery/ non-Caesarean sectionc 0.037** 0.848 0.315 0.751 0.741 0.739 
Primiparousd 0.509 0.902 0.932 0.882 0.449 0.507 
Previous complicationse 0.886 0.963 0.770 0.581 0.639 0.573 
Preterm birth 0.185 0.934 0.573 0.157 0.537 0.978 
Low birthweighta 0.494 0.411 0.916 0.050 0.575 0.881 
Prolonged ROM (>24h)f 0.113 0.130 0.617 0.927 0.019** 0.297 
Intrapartum antibioticsg 0.896 0.488 0.995 0.982 0.882 0.889 
Smoking during pregnancyh 0.702 0.549 0.354 0.258 0.836 0.276 
SAMPLE COLLECTIONb 
At the maternal ward (or neonatal ward) 0.676 0.033** 0.004** 0.232 0.010** 0.472 
Samples collected within 12 hours of birth 0.717 0.904 0.124 0.507 0.634 0.707 
data not known for: a1 case, b3cases, c4 cases, d23 cases, ; data only known for e112cases,f112 cases, g201 cases, h190 cases. * p-values determined 
using Mann Whitney U Test.  ** Significant difference as determined by p<0.05. 
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Table 5.6  Comparisons between relative amounts of periodontal bacteria in NGA determined by q-PCR analysis with demographical and clinical data. 
 
 
COMPARISONS BETWEEN RELATIVE AMOUNTS (%) OF BACTERIA 
AND   DEMOGRAPHICAL AND CLINICAL VARIABLES (p-values*) 
DEMOGRAPHICAL DATA 
F. nucleatum A. actinomyce-temcomitans P. gingivalis T. forsythia G. elegans 
Neonate's gender (M or F)a 0.846 0.263 0.552 1.000 0.823 
Maternal age at risk (<18 and >35 years)b 0.874 0.645 0.696 1.000 0.229 
Non-white maternal's ethnic origina 0.260 0.830 0.227 1.000 1.000 
CLINICAL CHARACTERISTICS 
Multiple delivery 0.171 0.281 0.390 1.000 0.043** 
Vaginal delivery/ non-Caesarean sectionc 0.146 0.028** 0.837 1.000 0.720 
Primiparousd 0.173 0.789 0.718 1.000 0.717 
Previous complicationse 0.866 0.635 0.618 1.000 0.272 
Preterm birth 0.607 0.890 0.189 1.000 0.914 
Low birthweighta 0.875 0.776 0.029** 1.000 0.690 
Prolonged ROM (>24h)f 0.001** 0.074 0.667 1.000 0.052 
Intrapartum antibioticsg 0.633 0.585 0.175 1.000 0.533 
Smoking during pregnancyh 0.351 0.711 0.290 1.000 0.586 
SAMPLE COLLECTIONb 
At the maternal ward (or neonatal ward) 0.153 0.967 0.467 1.000 0.265 
Samples collected within 12 hours of birth 0.732 0.671 0.715 1.000 0.907 
data not known for: a1 case, b3cases, c4 cases, d23 cases, ; data only known for e112cases,f112 cases, g201 cases, h190 cases. * p-values determined using 
Mann Whitney U Test.  ** Significant difference as determined by p<0.05. 
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Figure 5.5         Bar charts and box-plots describing prevalence, absolute and relative amounts of F. nucleatum in association with clinical variables. Only 
statistically significant associations (p<0.05) or close to significance are represented here. 
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Figure 5.6           Box-plots comparing absolute amount of specific bacteria (except F. nucleatum) where a statistical association with a clinical variable was 
observed. 
 
                                   
 
Figure 5.7           Box-plots comparing relative amount of specific bacteria (except F. nucleatum) where a statistical association with a clinical variable was 
observed. In box-plot representing % A. actinomycetemcomitans, one result indicating 3.9% has been omitted from the vaginal cases. 
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Preliminary work using q-PCR in a small set of samples of NGA (n=43) has been 
reported by Jones et al. (2010). Bacterial load ranged from 3.00E+03 to 1.74E+08 
cells/ml (average= 3.10E+05) using the TaqMan® method. Contrary to the results 
observed in the 175 samples analysed in this study, they demonstrated an association 
with pROM.  It is not clear if the association with pROM varied due to the number of 
samples included or the technique used. TaqMan® chemistry benefits from the use of 
a probe that hybridizes to an internal region of the PCR product and may provide 
higher specificity. Nevertheless, the levels of bacteria reported were very similar 
albeit through the use of different techniques. Another observation is that vaginal 
delivery, even though not significant, had a higher DNA load than those born by 
Caesarean section, although this association did not remain after adjusting for 
pROM. 
 
P. gingivalis has been previously identified at high prevalence (30.8%) in the AF of 
woman with a diagnosis of threatened PTL (León et al., 2007). This species was 
identified by colony morphology and biochemical tests only; and its identity was not 
confirmed by sequencing analysis. Another study identified P. gingivalis antigens in 
placental tissues using immunocytochemistry in women with chorioamnionitis (Katz 
et al., 2009). It is therefore plausible that P. gingivalis was present in the samples. In 
this study, P. gingivalis was found to be present in only two samples (2.0%). When 
analysing the clinical information from these two cases, they did not show any 
consistency; the cases differed in gender, maternal origin, and ward where the 
sample was collected. Both mothers were primiparous, one infant was delivered 
preterm (36 weeks) and vaginally, while the other was term (40 weeks) and delivered 
by Caesarean section. Contrary to the q-PCR analysis, both samples were negative 
with gram staining, culture, and broad-range molecular techniques. Using q-PCR, the 
total bacterial load in the samples was relatively low (1.47E+03 and 1.50E+3 
cells/ml), indicating a high percentage in the samples (11.7 and 20.3%). The relative 
levels could be overestimated due to the difficulty to calculate precisely the levels of 
general bacteria in the NGA as explained previously (Section 5.4). Similarly to the 
absolute levels of P. gingivalis observed in this study (2.98E+02 and 1.75E+02 
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cells/ml), Barak et al. (2007) reported an average level of 3.61E+02 cells/cm3 in 
homogenated placenta tissue of women with pre-eclampsia and PTB. 
 
Barak et al. (2007) also identified T. forsythia (2.31E+02) at significantly high levels 
compared with their controls with no pre-eclampsia (5.10E+01 and 1.70E+01 for P. 
gingivalis and T. forsythia, respectively). A. actinomycetemcomitans (1.88E+01) and  
F. nucleatum (3.30E+01) were also observed only in the cases group. Similar to their 
results, A. actinomycetemcomitans was identified at very low levels in the current 
study (max: 4.65E+01 cells/ml). These low levels did not allow identification by 
sequencing even when performing a nested PCR (two successive PCR runs, the first 
one using universal primers and the second one using specific primers that target a 
sub-fragment within the first PCR product). Furthermore, in contrast to the current 
study, T. forsythia was identified at high levels and F. nucleatum was identified at 
low levels in the placental samples. One reason for the differences between levels of 
bacteria may be the samples analysed, and the fact that the gene copy number was 
not considered before hand, so numbers may have been miscalculated (Rajendhran 
and Gunasekaran, 2010). There is not sufficient information provided as regards the 
methods used, therefore it is not possible to draw further conclusions. No other study 
has identified periodontal bacteria in an amniotic environment using a quantitative-
PCR approach. 
 
Interestingly, the sample that contained the highest level of P. gingivalis (2.98E+02 
cells/ml) also harboured similar levels of F. nucleatum (1.51E+02 cells/ml). Possible 
co-migration mechanisms have been proposed in a previous in vitro study, in which 
co-infection with F. nucleatum  increased 20-fold the invasion ability of P. gingivalis 
in both gingival epithelial and aortic endothelial cells (Saito et al., 2008). Fardini et 
al. (2010) observed, in an animal model, that F. nucleatum but not P. gingivalis or 
any other member of the red-complex (P. gingivalis, T. forsythia and T. denticola) 
was able to invade the murine placenta, although it was present in the plaque sample 
that was inoculated directly into the bloodstream. The possible co-migration 
properties should be further investigated in experimentally controlled studies. 
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The relative amount of bacteria was also analysed in this study. Indeed, relative 
levels provided a better understanding of the potential role of periodontal bacteria in 
APO. With a few exceptions, the percentage of oral pathogens in NGA was very low. 
Therefore, their contribution to the APO may be minimal. Bacteria may have 
translocated from the oral cavity to the amniotic environment during an episode of 
bacteraemia. However, there is also a need to evaluate other possible means whereby 
an oral pathogen might be transferred to the samples, such as from medical staff 
during delivery, and earlier colonization through oral-genital transmission from the 
partner and subsequent spread through the ascending route. It should be considered 
that the relative amount of bacteria, calculated from the total bacterial load, may be 
inaccurate since it was not possible to calculate the precise number of rrn operons 
per bacterial species. This number varies between one and 15; therefore, it can be 
anticipated that the discrepancy would not be higher than a factor of 10. 
 
Few associations were observed following statistical analysis. These varied between 
bacteria and for prevalence, absolute or relative amounts. F. nucleatum, A. 
actinomycetemcomitans, and T. forsythia showed association with maternal ward. 
Nevertheless, these associations were not confirmed with the multivariable analysis. 
In most cases, levels of the bacteria were too low and therefore not able to be 
amplified with specific primers for identification. The presence of oral bacteria in the 
amniotic environment (AF, placenta) has usually been noted in case reports only; 
which indicates it is relatively rare that translocation of periodontal bacteria to the 
amniotic environment can cause an APO. This suggests that other factors, such as 
gene-environmental or gene-gene factors may be involved (Romero et al., 2006).  
 
Conversely, F. nucleatum and G. elegans have been observed at high prevalence and, 
in some cases, as an elevated percentage of the total bacterial load. F. nucleatum is 
one of the most common species isolated from AF in cases of PTL and intact 
membranes (Romero et al., 1989b, Hill, 1998). However, Fusobacterium spp., 
although at low levels, are inhabitants of the vagina (Hillier et al., 1993, Bennett and 
Eley, 1993), although their precise origin needs to be further investigated. 
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6.1 Introduction. 
 
This study has demonstrated the presence of potential oral bacteria in the samples of 
NGA including F. nucleatum, P. gingivalis and G. elegans. The findings suggest the 
possibility that these bacteria may have translocated from the oral cavity to the 
amniotic environment. Studies in animal models support this hypothesis, since F. 
nucleatum and P. gingivalis have both demonstrated the ability to translocate through 
the bloodstream and invade the fetal tissues (Lin et al., 2003b, Han et al., 2004, 
Boggess et al., 2005). Presence of certain oral pathogens and no other prevalent oral 
inhabitants might be explained by specific mechanisms that allowed these 
opportunistic species to cross the placental membranes and invade the amniotic 
cavity, while other oral pathogens may not possess the same ability (Fardini et al., 
2010). The specific ability to invade the placental tissues and no other organs has 
also been demonstrated in animals (Han et al., 2004).  
 
Nevertheless, presence of potential oral bacteria in the samples does not indicate 
their source. It is possible that the bacteria observed in the samples may have 
originated from other body sites. The oral cavity and the vagina harbour similar 
microbiota. Species such as Prevotella, Veillonella, Megasphera, 
Peptostreptococcus, Lactobacillus, Leptotrichia and Streptococcus are common to 
both sites. To date, no species of the genus Aggregatibacter (Actinobacillus), 
Porphyromonas, Tannerella and Granulicatella have been reported as common 
inhabitants of the woman’s genitourinary tract in humans, even though 
Porphyromonas spp. and G. elegans have been identified in the vagina previously 
(Hill et al., 2005, Yamamoto et al., 2009). However, there is no report of the use of 
species-specific and sensitive techniques to investigate the prevalence of these 
pathogens in the women’s genitourinary tract. 
 
On the other hand, Fusobacterium spp. has been reported as a common inhabitant of 
the vagina (Hillier et al., 1993). The maternal vagina could therefore represent a 
reservoir for this species. Previously, Hill (1993) suggested that F. nucleatum 
subspecies (F. nucleatum subsp. vincentii, subsp. nucleatum and subsp. 
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polymorphum) found in the AF from women with intact membranes match more 
closely to the strains present in subgingival sites. However, Han et al. (2010) 
demonstrated a sequence match between the subgingival F. nucleatum subsp. 
animalis strain and the strain isolated from the fetus in a case of a term stillbirth; the 
same strain was not found in the vagina, rectum or supragingival sample of the same 
woman. F. nucleatum subsp. animalis has also been reported as commonly prevalent 
in the human gut (Strauss et al., 2008). There is a need to further investigate 
prevalence of Fusobacterium spp. at different body sites and the potential sources of 
the bacteria associated with APO. 
 
This study aimed to determine the presence of periodontal bacteria in the maternal 
oral cavity and the vagina, and to compare the prevalence, absolute and relative 
levels of the bacteria in the mothers with the levels in samples of NGA. Also, 
similarities and differences in species and subspecies of Fusobacterium among the 
three sites were investigated. 
 
6.2 Participant’s recruitment. 
 
Women were recruited during an initial five month period from January to May 2009 
(16 mothers), and later by post from January to March 2010 (3 mothers). The rate of 
acceptance was 69.6% (16 of 23) for women approached at the hospital, and 23.1% 
(3 of 13) for the women invited by post. Women invited by post were limited to 
those whose infant’s sample was known to contain any of the bacteria of interest (F. 
nucleatum, P. gingivalis and G. elegans) and from whom there was a remaining 
sample of NGA or DNA from their respective infant for further experiments. Of the 
19 women included in the study, 13 (68.4%) agreed to provide a vaginal swab. 
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6.3 Demographical and clinical characteristics of the women included in the 
study. 
 
The 19 women included in this part of the study constituted a representative subset of 
the initial group of cases. Maternal ethnicity comprised five Asian/Bangladeshi, two 
Asian-Indian, one black African, 10 white British/Irish, and one white-other. The 
mean age was 28 years with only two subjects who were over 35 years of age (age at 
risk of PTB). Ten women were primigravidae (56%) and in one case parity was 
unknown. Mode of delivery included 10 vaginal deliveries (52.6%), eight emergency 
caesareans (42.1%), and one elective caesarean (5.3%). The mean gestational period 
was 35 weeks and ranged from 24 to 41 weeks. The number of PTB was 11; seven 
cases were mild PTB (32-36 weeks), two cases were very PTB (28-31 weeks), and 
two cases were extremely PTB (<28 weeks). The mean weight at delivery was 2360 
g with the lowest measure observed being 700 g and the highest being 3848 g. Nine 
women delivered LBW infants, three were cases of pROM, and four women received 
iATB. One of the women had twins and they both provided a sample of NGA at the 
NICU. Finally, 14 (73.7%) of the samples were collected in the neonatal ward, and 
five (26.3 %) in the labour wards. 
 
6.4 Bacterial profiles in the neonates whose mothers were included in the study. 
 
The profile of bacteria observed in the NGA acquired from the respective neonates of 
those mother’s included in this part of the study is described here. Using the broad-
range molecular analysis, 10 (52.6%) samples were positive for presence of bacteria 
when including only this samples; three samples were shown to contain S. 
pneumoniae/mitis/oralis/infantis; one sample was positive for other members of the 
S. mitis group (S. sanguinis/gordonii and S. sinensis/parasanguis) and S. 
salivarious/vestibularis. Two samples contained U. urealyticum. Two samples were 
positive for E. coli; and the other two samples contained S. agalactiae. F. 
necrophorum was identified in one sample and S. epidermidis and H. influenza were 
both present in one sample. Most of these bacteria were observed in vaginal 
deliveries with only one exception (S. pneumoniae/mitis/oralis/infantis) which was 
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also obtained from a case of caesarean section. Bacteria in NGA from women that 
received iATB were observed as U. urealyticum, S. agalactiae and F. 
necrophorumand were all present in samples obtained in the labour ward. No other 
bacteria were identified in this group of samples with the broad-range methods used. 
Species from the genera Lactobacillus, Pseudomonas, Gardnerella, Sneathia, 
Veillonella, and Prevotella were not observed in these group of infants. In general, 
this group presented with low prevalence and richness of potential bacterial 
contaminants as compared to the original group. 
 
On the other hand, using the q-PCR analysis, the average level of general bacteria for 
this group was 2.65E+05 cells/ml; 15 samples (79.0%) were considered positive with 
the 500 cells/ml detection limit. Positive samples were obtained from both cases of 
vaginal (52.6%) and caesarean deliveries (47.4%). Using species-specific primers for 
periodontal bacteria, four samples were considered positive (>100 cells/ml) for F. 
nucleatum (mean= 8.07E+02 cells/ml) in the 18 samples able for analysis (one 
vaginal and three Caesarean deliveries). Interestingly, both NGA samples obtained 
from the twins included in this part of the study were positive for F. nucleatum. 
Samples of NGA which presented results for the quantification of bacteria were: A. 
actinomycetemcomitans (11), P. gingivalis (8), T. forsythia (6) and G. elegans (2). 
As determined previously, all the samples were negative for A. 
actinomycetemcomitans and T. forsythia. One of the cases included in this analysis 
was positive for both P. gingivalis and F. nucleatum. No positive cases of G. elegans 
were included. 
 
6.5 Periodontal examination and other clinical data. 
 
Results from the periodontal examination and clinical variables collected using the 
questionnaires are detailed in Table 6.1. In most of the cases, the woman presented 
with few localized periodontal pockets (between 4 mm and 6 mm). In only one of the 
cases the number of sites with pockets was 18 (10% of the sites), distributed in eight 
different teeth. Presence of pockets in at least one site and number of pockets were 
therefore included in this report. 
CHAPTER 6. PERIODONTAL BACTERIA IN MATERNAL ORAL CAVITY AND VAGINA 
170 
 
Table 6.1 Data obtained from performing a periodontal examination and from the 
questionnaires provided to the participants. 
PERIODONTAL STATUS 
TOTAL (%) 
(N=19) 
Presence of pockets >4mm (n) (%) 13 (68.4) 
Number of sites with pockets >4mm  (median) (range) 2 (0-18) 
DATA OBTAIN FROM QUESTIONNAIRE  
Drinking habits (n) (%) 1 (5.3) 
Smoking during pregnancy/ smoker (n) (%) 2 (10.5) 
Infections/antibiotic during pregnancy (n) (%) 3 (15.8) 
Regular dental care (n) (%) 10 (52.6) 
Antenatal care (n) (%) 6 (31.6) 
Stress during pregnancy (n) (%) 7 (36.8) 
Married or living together (n) (%) 17 (89.5) 
Father's agea (mean) (range) 31 (20-40) 
Education: college/universitya (n) (%) 13 (72.2) 
Sexual relations during pregnancya (n) (%) 16 (88.9) 
Oro-genital contacta (n) (%) 11 (61.1) 
adata not known for 1 case 
 
 
 
6.6 Quantitative analysis of periodontal bacteria in the maternal oral cavity and 
vagina. 
 
The q-PCR analysis was performed directly from the genomic DNA extracted from 
the samples. Levels of F. nucleatum, A. actinomycetemcomitans, P. gingivalis, T. 
forsythia, G. elegans and total bacterial load were determined from the maternal oral 
cavity and vagina samples. Absolute amounts, relative amounts, and prevalence of 
bacteria were calculated as detailed before. 
 
Absolute amounts of bacteria were obtained from all the available samples of the 
mother’s oral cavity and vagina. All the samples were positive for presence of 
bacteria (>500 cells/ml). The minimum and maximum levels of general bacteria in 
the samples from the oral cavity were 3.47E+04 and 1.09E+07 cells/ml, respectively, 
with the mean amount determined as 1.65E+06 cells/ml (median=8.41E+05 
cells/ml). The vaginal samples contained a minimum of 3.49E+03 cells/ml, and a 
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maximum of 1.98E+06 cells/ml (mean= 6.00E+05; median= 2.00E+05). Using a 
detection limit of 100 cells/ml, F. nucleatum was present in 19/19 (100%) samples of 
the oral cavity and 7/13 (53.8%) samples from the vagina. A. 
actinomycetemcomitans, P. gingivalis, T. forsythia and G. elegans were present in 
four (21.1%), four (21.1%), 19 (100%) and two (10.5%) of the oral samples 
respectively, but were not present in the vagina. Absolute and relative amount of 
bacteria in the oral cavity and vaginal samples are detailed in Table 6.2 and Table 
6.3, respectively. Figure 6.1 represents the absolute amounts of bacteria in the 
maternal oral and vaginal samples. A red horizontal dashed line has been placed at 
the 100 cells/ml detection limit to indicate presence or absence of specific bacteria in 
the samples. Figure 6.2 allow comparisons between absolute levels of bacteria in the 
neonatal and maternal sites. 
 
Table 6.2 Levels of periodontal bacteria in the maternal oral cavity. 
ORAL CAVITY 
Absolute amount (cells/ml) 
Relative 
amount (%) 
  min max average median   max average 
F. nucleatum 5.43E+02 2.66E+06 2.44E+05 2.14E+04 32.4 9.6 
A. actinomyce- 
temcomitans 3.63E+00 4.35E+03 5.83E+02 6.88E+00 5.2 0.4 
P. gingivalis 1.08E+00 2.47E+05 2.03E+04 7.07E+00 10.9 1.2 
T. forsythia  1.26E+02 5.68E+05 8.41E+04 1.22E+04 22.2 5.7 
G. elegans 1.82E-05 2.33E+04 2.69E+03 1.82E-05   0.6 0.1 
 
Table 6.3 Levels of periodontal bacteria in the maternal vagina. 
VAGINA 
Absolute amount (cells/ml) 
Relative amount 
(%) 
  min max average median   max average 
F. nucleatum 8.00E+00 8.18E+03 1.53E+02 1.74E+02 3.68 0.67 
A. actinomyce-
temcomitans 3.63E+00 1.97E+01 1.03E+01 9.37E+00 0.27 0.03 
P. gingivalis 5.42E-01 8.96E+00 3.77E+00 2.96E+00 
 
0.03 0.01 
T. forsythia  2.50E-02 2.21E+00 6.11E-01 2.77E-01 0.01 0.00 
G. elegans 1.82E-05 4.95E+01 1.66E+01 1.79E-01   0.00 0.00 
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Figure 6.1 Box-plots representing absolute amounts of general and periodontal bacteria in the 
maternal oral cavity and vagina.  Red dashed line placed at 100 cells/ml detection limit.
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Figure 6.2 Box-plots comparing levels of general bacteria and periodontal pathogens in three 
sites: NGA, maternal oral cavity and maternal vagina. Red dashed line placed at 100 cells/ml 
detection limit. 
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6.7 Statistical analyses and observations. 
 
Where possible, statistical associations were performed, although due to the limited 
number of samples limited observations could be made from the data. Few 
associations were observed between levels of periodontal bacteria in the oral and 
vaginal samples and demographical and clinical data. Higher amounts of general 
bacteria in the oral cavity was associated with white maternal origin (p= 0.048) and 
smoking (p= 0.035), while low levels of general bacteria in the vagina was associated 
with pROM (p= 0.039). F. nucleatum in the oral cavity was also associated with 
smoking (p= 0.025). Relative amount of A. actinomycetemcomitans in the oral cavity 
was associated with non-white maternal origin (p= 0.015); particularly women from 
Asian/Bangladeshi origin. Even though levels may be negative, higher levels of A. 
actinomycetemcomitans and lower levels of P. gingivalis in the vagina was 
associated with pROM (p= 0.031 and 0.021, respectively), and high levels and 
percentage of A. actinomycetemcomitans in the oral cavity was associated with 
sexual relations during pregnancy (p= 0.026 and 0.010 respectively). Table 6.4 
represent the p-values observed when levels of bacteria were compared with the 
demographical and clinical data using a bivariate analysis. However, the associations 
did not remained using the multivariable analysis. 
 
It was also observed that women who presented with periodontal inflammation 
(regardless of the number of sites affected) tended to have higher levels of general 
bacteria (p= 0.023), and specifically of F. nucleatum (p= 0.027), in the NGA 
samples. Interestingly, no sample of NGA contained F. nucleatum when women did 
not present with periodontal pockets, they also presented the lowest levels of F. 
nucleatum in the oral cavity, while the prevalence in the vagina was mixed.
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Table 6.4  Comparisons between absolute and relative amounts of periodontal bacteria in the maternal oral cavity and vagina determined by q-PCR analysis 
with demographical and clinical data. 
COMPARISONS BETWEEN LEVELS OF PERIODONTAL BACTERIA AND DEMOGRAPHICAL 
AND CLINICAL DATA (p-values*) 
ORAL CAVITY 
DEMOGRAPHICAL AND 
CLINICAL DATA 
Absolute amount (cells/ml) Relative amounts (%) 
UNIV. F.n. A.a. P.g. T.f. G.e.   F.n. A.a. P.g. T.f. G.e. 
Non-white ethnic origin 0.048** 0.069 0.062 0.457 0.680 0.200 0.213 0.015** 0.271 0.563 0.297 
Vaginal delivery 0.102 0.102 0.656 0.369 0.288 0.592 0.460 - 0.060 0.438 0.383 
Preterm birth 0.322 0.869 0.213 0.680 0.869 0.283 0.263 0.200 0.161 0.680 0.467 
Low birthweight 0.253 0.414 0.401 0.870 0.683 1.000 0.460 0.903 0.322 0.540 0.662 
Prolonged ROM 0.248 0.564 0.585 0.386 0.564 0.453 0.942 0.922 1.000 0.885 0.568 
Intrapartum antibiotics 0.332 0.182 0.089 0.716 0.808 - 0.464 0.111 0.768 0.544 - 
Smoking during pregnancy 0.035** 0.025** 0.371 0.888 0.092 0.352 0.139 0.501 0.374 0.399 0.453 
Sexual relationship 0.726 0.257 0.026** 0.487 0.397 0.756 0.327 0.01** 0.272 0.129 0.490 
Oro-genital contact 0.187 0.073 0.172 0.545 0.724 0.856   0.145 0.230 0.413 0.659 0.297 
VAGINA 
DEMOGRAPHICAL AND 
CLINICAL DATA 
Absolute amount (cells/ml) 
 
Relative amounts (%) 
UNIV. F.n. A.a. P.g. T.f. G.e.   F.n. A.a. P.g. T.f. G.e. 
Non-white ethnic origin 0.176 0.091 0.498 0.866 0.893 0.317 0.304 0.154 0.115 0.157 1.000 
Vaginal delivery 0.558 0.464 0.341 0.464 0.522 0.317 0.843 0.757 0.688 0.264 1.000 
Preterm birth 0.758 0.440 0.122 0.355 0.686 0.317 0.211 1.000 0.933 0.480 1.000 
Low birthweight 0.775 0.317 0.352 0.668 0.371 0.317 - 0.880 0.876 0.264 1.000 
Prolonged ROM 0.039** 0.071 0.302 0.197 0.593 - 0.289 0.031** 0.021** 0.248 - 
Intrapartum antibiotics 0.794 0.794 0.117 0.602 0.845 - 0.335 1.000 0.778 0.114 - 
Smoking during pregnancy 0.076 0.114 0.075 0.430 - - 0.505 0.145 0.194 - - 
Sexual relationship 0.789 1.000 0.789 0.789 0.746 0.533 0.588 0.778 0.558 0.724 - 
Oro-genital contact 0.758 0.643 0.279 1.000 0.628 0.186   0.917 0.464 0.612 0.264 - 
* p-values determined using Mann Whitney U test. UNIV., General bacteria; F.n. , F. nucelatum; A.a., A. actinomycetemcomitans;  
P.g., P. gingivalis; T.f., T. forsythia; G.e., G. elegans. ** Significant difference as determined by p<0.05. 
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6.8 Comparison between prevalence, absolute and relative amounts of F. 
nucleatum in the three sites. 
 
Figure 6.3 illustrates the comparison between prevalence, absolute and relative levels 
of F. nucleatum between the three sites. Overall, prevalence and levels of the 
bacteria in the oral cavity was high (100% prevalence; median= 2.14E+04 cells/ml, 
7.0%) compared to the equivalent in the vagina (53%; 1.13E+02 cells/ml, 0.05%), 
whereas in the NGA the levels of F. nucleatum were in average low and only a few 
cases showed high levels (16%; 2.17E+01, 1.2%).  Comparisons between absolute 
and relative amounts of F. nucleatum between the three sites comparing individual 
cases are also illustrated in Table 6.5.  
 
 
 
 
Figure 6.3 Diagrams representing comparisons between the prevalence, absolute and relative 
amount of F. nucleatum between the neonatal and maternal samples. 
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6.9 Comparison between Fusobacterium species/subspecies in the neonatal and 
maternal sites. 
 
All the available samples from the NGA (n=201), oral cavity (n=19) and vagina 
(n=13) were included in the analysis. The identification of the Fusobacterium species 
was performed using species-specific primers in an end-point PCR. Primers Fn1F 
and Fn2R (Table 2.4, Chapter 2) would amplify the 16S rRNA gene of all members 
of the genus  Fusobacterium. The products were cleaned and sequenced directly for 
identification. The primer Fn1F was used for sequencing. Sequences were verified 
using Chromas software. The sequences were finally identified by comparisons 
against the HOMD database. Usually, the species with the highest similarity was 
selected to identify the taxa. However, some samples identified more than one 
species with the same percentage of nucleotides matches in which case both were 
included. This was observed in two samples of NGA and one sample of the oral 
cavity. Also, similarity was >97% in most of the cases except for two samples from 
the vagina which similarity with the closest relative was 94.4% with F. nucleatum 
subsp. nucleatum (case 1) and 89% F. nucleatum subsp. animalis (case 55).  
 
Identification of F. necrophorum in one of the samples of NGA confirmed the result 
obtained using the broad-range approach. F. necrophorum was also observed in the 
vagina, but not detected in the oral cavity of any women. F. naviforme was only 
observed in the NGA while F. periodonticum was only observed in the oral cavity. 
Table 6.6 summarizes the results obtained. 
 
The results obtained with this technique were also evaluated to compare the species 
and subspecies identified between samples of each individual case available. Table 
6.7 summarises the findings. Figure 6.6 represents the sequence comparisons by 
alignment of case 54. Sequences were aligned using Multalign and the 
chromatograms of the bases showing differences were included. 
 
In summary, eight samples provided results for the species/subspecies of 
Fusobacterium amplified in the neonatal sample and at least one maternal sample.  
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The results from the respective mother were available for all the samples of the oral 
cavity and only two samples of the vagina. In four cases, bacteria from the vaginal 
samples were not able to be amplified; this may be due to either low amount of 
bacteria in the sample (cases 5 and 65) or due to low percentage of the total load 
(cases 5, 10 and 65) as observed with the q-PCR analysis. In two cases, samples were 
not available.  
 
Table 6.5 Absolute and relative amount of F. nucleatum comparing levels between the 
neonatal and maternal sites from each individual case. 
NGA ORAL CAVITY VAGINA 
CASE 
ID 
Absolute 
amount 
(cells/ml) 
Relative 
amount 
(%)   
Absolute 
amount 
(cells/ml) 
Relative 
amount 
(%)   
Absolute 
amount 
(cells/ml) 
Relative 
amount 
(%) 
1 2.32E+03 n/a 1.22E+05 17.0 8.35E+02 3.7 
4 4.10E+01 2.0 2.14E+04 2.4 3.55E+02 0.0 
5 1.51E+02 10.3 4.46E+03 0.2 4.73E+01 0.0 
10 6.24E+02 36.6 1.67E+05 4.5 1.13E+03 0.0 
18 1.74E+00 3.5 1.89E+03 0.4 9.25E+02 3.3 
53 4.51E+01 0.4 1.59E+05 7.0 8.65E+00 0.2 
54 2.07E+01 1.8 2.66E+06 24.4 6.43E+02 0.8 
55 4.66E+01 0.0 2.71E+05 10.6 1.74E+02 0.3 
62 6.65E+00 0.4 3.97E+05 15.1 8.18E+03 0.1 
65 6.46E+00 15.0 3.06E+05 23.7 2.05E+01 0.0 
162 1.34E+02 5.3   2.35E+05 32.4   5.19E+01 0.0 
NGA; neonatal gastric aspirates; n/a, sample not available; amounts in bold indicate 
samples considered positive (>100 cells/ml). 
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Table 6.6 Detection and identification of Fusobacterium spp. amplified in the neonatal and 
maternal sites using a direct sequencing approach. 
 
Fusobacterium spp. and                                         
F. nucleatum  subspecies 
NGA ORAL CAVITY VAGINA 
Number of samples (N) 201 19 13 
Fusobacterium spp. primers-    
positive N(%) 18 (8.9) 19 (100) 5 (38.5) 
F. necrophorum 1 (0.5) -- 1 (7.7) 
F. periodonticum -- 3 (15.8) -- 
F. naviforme 2 (1.0) -- -- 
F. nucleatum* 17 (8.5) 16 (84.2) 4 (30.8) 
F. nucleatum subsp. polymorphum  13 (72) 6 (32) -- 
F. nucleatum subsp. animalis 2 (11) 1 (5) 3 (60) 
F. nucleatum subsp. vincentii 3 (18) 7 (37) -- 
F. nucleatum subsp. nucleatum -- 3 (16) 1 (20) 
NGA; neonatal gastric aspirates. * Percentages of each subspecies of F. nucleatum 
were calculated from the total of F. nucleatum species. 
 
 
6.10 Discussion. 
 
Most of the studies reporting presence of an oral pathogen in the amniotic 
environment have not confirmed the origin of the bacteria. Animal studies support 
the possibility that oral bacteria can translocate through the bloodstream and 
specifically invade the amniotic tissues. However, in these experiments bacteria are 
usually inoculated directly into the bloodstream, which does not entirely support the 
oral-utero translocation hypothesis. In this chapter the possibility that potential oral 
bacteria present in the NGA may have originated from a non-oral site was evaluated. 
 
The results presented demonstrate that the most common bacteria associated with PD 
(A. actinomycetemcomitans, P. gingivalis, and T. forsythia) are not normally present 
in the vagina. It has been suggested that oral bacteria may reach the female genito-
urinary tract during oro-genital sex (Edwards and Carne, 1998, Saini et al., 2010). 
Nonetheless, in this study, oro-genital contact did not show any influence as regards 
the presence and levels of these bacteria in the vagina.  
  
 
 
 
Table 6.7 Fusobacterium spp. identified with species-specific primers directed to the 16S rRNA gene in an end-point PCR followed by direct sequencing in 
neonatal and maternal sites. 
 
PARTICIPANT’S 
ID NGA ORAL CAVITY VAGINA 
1 Fnp 99.5%; Fnv 99.1% Fnv 99.8%; Fnp 99.6% Fnn 94.3% 
4 Fnp 99.3%; Fnv 99.1% F. periodonticum 100% Negative 
5 
 
Fnv, F. naviforme 99.5%; Fnn 
99.3% 
Fnv 99.8%; Fnp 99.6% 
 
Negative 
 
10 Fnp 99.5%; Fnv 99.3 Fnv 99.5%; F. naviforme 99.3% Negative 
16 F. necrophorum 97.4% Fnn 99.6% Not available 
53 Fnp 97.9%; Fnv, Fnn 97.7% Fnv 99.6%; Fnp 99.5% Not available 
54 
 
Fnp 98.1%; Fnn, Fnv 98% 
 
Fnn, Fnp 99.3%; Fnv 99.1% 
 
 
Fna 99.6%; Fnn, Fnv, F. 
naviforme 99.2% 
65 
 
Fna, Fnv, F. naviforme 99%; Fnn 
98.7% 
Fnp 100%; Fnv 99.5% 
 
Negative 
 
NGA; neonatal gastric aspirates; Fnp, F. nucleatum subsp. polymorphum; Fna, F. nucleatum subsp. animalis; Fnv, F. nucleatum subsp. vincentii; 
Fnn, F. nucleatum subsp. nucleatum. 
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CASE 54 
 
Figure 6.4 Diagram representing the alignments of the Fusobacterium spp. amplified from the NGA and their respective counterpart in the maternal 
oral cavity and vagina of CASE 54. Each mismatch has been amplified to show differences in the sequencing chomatograms.
181
 
CHAPTER 6. PERIODONTAL BACTERIA IN MATERNAL ORAL CAVITY AND VAGINA 
182 
 
In one of the cases, P. gingivalis was observed in the neonatal (NGA) samples of a 
woman delivering a preterm infant vaginally; however, the same pathogen was not 
present in the woman’s oral cavity or vaginal sample. The participant confirmed 
having sexual relationships and performing oro-genital contact during pregnancy 
which, in this particular case, may explain presence of the bacteria in the neonate. 
However, the partners’ periodontal bacteria were not evaluated. Also, other potential 
routes of transmission should be explored, e.g. contamination acquired from other 
members of the family or the medical staff. 
 
Levels of periodontal bacteria in the pregnant female oral cavity have been studied 
previously (Persson et al., 2008, Urbán et al., 2010, Ryu et al., 2010). Interestingly, 
in this study, T. forsythia was not associated with PD as demonstrated previously 
(Mineoka et al., 2008). It was observed in all the maternal oral samples at a relatively 
high percentage (mean= 8.41E+04 cells/ml, median= 1.22E+04 cells/ml, average 
relative amount= 5.7%) compared to the other common periodontal bacteria (A. 
actinomycetemcomitans and P. gingivalis). These other bacteria were in contrast 
observed in high levels in a few samples and in association with the presence of 
periodontal pockets. This is the first study reporting high levels of T. forsythia in the 
oral cavity of pregnant women, and a more extensive analysis should be performed 
to investigate this observation. Furthermore, this is the first study that has measured 
levels of G. elegans. However, this pathogen was observed in low amounts and less 
than 1% relative levels in the oral cavity and in very low levels in the vagina (less 
than 0.01%). 
 
The results of this study confirm that F. nucleatum is  highly prevalent in the oral 
cavity (Moore and Moore, 1994) and is also present in the vagina, though at a much 
lower prevalence and at very low levels and relative amounts. Therefore, the female 
genitourinary tract may as well represent a reservoir for the pathogen. Interestingly, 
in all the four cases that were shown to contain F. nucleatum and P. gingivalis in the 
newborn’s gastric aspirates, women presented with at least one pocket of 4 mm to 6 
mm, with three of the cases being emergency Caesarean sections. Conversely, 
mothers who did not have periodontal pockets did not haurbour F. nucleatum in the 
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corresponding NGA. However, all had sexual relationships during pregnancy and, 
except for one woman, all performed oro-genital contact during pregnancy and some 
cases were shown to contain F. nucleatum in the vaginal sample. Levels of this 
pathogen in the vagina, when comparing samples for each individual case, supported 
a potential vaginal origin since every case was shown to contain the bacterium, 
although in some cases this was observed at non-detectable levels (<100 cells/ml) 
and at low prevalence in the samples. 
 
To help confirm the precise source of the bacteria present in the NGA further 
analysis of the species/subspecies was performed by 16S rRNA gene sequence 
analysis. The PCR primers used were designed to amplify the 16S rRNA gene of 
bacteria from genus Fusobacterium (F. canifelinum, F. equinum, F. gonidiaformans, 
F. mortiferum, F. naviforme, F. necrogenes, F. necrophorum, F. nucleatum, F. 
perfoetens, F. periodonticum, F. pseudonecrophorum, F. russii, F. simiae, F. 
ulcerans and F. varium). In this study, those of most clinical significance were 
identified in the samples (F. nucleatum, F. periodonticum, F. necrophorum and F. 
naviforme). F. periodonticum was limited to the oral cavity, even though it has been 
reported not to be restricted to the oral niche (Strauss et al., 2008). F. necrophorum 
was observed in the NGA and also in the vagina (of a different women), but not in 
the oral cavity. In accordance with Bennett and Eley (1993), they observed that  F. 
necrophorum is more commonly found in the lower part of the body and genitals, 
whereas F. nucleatum is more commonly found in the upper body and oropharynx.  
 
The most common subspecies of F. nucleatum in the samples of NGA was F. 
nucleatum subsp. polymorphum (72% of F. nucleatum species). Other subspecies 
observed were subsp. vincentii (18%) and subsp. animalis (11%). Similar to what has 
been previously suggested (Hill, 1993), the range of subspecies observed in the 
infants resemble more closely those observed in the oral cavity of the mothers, which 
showed a higher prevalence of F. nucleatum subsp. vincentii (37%), followed by 
subsp. polymorphum (32%), subsp. nucleatum (16%) and subsp. animalis (5%). On 
the other hand, the subspecies of F. nucleatum observed in the vagina were mostly F. 
nucleatum subsp. animalis (16%) and only one case showed the presence of F. 
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nucleatum subsp. nucleatum (20%). Previous evidence confirmed that the subsp. 
animalis causing a stillbirth originated from the oral cavity (Han et al., 2010). F. 
nucleatum subsp. animalis has also been reported as an uncommon oral strain but 
significantly more prevalent in necrotizing ulcerative gingivitis in a Chinese 
population (Gmür et al., 2006), and is also common inhabitant of the human gut 
(Strauss et al., 2008). 
 
Finally, the comparisons performed between samples of individual cases showed that 
the species observed in the NGA most closely related with those in the oral cavity 
than with those in the vagina. Specifically, the alignment of the sequences of F. 
nucleatum for case 54 demonstrated eight sites in the sequences that do not match 
with the vaginal but do match with the oral strain. In three remaining sites, the oral 
and vaginal strain sequences do match, while in one case there is no match among 
any of the strains. These variations might be due to the presence of a range of 
different species/subspecies since the samples are likely to carry a mixture of the 
bacteria. No member of the subsp. fusiforme was identified. 
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7.1 Introduction.  
 
In previous chapters, the results of investigations were based on the ability of the 16S 
rRNA gene to identify and quantify bacteria.  Samples sequencing of the 16S rRNA 
gene has been established as the gold standard for identification and taxonomic 
classification of bacterial species. It has been previously demonstrated that all the 
Fusobacterium species present with unique sequences of the 16S rRNA gene and 
substantial intrageneric heterogeneity (Lawson et al., 1991, Gmür et al., 2006, 
Strauss et al., 2008). This was also observed for F. nucleatum subspecies, even 
though they exhibited relatively high levels of sequence similarity. However, the 
disadvantage of using the 16S rRNA gene for discrimination is the lack of sufficient 
resolution to enable a precise differentiation between strain variations within a 
species. Identification to a species level may be insufficient proof of translocation of 
bacteria from one site to another. More precise techniques are necessary to compare 
the strains of F. nucleatum observed in the NGA with strains present in the maternal 
oral and vaginal samples in order to determine the origin of the bacteria.  
 
The 16S-23S rDNA ISR is increasingly being used for the analysis of phylogenetic 
relationships among species and subspecies of the same genus (Barry et al., 1991, 
Tyrrell et al., 1997, Sadeghifard et al., 2006) due to its more divergent sequence as 
compared to the 16S rDNA (Söller et al., 2000).  The heterogeneity of the ISR in 
terms of both copy number and length has raised the possibility of using this 
methodology for bacterial identification and typing purposes (Gürtler and Stanisich, 
1996). Previously, the ISR located between the 16S and the 23S rRNA genes has 
been used to examine inter- and intraspecies relationships of the Fusobacterium 
species demonstrating a high phylogenetic resolution (Conrads et al., 2002).  
 
As observed in this report, the subspecies of F. nucleatum identified in the NGA 
samples seemed to present a better match with oral stains than with vaginal strains. 
Although the match was closer with the oral clones, there were still mismatches at 
the 16S rDNA level. A 100% match between the site of origin and the recipient site 
would be expected in order to determine origin. Variability of the ISR has been 
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previously exploited in a case report of a 39th week stillbirth to determine the origin 
of F. nucleatum (Han et al., 2010). F. nucleatum was, for the first time, demonstrated 
to originate from the maternal oral cavity since the same clone was identified in the 
placenta/fetus and the mother’s subgingival plaque but not in maternal supragingival 
plaque, vagina or rectum. However, the match was performed through identification 
of an end-point PCR positive band using Fusobacterium-specific primers directed to 
the ISR (constructed from the fetal F. nucleatum strain). Little information was 
provided regarding the construction of the primers and the primer detection limits 
were not mentioned and probably not considered in this study. It is possible the same 
species might be present in the vagina or gut at levels that were undetectable using 
end-point PCR, as observed in the current study. 
 
After a thorough evaluation of the literature, a lack of information regarding the 
ability of this genomic region to discriminate between species and strains of the 
genus Fusobacterium was noted. Therefore, the first part of this chapter presents an 
assessment of the ISR as a tool to discriminate strains of F. nucleatum and the 
second part includes the use of this methodology to precisely identify the origin of F. 
nucleatum in NGA. 
 
7.2 Specific amplification of the intergenic spacer region of Fusobacterium 
species/subspecies origin. 
 
Unlike the 16S rDNA sequences, the 23S rDNA has not been extensively studied and 
therefore there is still very little information about this gene. Hence, a species-
specific primer for the genus Fusobacteria targeting the 16S rRNA gene was used in 
combination with a universal primer in the 23S rRNA gene to amplify the complete 
ISR from both reference strains and samples. The 456R primer has been suggested as 
the most highly conserved universal primer in the 23S rDNA for amplification of 
most bacteria  (Gürtler and Stanisich, 1996). Primer 456R were therefore used in this 
study. Exceptional cases where the primer 456R did not amplify a product, primer 
129R was used. 
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Conrads et al. (2002) previously determined that the ISR of Fusobacterium strains 
ranged in length between 108 bp (Leptotrichia buccalis) and 262 bp (Fusobacterium 
prausnitzii). It was therefore expected that the forward primer Fn1F in the 16S 
rDNA, and the reverse primer 456R in the 23S rDNA would amplify a fragment with 
a length range between ca. 1860 and 2020 bases. The proposed amplicon would 
consist of: i) 1290 bases of the 16S rRNA gene, ii) the ISR between the 16S and 23S 
rRNA genes, and iii) the first 460 bases of the 23S rRNA gene (Figure 7.1). 
 
 
Figure 7.1 Schematic representations of the 16S, the ISR, and the 23S rDNA portions of the 
rrn operon including the primers used for amplification and sequencing in this study. 
 
 
7.3 Cloning and analysis of fragment lengths in agarose gels. 
 
The ISR was amplified from the five different subspecies of F. nucleatum grown in 
pure culture in this study (Table 2.2 Chapter 2). The products were then subjected to 
cloning and 10-20 randomly selected clones were amplified following the same 
protocol as the initial amplification. This was followed by the use of an extended 
agarose gel analysis to resolve the products. Different fragment lengths could be 
clearly observed in all the strains, evaluated suggesting this variation might be due to 
differening numbers of rrn operons. Figure 7.2 represents fragment lengths from 
clones of the F. nucleatum subsp. polymorphum strain NCTC 10562. At least three 
different fragment sizes could be differentiated in the gel for this strain. Two 
fragment sizes were observed for the other subspecies of F. nucleatum. As observed 
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in the gels, fragment lengths ranged between ca. 1900 and 2300 bp. 
 
 
 
Figure 7.2 Picture of agarose gel showing three different fragment sizes of clones amplified 
from F. nucleatum  NCTC 10562 using primers Fn1F (16S) and 456R (23S). Stars in different colours 
indicate possible different fragment lengths. Blue star, long fragments; green star, medium size 
fragment; red star, short fragments. 
 
 
7.4 Sequencing and alignment of clones. 
 
A library of clones was constructed from the reference strains. This was later 
performed for the clinical samples of NGA, maternal oral cavity, and vagina in order 
to individualize species, subspecies, and operons within them. Basically, 
representative clones observed at variable levels in the extended agarose gel analysis 
were sequenced for analysis. The total number of clones analysed from each 
subspecies were: nine F. nucleatum subsp. animalis, 10 F. nucleatum subsp. 
fusiforme; 10 F. nucleatum subsp. nucleatum, 11 F. nucleatum subsp. polymorphum, 
and six F. nucleatum subsp. vincentii.  
 
Each clone was sequenced with the forward primer 1114F and the reverse primer 
456R (Table 2.7, Chapter 2). The sequences were analysed using the software 
Chromas and aligned using Multalign. Whenever a mismatch was observed between 
the sequences produced with the forward primer and the reverse complement of the 
sequences obtained with the reverse primer, this was corrected by looking at the 
sequencing chromatograms. Finally, identification of the species/subspecies was 
performed through sequence comparison against BLAST, the RDP, and HOMD 
libraries of sequences. 
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7.5 Determination of the intergenic spacer region sizes. 
 
The ISR lengths of the F. nucleatum species were determined using the sequences 
obtained from the reference clones of the five subspecies of F. nucleatum. Alignment 
of tclone sequences against published data of the 16S, the ISR, and the 23S rDNA of 
F. nucleatum ATCC 25586 were performed using Multalign. By comparisons with 
these data, the limits of the ISR fragments were identified in the clones and the 
lengths of ISR calculated. 
 
7.6 Identification of the five subspecies of F. nucleatum using standard 
sequence comparison methods. 
 
Variable results were observed when using different sequence libraries sites to 
identify the clones of the subspecies of F. nucleatum grown and analysed in this 
study. The data was analysed with HOMD, RDP, and BLAST. In general, all the 
strains were identified as Fusobacterium spp. In the case of F. nucleatum subsp. 
animalis and subsp. nucleatum, both were successfully identified by all three 
databases. F. nucleatum subsp. polymorphum was identified with RDP and HOMD, 
but the HOMD also identified these clones as F. periodonticum. On the other hand, 
BLAST identified the strain of F. nucleatum subsp. polymorphum as both subsp. 
nucleatum and F. periodonticum. F. nucleatum subsp. fusiforme was only identified 
by BLAST; HOMD and RDP identified this strain as F. nucleatum subsp. vincentii 
or F. naviforme. Finally, F. nucleatum subsp. vincentii was identified only by 
HOMD, while the RDP and BLAST identified it as F. nucleatum subsp. fusiforme. 
 
7.7 Analysis of the intergenic spacer region by sequence comparisons and 
phylogenetic analysis. 
 
The sequence data was used to analyse differences among the five different 
subspecies of F. nucleatum, as well as the five rrn operons of F. nucleatum ATCC 
25586 published in the Oral Pathogen Sequence Database, Los Alamos National 
Laboratory website. The published data was also used to investigate the efficacy of 
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the methodology used in this study to make comparisons with the equivalent data 
obtained from the F. nucleatum ATCC 25586 grown in this study. Finally, sequences 
of clinical strains were compared with their corresponding counterpart in the oral and 
vaginal samples to confirm origin. Phylogenetic trees were constructed with the 
clone sequences to investigate relationships between the samples’ F. nucleatum 
strains found in the samples. 
 
7.7.1 Sequence comparisons between the five operons of F. nucleatum 
ATCC 25586 using published data of the complete genome. 
Figure 7.3 represents a sequence comparison between the five different operons of 
the F. nucleatum subsp. nucleatum ATCC 25586. Data was obtained from the Oral 
Pathogen Sequence Database, Los Alamos National Laboratory 
(http://www.oralgen.lanl.gov/). The data indicates that this subspecies possesses four 
short identical operons and one long operon due to size variation of the ISR fragment 
(155 and 330 bp). Only three mismatches were observed when comparing the short 
and the long fragment. It could also be observed that the long fragment of the ISR 
contained an extra 9 bp fragment, followed by one tRNAAla and one tRNAIle (each 77 
bp in length and separated by 3 bp), and another 9 bp fragment in the ISR (Figure 
7.4). 
 
Figure 7.3 Sequence comparison of the 16S-23S ISR between the five different operons of F. 
nucleatum ATCC 25586, Oralgen, Los Alamos National Laboratory, New Mexico. The ISR is located 
between base 1503 and 1835. 
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>FnnATCC25586_ISR_Operon2 
…TCTTGTACACACCGCCCGTCACACCACGAGAGTTGGTTGCACCTGAAGTAGCAGGCCT
AACCGTAAGGAGGGATGTTCCGAGGGTGTGATTAGCGATTGGGGTGAAGTCGTAACAAG
GTATCCGTACGGGAACGTNGCGGATGGATCACCTCCTTTCTAAGGAGAATGTGTCTTT
CTCTATTCTATTGGTAATGTTCTTGCATGAACTTATCAATAACGCGTTTGTAGCTCA
GCTGGTTAGAGCACACGCCTGATAAGCGTGAGGTCGGTGGTTCAAGTCCACTCAAA
CGCACCATGTGGGGATATAGCTCAGTTTGGGAGAGCGACGCACTTGCACTGCGTAG
GTCAGCGGTTCGATCCCGCTTATCTCCACCATTATTTTATCTGAACATTGGAAACTA
TATAGTAGAACAAACAAGAAAAAAATTAACTCTAAACAATTTCTTTAGAGTTAGCTG
TCAAAAAATAGNGTTAAAATAATTAAGGGCACACAAAGGATGCCTAGGTAGTAAGAGC
CGATGAAGGACGTGGTAAGCTGCGATAAGCCTAGATAAGTTGCAATCGAACGTAAGAGT
CTAGGATTTCCGAA… 
 
Figure 7.4 Sequence deduced from the published data of F. nucleatum ATCC 25586, long 
fragment (Operon 2). Ns were placed at the beginning and end of the ISR (in bold). Bases in blue 
indicate the sequence contained only in the long fragment of the ISR. Section highlighted in green 
represents the tRNAAla and the section in yellow represents tRNAIle. 
 
 
7.7.2 Sequence comparisons between published data of F. nucleatum 
ATCC 25586 and clones produced in this study. 
 
In order to evaluate the data obtained in this study against the data already published 
in the literature, a comparison between known sequence data and data produced in 
this study for the ATCC 25586 strain of F. nucleatum were performed. Figure 7.5 
demonstrates that the methodology used in this study, successfully amplify the two 
different sized rrn operon fragments from the F. nucleatum spp. nucleatum and these 
matched 100% with the published data. 
 
7.7.3 Sequence analysis of the intergenic spacer region of the five 
subspecies of F. nucleatum. 
 
The clones obtained from each strain of F. nucleatum grown in this study were 
aligned to identify different lengths of the ISR. This demonstrated that subspecies 
animalis, fusiforme, nucleatum, and vincentii possess ISR of two different sizes, 
while F. nucleatum subsp. polymorphum contained three different ISR fragment 
lengths. A total of five different lengths of the ISR were identified in the five strains: 
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331, 322, 222, 156 and 147 bases in length. The ISR fragments present in each 
subspecies varied: F. nucleatum subsp. polymorphum contained ISR 331, 222, and 
156 bp lengths; subsp. animalis and subsp. nucleatum presented fragments sizes of 
331 and 156 bp; subsp. fusiforme and subsp. vincentii presented fragment sizes of 
322, and 147 bp. It could be observed that the long ISR fragments length (331 and 
322) contained both tRNAAla and tRNAIle. Figure 7.6 shows alignment of the clones 
of the different F. nucleatum strains. Identical sequences were identified and 
eliminated. Sequences presenting at least one mismatch in any region were kept and 
included in the analysis. An N was introduced at the beginning and at the end of one 
representative sequence for each length for identification. It could be observed that 
the variability in length of ISR was due to the presence or lack of certain regions (of 
different lengths) along the ISR. It is also evident that the five subspecies present few 
mismatches along the 16S, ISR, and 23S rDNA. 
 
7.7.4 Phylogenetic analysis of the intergenic spacer region of the five 
subspecies of F. nucleatum. 
 
Figure 7.7 demonstrates the ability of 16S, ISR, and 23S to discriminate bacteria at 
the subspecies level, and also possibly at the strain level. The variability in fragments 
of 16S and 23S rRNA genes were important to allow discrimination between 
subspecies, since when the ISR alone was used the same discrimination could not be 
observed (Figure 7.8). Clinical strain identified as S. sanguinegens and L. buccalis 
were included as outgroups with and confirmed distant relation with both fragments 
of the rrn operon (not included in the graphs). 
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Figure 7.5 Sequence comparison of the ISR between operons of F. nucleatum ATCC 25586 
(Fnn_ISR_Operon#) obtained from the Oral Pathogen Sequence Database, and the sequences obtained 
in this study from a pure culture of F. nucleatum ATCC 25586 (CeGo_Fnn_#). 
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Figure 7.6 Sequence comparison of the 16S-23S ISR of F. nucleatum subspecies grown in this 
study. Fna, F. nucleatum subsp. animalis; Fnf, F. nucleatum subsp. fusiforme; Fnn, F. nucleatum 
subsp. nucleatum; Fnp, F. nucleatum subsp. polymorphum; Fnv, F. nucleatum subsp. vincentii. 
Different fragment sizes were identified as: A1, 331 bases; A2, 322 bases; B, 222 bases; C1, 156 
bases; and C2, 147 bases.  
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Figure 7.7 Phylogenetic relationships between the five subspecies of F. nucleatum clones 
constructed using fragments of DNA composed of 1290 bases of the 16S rDNA, the complete ISR, 
and the first 460 bases of the 23S rDNA of the rrn operon. Fna, F. nucleatum subsp. animalis; Fnf, F. 
nucleatum subsp. fusiforme; Fnn, F. nucleatum subsp. nucleatum; Fnp, F. nucleatum subsp. 
polymorphum; Fnv, F. nucleatum subsp. vincentii. 
CHAPTER 7. THE 16S-23S ISR TO DETERMINE ORIGIN OF F. NUCLEATUM 
197 
 
 
 
Figure 7.8 Phylogenetic tree showing genetic relationships between the five subspecies of F. 
nucleatum clones using the complete ISR of the rrn operon only. Fna, F. nucleatum subsp. animalis; 
Fnf, F. nucleatum subsp. fusiforme; Fnn, F. nucleatum subsp. nucleatum; Fnp, F. nucleatum subsp. 
polymorphum; Fnv, F. nucleatum subsp. vincentii. 
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7.7.5 Sequence analysis of F. nucleatum clones from samples of NGA, 
oral cavity and vagina from a single case. 
 
Clones obtained from an individual sample of NGA were compared against the 
corresponding samples of the maternal oral cavity and vagina. Clones amplifying 
other non-Fusobacterium species were also observed in the samples; seven clones 
from the NGA sample were identified as S. sanguinegens and the remaining seven 
clones were confirmed as F. nucleatum. Two Leptotrichia spp. and two L. buccalis 
clones were identified in the oral cavity and the vagina, respectively, and these 
clones were excluded from the analysis. Consequently, 20 clones from the oral cavity 
and 14 clones from the vagina identified as F. nucleatum were included. 
 
A 100% match between none of the clones of the NGA and either the oral cavity or 
the vagina was observed in case 10 (Figure 7.9 A-D). To facilitate analysis, the 
number of mismatches was calculated and the data grouped by size of ISR. Clones of 
the NGA were aligned against each clone of the oral cavity and the vagina and 
mismatches were counted. For the 331 bp ISR, the clone with the lowest number of 
mismatches in the 16S-ISR-23S rDNA fragment was observed with an oral clone (n= 
14), compared to 19 in the vaginal clone (mismatches in the ISR were eight for both) 
(Figure 7.9 A). For the 222 bp ISR (Figure 7.9 B), no vaginal clones were identified 
and the minimum number of mismatches was 21 between the NGA and the oral 
clones (17 mismatches in the ISR only). For the 156 bp ISR clones, a minimum 
number of mismatches was observed with clones from the oral cavity (10 
mismatches, only one in the ISR), while a minimum of 12 mismatches (3 in the ISR) 
were observed between the NGA and the vaginal clones (Figure 7.9 C). No clones 
from the NGA were identified of sizes 322 and 147 bp. In conclusion, the least 
number of mismatches were observed with the oral cavity clones. 
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7.7.6 Phylogenetic analysis to compare clones from samples of NGA, 
oral cavity and vagina from a single case. 
 
Figure 7.10 represents the phylogenetic tree produced with clones obtained from the 
NGA and maternal samples (oral cavity and vagina) from a single case. Interestingly, 
it can be seen that clones from the NGA appear to originate from the same ancestor 
as clones the oral cavity, whereas clones from the vagina originate from a more 
distant ancestor. The data is also represented by grouping the clones by ISR length 
together with the clones of the five strains of F. nucleatum grown in this study 
(Figure 7.11 A-E). Figure 7.11 D clearly shows that the F. nucleatum strain (s) in the 
NGA may have originated from the oral cavity of the respective mother. 
 
A 
 
 
Figure 7.9 Comparison of aligned sequences of the 16S-ISR-23S rDNA of those clones 
obtained from the neonatal and maternal sites from CASE 10. Sequences from each ISR size are 
represented separately in figures A, B and C. GA10; neonatal gastric aspirate case 10; OC10, maternal 
oral sample case 10; V10, vaginal sample case 10. A. ISR fragment size 331 bp (A1). 
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Figure 7.9 (cont.) B. ISR fragment size 222 bp (B). C. ISR fragment size 156 bp (C1). 
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Figure 7.10 Phylogenetic tree showing genetic relationships amongst clones of F. nucleatum 
strains amplified from the neonatal and maternal samples from a single case study (CASE 10). GA10, 
clones of NGA from case 10; OC10, clones from the maternal oral cavity from case 10; V10, clones 
from the maternal vagina from case 10.  
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Figure 7.11 Phylogenetic relationships among clones of F. nucleatum strains amplified from the 
neonatal and maternal samples from a single case study (CASE 10) and comparisons with the F. 
nucleatum subspecies strains. GA10, clones of NGA from case 10; OC10, clones of the maternal oral 
cavity from case 10; V10, clones of the maternal vagina from case 10. Fna, F. nucleatum subsp. 
animalis; Fnf, F. nucleatum subsp. fusiforme; Fnn, F. nucleatum subsp. nucleatum; Fnp, F. nucleatum 
subsp. polymorphum; Fnv, F. nucleatum subsp. vincentii. A. ISR fragment size 331 bp (A1). B. ISR 
fragment size 322 bp (A2). C. ISR fragment size 222 bp (B).  
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Figure 7.11 (cont.) D. ISR fragment size 156 bp (C1). E. ISR fragment size 147 bp (E). 
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7.8 Discussion. 
 
This study aimed to assess the ability of the 16S-23S rDNA ISR to differentiate 
species of F. nucleatum at the strain level and to apply this methodology to 
determine the precise origin of F. nucleatum in NGA. Several studies have been 
performed to define bacterial species/subspecies and to investigate phylogenetic 
relationships using the ISR in a range of important clinical strains including 
Enterococcus spp. (Tyrrell et al., 1997), Campylobacter spp. (Christensen et al., 
1999), Pseudomonas spp. (Guasp et al., 2000), strains of Clostridium difficile 
(Gürtler, 1993, Sadeghifard et al., 2006), subspecies and serotypes of Salmonella 
enterica (Christensen), Streptococcus spp. (Hassan et al., 2003, Chen et al., 2004), 
and P. gingivalis (Rumpf et al., 1999). In general, these studies demonstrated the 
markedly higher heterogeneity of this region as compared to the gold standard, the 
16S rRNA gene, to differentiate closely related taxa. 
 
Also, the ability of the ISR to allow discrimination of species belonging to the 
Fusobacterium genus has been analysed previously (Narayanan et al., 2001, Conrads 
et al., 2002, Jin et al., 2002b, Jin et al., 2002a). Only one study has presented data 
related to the length of the five subspecies of F. nucleatum (Conrads et al., 2002). 
The band sizes were calculated by approximation in an agarose gel and were 
determined as three to four bands for F. nucleatum subsp. nucleatum, three bands for 
F. nucleatum subsp. animalis, fusiforme and animalis and one band for F. nucleatum 
subsp. polymorphum. The ISR length was calculated for the shorter fragment only 
and lengths varied between 121 and 151 bp. The results presented here differ greatly 
with the ones previously published with respect to the number of bands and the 
length of the ISR. 
 
As observed in this study, a total of five different lengths of the ISR were identified 
and calculated precisely in the five strains of F. nucleatum examined. A clear pattern 
was observed in terms of ISR length for each strain. Two fragments (a short 156 or 
147 bp version, and a long 331 or 322 bp version) were presented in each strain, 
except for the subsp. polymorphum which also contained a third ISR (222 bp). This 
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variability is known to be due to differences in the rrn operons (Sadeghifard et al., 
2006). As observed, the short and long fragments were identical in size for subsp. 
animalis, subsp. nucleatum and subsp. polymorphum (short: 156 bp, long: 331 bp). 
These differ from the corresponding ones for F. nucleatum subsp. fusiforme and 
vincentii (short: 147 bp, long: 322 bp). Both long versions contained a tRNAIle and a 
tRNAAla inserted in the ISR as detailed previously. 
 
Differences in the size of the intergenic spacer region are not always suitable for 
strain identification (McLaughlin et al., 1993, Gill et al., 1994). The results presented 
here may not allow discrimination of the five subspecies using only a band pattern in 
a gel electrophoresis based technique.  However, this information combined with 
construction of specific primers, could represent a useful tool for differentiation of 
the subspecies of F. nucleatum and possibly at the strain level. The mosaic pattern 
described for the F. nucleatum subspecies ISR has been previously described for 
other genera and species (Gianninò et al., 2001, Carr et al., 2004, Osorio et al., 2005, 
Sadeghifard et al., 2006) in which the presence and absence of one or more regions 
(also known as block types) were the reason for the length differences and the basis 
for more sensitive and discriminatory strain typing methods. In this study, a short 
variable region in the ISR (bases 28 to 32) (see Figure 7.6) could be clearly identified 
with variations specific for F. nucleatum subsp. nucleatum (AATGT), subsp. 
polymorphum (AATAA), subsp. animalis (TATAA), and F. nucleatum subsp. 
vincentii and subsp. fusiforme (AAAAA) that could be used for primer design or as a 
target site for restriction endonucleases. There is an ongoing discussion regarding F. 
nucleatum subsp. vincentii and subsp. fusiforme as regards classifying these as the 
same subspecies (Gharbia and Shah, 1992, Kim et al., 2010), which would explain 
the homogeneity found in this study and the inability to be correctly identified. This 
may also explain why subsp. fusiforme was not identified in the samples of NGA, 
oral cavity or vagina in this study.  
 
Case 10 was included in this study to test the methodology proposed. This was a 
preterm infant, delivered by Caesarean section at 35 weeks of gestation; the mother 
had suffered a previous miscarriage and presented with localized chronic 
CHAPTER 7. THE 16S-23S ISR TO DETERMINE ORIGIN OF F. NUCLEATUM 
206 
 
periodontitis and pockets in four sites (4-5mm depth). As suggested in previous case 
reports (Han et al., 2006, Han et al., 2010), a 100% match was expected between the 
site of origin and the recipient site to precisely determine strain origin. However, the 
results of this study show that the clones did not show a 100% match. Instead, 
sequence variations were observed all of between the samples. This may be due to 
the limited number of clones per sample investigated or due to genetic changes 
within strains. The 16S-23S ISR region possess a non-coding function, therefore is 
less susceptible to selection pressure and it can therefore accumulate a higher 
percentage of mutations than the rRNA genes (Tyrrell et al., 1997). However, a 
certain degree of variation was also observed in the more conserved 16S and the 23S 
rDNA fragments included. The sequences of multicopy rRNA genes are mostly 
identical or nearly identical (Rajendhran and Gunasekaran, 2010). Another 
possibility may be due to PCR or sequencing bias and the formation of chimeric 
molecules (Wang and Wang, 1997), even though this was demonstrated to be very 
unlikely since a 100% match was observed when comparing the sequences obtained 
in this study with published sequence information for strain ATCC 25586. There is a 
clear need to accumulate more data regarding inter- and intraspecies variation of 
Fusobacterium species and subspecies, specifically of the ISR and the 23S rDNA 
regions, and to further evaluate the utility of this methodology to confirm 
translocation in a well designed study with an appropriate number of cases. 
Nevertheless, the preliminary data presented here demonstrates a high possibility that 
the strain of F. nucleatum present in the NGA originated from the maternal oral 
cavity strain rather than from the vagina. 
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Samples of NGA contain a highly diverse range of bacteria. These sample have 
demonstrated a potential suitability to be analysed for investigation of those potential 
pathogens associated with the occurrence of perinatal infections and APO. Indeed, 
NGA should contain the bacteria that were able to reach and colonise the amniotic 
cavity before birth and therefore include those potential pathogens possibly involved 
in the initiation of the complications or the cause of early-onset infections in 
neonates. In general, the bacterial species identified in this study were consistent 
with observations made in previous studies (Oue et al., 2009, Jones et al., 2010). The 
bacteria identified in NGA also resembled those identified in studies investigating 
bacteria in the AF (Miralles et al., 2005). For example, high levels of U. urealyticum 
and S. agalactiae, as well as bacteria usually implicated in nosocomial outbreaks, 
have been observed in neonates that presented with a complication (Waites et al., 
2009). Conversely, higher prevalence of Lactobacillus spp. has been observed in 
women/infants with no complications and therefore may have contributed to the 
prevention of adverse outcomes (Verstraelen et al., 2009).  
 
One disadvantage, related to the analysis of these samples, may be associated with 
the presence of various bacterial contaminants. As observed in this study, bacteria 
identified in the samples may have originated from a range of external sources 
including aspiration of vaginal fluids during labour, vaginal and cervical bacteria 
acquired during vaginal delivery, skin bacteria, and other environmental bacteria 
obtained during collection and transportation of the samples. These circumstances 
would effectively make it more difficult to determine the true pathogens associated 
with pregnancy complications. The results from this study clearly demonstrated the 
need to control for certain confounding factors when the presence of given bacteria is 
being assessed. By excluding these interfering variables (i.e. neonates born vaginally, 
presentation of pROM, women who received iATB, smokers, samples collected at 
the maternal wards, and samples collected at more than 12 hours post delivery), the 
profile of bacteria in these samples will be limited to those most likely to be 
associated with pregnancy complications.  
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Similarly, the introduction of more advanced technologies for the investigation of 
complex bacterial communities in this study was of great value for the 
characterisation and understanding of the samples analysed. The range of taxa 
identified in NGA using a combination of molecular techniques has not been detailed 
before. Both clone analysis and DGGE were equally efficient in detecting the most 
common bacteria in the samples, yet DGGE is less expensive and facilitated a profile 
of the bacteria contained in the samples which may represent an advantage over 
clone analysis. Conversely, clone analysis seems to be more effective in identifying 
less prevalent species which was of a great benefit for the aims of this study. 
Particularly, the combination of both techniques represented a valuable methodology, 
specifically due to the great improvement in identifying those less prevalent species, 
such as potential bacteria from an oral origin. 
 
The advent of new technologies such as next-generation sequencing allows a great 
leap forward in the analysis of complex microbial ecosystems (Snyder et al., 2009). 
The use of this technology to evaluate samples of NGA would not only allow the 
identification of the numbers and types of bacteria present in these complex samples, 
but also to better understand the pathophysiology of diseases and maternal 
susceptibility as regards APO. Nevertheless, the adjunctive use of a more sensitive 
quantitative technique, q-PCR, as used in this study provided an important 
contribution to the analysis of specific periodontal pathogens in the samples of NGA. 
In this context, next-generation sequencing technology does not yet provide a 
quantitative approach. Therefore, quantitative analysis remains the best approach for 
the measurement of levels of pathogens in neonatal samples (NGA). These estimates 
are particularly important in evaluating the clinical relevance of the bacteria in the 
complications since they allow quantification and also determination of the relative 
amounts of the total bacteria load. 
 
The use of a species-specific and more sensitive technique also allowed a better 
understanding of the origin of the bacteria present in the samples. For example, using 
a detection limit of 500 cells/ml for identification of general bacteria, it could be 
inferred that higher levels of vaginal bacteria present in the samples of NGA were 
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most likely to be introduced into the uterine cavity during labour due to a suction-
like effect rather that from the birth canal (Seong et al., 2008). An association with 
increase in gestational age at delivery and a lack of association with vaginal delivery 
when a detection limit was included supports this theory. This observation could 
explain presence of common vaginal strains in the samples obtained from Caesarean 
section deliveries, possibly acquired during labour. However, levels of bacteria in the 
birth canal during diseases such as BV may be altered. Therefore, in order to 
understand these associations, initiation of labour and diagnosis of BV should be 
investigated in further studies. 
 
Of particular note, the use of a quantitative approach compared to the other method 
used allowed periodontal pathogens to be identified at a higher prevalence in the 
NGA samples. Prevalence of F. nucleatum and G. elegans was increased when 
compared to the end-point broad-range approach (clone analysis and DGGE), and P. 
gingivalis was for the first time detected in a relatively high percentage in two 
samples.  In addition, absence of A. actinomycetemcomitans and T. forsythia in the 
neonatal samples was demonstrated. In general, even though the main pathogens 
associated with PD possess the mechanisms and virulence factors to translocate 
haematogenously, they were not commonly found in the samples of NGA samples. 
Conversely, F. nucleatum was observed at high prevalence and in high levels in the 
NGA; and P. gingivalis was observed in association with F. nucleatum. This 
indicates that F. nucleatum may not only be able to translocate haematogenously as 
extensively demonstrated previously; but may also serve as a bridge to assist other 
pathogens to invade and proliferate within the amniotic tissues. Co-migration 
properties between F. nucleatum and P. gingivalis have been demonstrated 
previously in cell culture (Saito et al., 2008), and their joint mechanisms in APO 
should be further investigated in animal studies. 
 
Levels of the periodontal pathogens in the maternal oral cavity and vagina were also 
measured in this study. Their prevalence varied in the oral cavity: T. forsythia was 
observed in 100% of the oral samples, A. actinomycetemcomitans and P. gingivalis 
in 21%; and G. elegans in only 10% of maternal oral samples. Only F. nucleatum 
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was found to be present in the vaginal samples from women. G. elegans should be 
further analysed; as this was identified in 5 (8.6%) samples of NGA using both the 
broad-range and specific approaches. This oral pathogen has not been previously 
reported as a common inhabitant of any non-oral site in health but has been involved 
in several cases of infective endocarditis (Ohara-Nemoto et al., 2005). In this study, 
only a small number of samples could be evaluated for G. elegans. As observed, it 
was presented in low amounts and less than 1% of the total bacterial load in the oral 
cavity, and also at very low levels in the vagina (less than 0.01%). Further studies 
should include controlled studies in animal models, as well as using a higher number 
of neonatal and maternal samples to explore possible translocation of this potential 
oral pathogen. 
 
Particular attention was given to F. nucleatum as this and previous studies strongly 
support its potential ability to translocate and cause APO (Han et al., 2004, Liu et al., 
2007). In this study, the F. nucleatum in NGA closely resembled the strain(s) 
obtained from the oral cavity. This was demonstrated using two different 
methodologies. First, by means of direct sequencing to compare fusobacterial 
subspecies amplified from paired samples from the infant and the respective mother. 
Subspecies of F. nucleatum in neonates demonstrated a better agreement with the 
strains in the maternal oral cavity (F. nucleatum subsp. polymorphum, vincentii, and 
nucleatum) in contrast to F. nucleatum subsp. animalis which was more commonly 
present in the vagina. The sequence alignment comparison between the strains of 
Case 54 confirmed this. Secondly, with the analysis of the ISR obtained from the 
different clones/operons of each sample, Case 10 demonstrated sequence agreement 
between the neonatal and the oral F. nucleatum strains. Furthermore, a phylogenetic 
analysis clearly illustrated that the NGA strain may have originated from the oral 
cavity and not from the vagina.  
 
It remains to be determined from analysis of a greater number of samples as to 
whether the vagina may also represent a reservoir for fusobacterial species that are 
able to translocate to the neonates.  Besides, it would be of great interest to determine 
the proportion of mothers who can transmit to their infants (either oral or vaginal 
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strains), the proportion of mothers who possess the strains but do not transmit to their 
infant, and also the proportions of mothers not presenting with the suspected species 
but with a positive result in the infant. Finally, it will be interesting to explore those 
factors possibly involved in the association. 
 
It can be inferred from the data that women who smoke during pregnancy may be at 
a higher risk of an intrauterine fusobacterial infection, since association with levels 
of general bacteria and F. nucleatum was observed with smoking in this study. 
Presence of periodontal pockets may represent another risk factor, since woman with 
pockets demonstrated higher levels of F. nucleatum in NGA. However, other 
parameters such as plaque levels or bleeding on probing should be investigated along 
with translocation, since periodontitis was not found to be a condition required for 
potential transmission of bacteria. Other potential ways of translocation were 
evaluated, such as oro-genital contact during pregnancy. Even though there was not 
an association with the presence of F. nucleatum in the vagina, most of the women 
whose infants contained F. nucleatum admitted having oro-genital sexual contact 
during pregnancy. Nevertheless, no other potential periodontal bacteria were 
observed in the vagina of women reporting as having had oro-genital contact during 
pregnancy. Transmission of periodontal bacteria during oro-genital contact is 
therefore not supported in this study. 
 
Furthermore, it remains unclear if a 100% genetic match between a strain found at 
two different sites should be expected in order to unequivocally determine origin. In 
this study a 100% match was never observed between all strains examined. The 
complexity with respect to the number of rrn operons may represent a limiting 
factor, and therefore requires the need to analyse a greater number of clones. To 
avoid this disadvantage, analysis of a gene that exists in a single copy should be 
considered as an alternative. In any case, it is clear that there is a great need to 
increase generally the sequence information regarding F. nucleatum from a range of 
different strains. It should be advantageous if an agreement of data accessible from 
the different libraries available could be achieved. The recent developing 
technologies, such as next-generation sequencing, will help to ensure an exponential 
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increase in the current data regarding this and other bacterial species. The diversity 
of F. nucleatum subspecies, strains and rrn operons could then be favourably used to 
characterise patterns of strains of F. nucleatum in different body sites. For example, 
the analysis of agarose gel bands could be better evaluated as a tool for typing F. 
nucleatum strains. 
 
Finally, it remains to investigate whether a direct mechanism involving entry of the 
infectious agents into the amniotic cavity can influence parturition through a local 
elevation of mediators regardless of the origin of the pathogen, or if the 
inflammatory response may differ considerably towards the bacterial species 
involved. It has been suggested that inflammatory responses vary in intensity 
depending on the pathogen(s) implicated in the intra-amniotic infection (Oh et al., 
2010). This is mainly due to their individual differences in structure, pathogenicity, 
mechanisms of host invasion and colonisation patterns. Hence, it is critically 
important to understand the individual potential to induce the release of 
inflammatory mediators, specifically those that have been indicated to play a central 
role in the induction of parturition (IL-1β, IL-6, IL-8) (Kamel, 2010). For example, 
in a previous study, the inflammation caused by F. nucleatum, rather than the 
bacterial colonisation, was shown to stimulate the TLR4-mediated placental 
inflammatory response causing fetal death in mice (Liu et al., 2007). This could be 
further evaluated in tissue culture studies, and cytokine profile analysis in animal 
models and clinical cases. It is likely that a combination of pathogens, rather than a 
single strain increases the risk for APO through an additive effect. 
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Redbridge & Waltham Forest Local Research Ethics Committee 
Board Room A 
2nd Floor 
Becketts House 
2/14 Ilford Hill 
Ilford 
Essex 
IG1 2QX 
 
Telephone: 0208 9265025  
Facsimile: 0208 926 5009  
22 August 2008 
 
Dr. Cecilia Gonzales-Marin 
MPhil/PhD Student. Research in Dental Institute 
Queen Mary, University of London 
4 Newark Street 
London 
E1 2AT 
 
 
Dear Dr. Gonzales-Marin 
 
Full title of study: Possible Association between the Oral 
Microflora and Adverse Pregnancy and/or 
Neonatal Outcomes 
REC reference number: 08/H0701/61 
 
Thank you for your letter of 20 August 2008, responding to the Committee’s request 
for further information on the above research and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by the Chair 
on the 21st August 2008  
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for 
the above research on the basis described in the application form, protocol and 
supporting documentation as revised, subject to the conditions specified below. 
 
Ethical review of research sites 
 
The favourable opinion applies to the research sites listed on the attached form. 
 
Conditions of the favourable opinion 
 
The favourable opinion is subject to the following conditions being met prior to the 
start of the study. 
 
Management permission or approval must be obtained from each host organisation 
prior to the start of the study at the site concerned. 
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Management permission at NHS sites (“R&D approval”) should be obtained from 
the relevant care organisation(s) in accordance with NHS research governance 
arrangements.  Guidance on applying for NHS permission is available in the 
Integrated Research Application System or at http://www.rdforum.nhs.uk. 
 
 
Approved documents 
 
The final list of documents reviewed and approved by the Committee is as follows: 
  
Document    Version    Date    
Application  2.2  21 July 2008  
Application  1  24 April 2008  
Investigator CV    24 April 2008  
Protocol  2.2  21 July 2008  
Protocol  2.1  23 April 2008  
Covering Letter  1  12 May 2008  
Covering Letter  1  20 August 2008  
Letter from Sponsor  1  07 May 2008  
Peer Review  1  21 April 2008  
Statistician Comments  1  14 April 2008  
Compensation Arrangements  1  07 May 2008  
Questionnaire  1     
Questionnaire  2.2  21 July 2008  
Participant Information Sheet  2.2  21 July 2008  
Participant Information Sheet  2.1  23 April 2008  
Participant Information Sheet  2.2  21 July 2008  
Participant Consent Form  2.2  21 July 2008  
Participant Consent Form  2.1  23 April 2008  
Response to Request for Further Information  1  21 July 2008  
Response to Request for Further Information  2  20 August 2008  
interactive material   2.2  21 July 2008  
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard 
Operating Procedures for Research Ethics Committees in the UK. 
 
After ethical review 
 
Now that you have completed the application process please visit the National 
Research Ethics Website > After Review  
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You are invited to give your view of the service that you have received from the 
National Research Ethics Service and the application procedure.  If you wish to make 
your views known please use the feedback form available on the website. 
 
The attached document “After ethical review – guidance for researchers” gives 
detailed guidance on reporting requirements for studies with a favourable opinion, 
including: 
 
• Notifying substantial amendments 
• Progress and safety reports 
• Notifying the end of the study 
 
The NRES website also provides guidance on these topics, which is updated in the 
light of changes in reporting requirements or procedures. 
 
We would also like to inform you that we consult regularly with stakeholders to 
improve our service. If you would like to join our Reference Group please email 
referencegroup@nres.npsa.nhs.uk. 
 
 
08/H0701/61 Please quote this number on all 
correspondence 
 
With the Committee’s best wishes for the success of this project 
 
Yours sincerely 
 
 
 
Rev. Dr Joyce Smith 
Chair 
 
Email: janet.carter@redbridge-pct.nhs.uk 
 
 
Enclosures: “After ethical review – guidance for researchers” [SL- 
AR2 for other studies]  
Site approval form 
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Outer North East London Research Ethics Committee 
Board Room A 
2nd Floor 
Becketts House 
2/14 Ilford Hill 
Ilford 
Essex 
IG1 2QX 
 
Tel: 0208 9265025 
Fax: 0208 926 5009  
 
29th October 2009  
 
 
Dr. C. Gonzales-Marin 
Research in Dental Institute 
Queen Mary University of London 
4 Newark Street 
LONDON E1 2AT  
 
 
Dear  Dr. Gonzales-Marin  
 
Study title: Possible Association between the Oral 
Microflora and Adverse Pregnancy and/or 
Neonatal Outcomes 
REC reference: 08/H0701/61 
Amendment number: 1 
Amendment date: 22 July 2009 
 
Further to my email today.  I am pleased to confirm that the Chair approved the 
amended documents submitted and I all conditions of the favourable opinion for this 
amendment have been met.       
 
Ethical opinion 
 
The amendment is approved. 
 
The Committee looks forward to receiving a report of your research findings in due 
course. 
 
With best wishes 
 
Yours sincerely 
 
 
Janett Carter 
Coordinator ONEL RE
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CONSENT FORM  (Version 2.2   Dated  21/07/08) 
 
Title of project:  Possible Involvement of the Oral Microbiota in Pregnancy 
Complications 
REC Number: 08/H0701/61 
Investigator:  Dr. Cecilia Gonzales-Marin 
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 Patient Identification Number for this trial: 
 
Please initial box to indicate agreement 
 
 
1.
I confirm that I have read and understand the Information Sheet 
dated 21/07/08 (version 2.2) for the above study. I have had the 
opportunity to consider the information, ask questions and have 
had these answered satisfactorily. 
 
 
 
2.
I understand that my participation is voluntary and that I am free to 
withdraw from the study at any time, without giving any reason, 
without my medical care or legal rights being affected.  
 
 
3.
I understand that relevant sections of any of my medical notes and 
data collected during the study may be looked at by responsible 
individuals from the Barts and the London/ Queen Mary University 
of London, where it is relevant to my taking part in this research.  I 
give permission for these individuals to have access to my 
records. 
 
 
4. I agree to my GP being informed of my participation in the study. 
 
 
5.
I give consent to the research group responsible for this study to 
obtain a surplus of my baby’s sample of gastric aspirate to be 
used for this study. 
 
 
6.
I agree to be examined with respect to the health of my mouth and 
to contribute with samples of dental plaque, tongue surface 
brushing/ gentle scraping and saliva. 
 
 
7. I agree to contribute a vaginal swab for the study.  
8.
I agree to complete the questionnaire provided and I give consent 
to the research team to access the information from my medical 
records as well as from my baby’s medical records. 
 
 
9.
I agree to the use of an audio record during my evaluation. I 
understand that this will be only for the evaluator’s aid to register 
my mouth health status information and that the examiner will not 
record any response, conversation or data using the audio record. 
I understand that the record will be destructed immediately after 
the information has been transferred to the appropriate chart. 
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10. I agree to take part in the above study. 
 
 
 
 
 
________________________ _____________                ___________ 
Name of Participant      Signature      Date        
 
________________________ _____________                ___________ 
Name of Interpreter (if required)      Signature      Date 
 
_________________________ _____________                ___________ 
Name of Person taking consent       Signature       Date 
(Investigator) 
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           Patient Identification Number for this trial: 
 
POSSIBLE ASSOCIATION BETWEEN THE ORAL MICROBIOTA AND 
ADVERSE PREGNANCY AND/OR NEONATAL OUTCOMES 
 
 
Please answer the following questions           Date: …………………... 
        
Please tick the box with a black pen   
 
 
Smoking and Drinking 
 
1 Do you smoke cigarettes now? 
 
Yes   No   (if no please go to Q.3) 
 
2 If yes, how many manufactured cigarettes do you smoke in a day? 
 
• Not every day, only  occasionally   
• Less than 5 per day     
• 5-10 per day      
• 11-20 per day     
• Over 20 per day     
 
(Now go to Q.6) 
 
3 If not a present smoker, did you smoke in the past? 
 
Yes   No   (if no please go to Q.7) 
 
4 If yes, how many manufactured cigarettes did you smoke per day? 
 
• Not every day, only  occasionally   
• Less than 5 per day     
• 5-10 per day      
• 11-20 per day     
• More that 20 per day    
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5 How old were you when you stopped smoking? 
 
……………… years. 
 
6 How old were you when you started smoking? 
 
……………… years. 
 
7 In the past 12 months have you taken an alcoholic drink? 
 
• No      
• Special occasions only  
• Once or twice a month  
• Once or twice a week  
• Twice a day or more  
• Almost daily    
 
 
8 Compared to 1 year ago do you now drink: 
 
• None at all (non drinker)  
• The same    
• A lot less    
• A lot more    
• A bit less    
• A bit more    
 
9 If you have given up or reduced drinking what was the main reason? 
 
• Illness/doctor’s orders  
• Health precautions   
• Pregnancy    
• Finance    
• Other     
• Non drinker        (if non drinker go to Q. 12) 
 
Please specify other reasons………………………………………………. 
………………………………………………………………………………… 
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10 When you drink spirits or wine how many drinks do you usually have 
during the occasion? (1 unit of alcohol being equal to 1 glass of wine) 
 
• 1-2 units     
• 3-4 units     
• 5+ units     
• I don’t drink spirits or wine   
 
 
11 If you do not drink spirits or wine and maybe drink beer instead, how 
many pints do you have during one occasion? 
 
• 1-2 pints   
• 3-4 pints   
• 5+ pints   
• I don’t drink beer  
 
 
Illness and medication during pregnancy 
 
12 Have you had any urinary tract infections (e.g. cystitis) during your 
pregnancy? 
 
Yes       No      (if no please go to Q.15) 
 
  No treatment/medication        
Treatment with medication      
 
13 Have you received any medication during this pregnancy? 
 
• No    
• Once    
• 2-4 times   
• more that 4 times  
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14 Did you receive any of the following medication during this pregnancy? 
 
No   Yes  
 
• Vitamin/iron supplements  
• Antibiotics    
• Topical creams   
• Other medication   
 
 
Dental treatment 
 
15 How often do you visit the dentist? 
 
• Never      
• Regularly once every six months  
• Regularly once a year   
• Only when in pain    
• Only when pregnant   
 
 
16 When did you last visit a dentist? 
 
• I have never visit the dentist     
• Within the last 3 months      
• Within this pregnancy but more than 3 months ago  
• More than 1 year ago      
• More than 5 years ago      
 
 
17 The last time you visited the dentist was it for: 
     (If last visit was during pregnancy, please refer to it and explain reason 
and treatment received) 
 
• No visit     
• A check up     
• Some trouble with your teeth  
• Some trouble with your gums  
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• Other (please specify)      
…………………………………………………………………………………… 
 
18 How often do you visit the dental hygienist? 
 
• Never        
• Regularly once every six months   
• Regularly once a year    
• I went during this pregnancy   
 
19 What treatment did the dental hygienist give you at the last visit? 
 
• Oral hygiene instruction   
• Polish your teeth    
• Scale your teeth    
• Hygiene instruction + polish  
• Scale and polish    
• Hygiene instruction + scale  
• All      
• No visit     
 
20 How often do you clean your teeth nowadays? 
 
• Never     
• Less than once a day  
• Once a day    
• Twice a day    
• More than twice a day  
• Other (please specify) …………………………………..  
 
21 Do you use anything other than an ordinary toothbrush and toothpaste 
for cleaning your teeth? 
 
Yes   No  
 
• Interdental brush    
• Dental floss     
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• Toothpicks     
• Chewing sticks    
• Mouthwash (please specify)     …………………………….. 
• Other (please specify)               ..…………………………... 
 
Diet 
 
22 Were there any particular foods you avoided during your pregnancy? 
 
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
 
23 Did you eat any particular foods more often than the normal during 
your pregnancy? 
 
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
Paan      
 
Yes             No 
 
24 Have you ever been a regular paan chewer?       
 
25 Do you add tobacco to your paan?        
 
26 Have you ever chewed paan with tobacco?      
 
27 Do you chew paan with tobacco at all nowadays?      
 
28 How many paan with tobacco do you usually chew each day? 
 
……………………………………………………………………………… 
 
(If not a paan with tobacco chewer, please go to Q. 31) 
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29 How soon after waking do you usually chew your first paan with 
tobacco of the day? 
 
• Less than 5 minutes  
• 5-15 minutes    
• 15-30 minutes   
• minutes-1 hour   
• 1-2 hours    
• more than 2 hours   
 
30 How many paan with tobacco have you chewed so far today? 
 
• Less than 5 per day   
• 5-110 per day   
• 11-20 per day   
• Over 20 per day   
 
 
Ante-natal Care 
 
31 Have you had ante-natal care? 
 
• GMP    
• Hospital/GMP  
• Hospital only   
• Ante-natal classes  
• None    
 
32 When did you start ante-natal care? 
 
• Before 20 weeks  
• 20-25 weeks   
• After 25 weeks  
• No care   
 
33 Do you remember your weight before this pregnancy? …………. Kg 
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34 Were you in the unfortunately situation of facing a stressful life event 
during this pregnancy? 
 
 
• Domestic violence     
• Close family death or serious disease  
• Separation/Divorce     
• Insecurity over food/home    
• Stress at work       
• Extent physical activity    
• No       (If no please go to Q.35) 
• Other  ………………………………………………………………… 
 
35 If yes, when during the pregnancy did the situation happen or start? 
 
• During first three months     
• After 3rd month and before 6th month    
• During last three months     
 
 
 
Paternal information 
 
36 How old is this infant’s father? 
 
…………………. years. 
 
37 What is your actual relationship with this infant’s father? 
 
• Married      
• Not-married but live together   
• Separated/Divorced     
• Not together, I have another partner  
• Other 
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38 During pregnancy, did you have sexual relations with the infant’s 
father/ or actual partner? 
 
No   Yes  
 
39 Did you perform any oral-genital contact during sexual relationship 
with your partner? 
 
No   Yes  
 
 
Socio-demographic characteristics 
 
40 Which category best describe you (your race or ethic group)? 
 
• Asian British    
• Asian Indian    
• Asian Bangladeshi      
• Asian Pakistani    
• Asian Middle East/Arab  
• Asian Chinese    
• Asian Japanese    
• Black British    
• Black European    
• Black Caribbean    
• Black American    
• Latino     
• White British   
• White West European  
• White Mediterranean  
• White North American  
• White Latin American  
• Mixed Asian/White  
• Mixed Black/White  
• Mixed Asian/Black  
• Other Mixed   
• Other (specify)   
 
               ………………………..
ANNEX 4 
 
 
      
QUESTIONNAIRE  (Version 2.2   Dated  21/07/08) 
Title of project:  Possible Involvement of the Oral Microbiota in Pregnancy 
Complications 
REC Number: 08/H0701/61 
Investigator:  Dr. Cecilia Gonzales-Marin                
266 
 
 
41 Which type of schools did you attend? 
 
• Primary   
• Secondary   
• College/University  
• None    
 
 
42 Please indicate your date of birth (dd/mm/yyyy) 
 
 
 
 
 
 
 
Thank you for your help. 
 
 
 
________________________ _____________                ___________ 
Name of Participant Signature Date  
 
 
________________________ ______________                ___________ 
Name of Interpreter (if required) Signature Date 
 
 
_________________________ _____________                ___________ 
Name of Person taking consent Signature Date 
(Investigator) 
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HOW TO COLLECT A SELF-TAKEN VAGINAL SWAB 
 
 
You can take the sample lying down with 
your legs apart, sitting down with your 
knees spread apart, 
or standing with one foot on a chair. 
 
 
Please read the following instructions 
before taking the swab: 
 
1. Wash your hands  
Wash your hands thoroughly and rub 
them with the antiseptic provided, before 
and after taking your vaginal swab. 
 
2. If you have never used a tampon… 
You may feel more comfortable if you are 
familiar with where the swab will be 
going. Using your fingers, feel your labia 
(the lips or folds of skin which cover the 
entrance to your vagina). When you have 
done this, you can gently part your labia 
and feel the entrance to your vagina. This 
is where the swab will be inserted. 
 
3. Take the swab out of its packaging 
Peel apart the plastic wrapping from the 
end that is indicated and take the swab 
out.  
Hold it at the end trying NOT to touch the 
‘cotton-bud’ tip end. 
You can ask for another swab if you make 
a mistake. 
 
4. Remove the swab 
Gently remove the swab, trying not to 
touch any other part of your body, as you 
may collect other bacteria by mistake! 
 
 
 
5. You are now ready to take the 
vaginal swab 
Holding the swab by its plastic lid end, 
gently part your labia. Guide the swab 
into your vagina. It will easily insert 
several centimetres – aim for about half of 
its length. This should not be 
uncomfortable. Once the swab is 
comfortable inside, turn it around five 
times. 
 
 
 
6. Open the plastic tube 
DO NOT put the swab down –continue 
holding it 
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7. Re-insert the swab into the plastic 
tube. 
Take the cap off the clear tube. 
Immediately, place the swab into the 
plastic tube with the end sitting in the 
liquid in the bottom of the tube. 
 
 
 
8. Return the swab to the person 
responsible for the study. 
 
 
 
 
Thank you for your help in 
this study! 
 
 
 
